Table of Contents

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Form 10-Q
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended June 30, 2012
Commission file number 001-15925
COMMUNITY HEALTH SYSTEMS, INC.
(Exact name of registrant as specified in its charter)

Delaware	 	13-3893191	
(State or other jurisdiction of
incorporation or organization)	 	(I.R.S. Employer
Identification Number)	
 	 	
4000 Meridian Boulevard
Franklin, Tennessee	 	37067
(Zip Code)	
(Address of principal executive offices)	 	 	
615-465-7000
(Registrant’s telephone number)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes  þ     No  ¨
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  Yes  þ     No  ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer þ	 	Accelerated filer ¨	 	Non-accelerated filer ¨	 	Smaller reporting company ¨	
                             (Do not check if a smaller reporting company)	
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes  ¨  No þ
As of July 19, 2012, there were outstanding 90,963,226 shares of the registrant’s Common Stock, $0.01 par value.

 

Table of Contents
Community Health Systems, Inc.
Form 10-Q
For the Three and Six Months Ended June 30, 2012

Part I.	 	Financial Information	  	Page	
 	 	 	
 	 	Item 1.	  	Financial Statements:	
 	 	 	 	
 	 	 	  	Condensed Consolidated Balance Sheets - June 30, 2012 and December 31, 2011 (Unaudited)	  	2	
 	 	 	 	
 	 	 	  	Condensed Consolidated Statements of Income - Three and Six Months Ended June 30, 2012 and June 30, 2011 (Unaudited)	  	3	
 	 	 	 	
 	 	 	  	Condensed Consolidated Statements of Comprehensive Income - Three and Six Months Ended June 30, 2012 and June 30, 2011 (Unaudited)	  	4	
 	 	 	 	
 	 	 	  	Condensed Consolidated Statements of Cash Flows - Six Months Ended June 30, 2012 and June 30, 2011 (Unaudited)	  	5	
 	 	 	 	
 	 	 	  	Notes to Condensed Consolidated Financial Statements (Unaudited)	  	6	
 	 	 	 	
 	 	Item 2.	  	Management’s Discussion and Analysis of Financial Condition and Results of Operations	  	44	
 	 	 	 	
 	 	Item 3.	  	Quantitative and Qualitative Disclosures about Market Risk	  	64	
 	 	 	 	
 	 	Item 4.	  	Controls and Procedures	  	64	
 	 	
Part II.	 	Other Information	
 	 	 	 	
 	 	Item 1.	  	Legal Proceedings	  	65	
 	 	 	 	
 	 	Item 1A.	  	Risk Factors	  	70	
 	 	 	 	
 	 	Item 2.	  	Unregistered Sales of Equity Securities and Use of Proceeds	  	70	
 	 	 	 	
 	 	Item 3.	  	Defaults Upon Senior Securities	  	70	
 	 	 	 	
 	 	Item 4.	  	Mine Safety Disclosures	  	70	
 	 	 	 	
 	 	Item 5.	  	Other Information	  	70	
 	 	 	 	
 	 	Item 6.	  	Exhibits	  	71	
 	 	 	 	
Signatures	 	 	  	 	  	72	
 	 	
Index to Exhibits	  	73	
 
1

Table of Contents
PART I FINANCIAL INFORMATION
Item 1.  Financial Statements
COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, except share data)
(Unaudited)

 	  	        June 30,        
2012	 	 	        December 31,         
2011	 	
ASSETS	  	 	 	 	 	 	 	 	
Current assets	  	 	 	 	 	 	 	 	
Cash and cash equivalents	  	$	115,109 	 	 	$	129,865 	 	
Patient accounts receivable, net of allowance for doubtful accounts of $2,105,051 and $1,891,334 at June 30, 2012 and December 31, 2011, respectively	  	 	2,055,292 	 	 	 	1,834,167 	 	
Supplies	  	 	358,597 	 	 	 	346,611 	 	
Prepaid income taxes	  	 	16,721 	 	 	 	101,389 	 	
Deferred income taxes	  	 	89,797 	 	 	 	89,797 	 	
Prepaid expenses and taxes	  	 	126,883 	 	 	 	112,613 	 	
Other current assets	  	 	234,764 	 	 	 	231,647 	 	
 	  	 	 	 	 	 	 	 	
Total current assets	  	 	2,997,163 	 	 	 	2,846,089 	 	
 	  	 	 	 	 	 	 	 	
Property and equipment	  	 	9,808,757 	 	 	 	9,369,528 	 	
Less accumulated depreciation and amortization	  	 	(2,760,532)	  	 	 	(2,513,552)	  	
 	  	 	 	 	 	 	 	 	
Property and equipment, net	  	 	7,048,225 	 	 	 	6,855,976 	 	
 	  	 	 	 	 	 	 	 	
Goodwill	  	 	4,372,993 	 	 	 	4,264,845 	 	
 	  	 	 	 	 	 	 	 	
Other assets, net	  	 	1,454,625 	 	 	 	1,241,930 	 	
 	  	 	 	 	 	 	 	 	
Total assets	  	$	15,873,006 	 	 	$	15,208,840 	 	
 	  	 	 	 	 	 	 	 	
LIABILITIES AND EQUITY	  	 	 	 	 	 	 	 	
Current liabilities	  	 	 	 	 	 	 	 	
Current maturities of long-term debt	  	$	83,877 	 	 	$	63,706 	 	
Accounts payable	  	 	770,450 	 	 	 	748,997 	 	
Accrued interest	  	 	82,742 	 	 	 	110,121 	 	
Accrued liabilities	  	 	962,056 	 	 	 	988,315 	 	
 	  	 	 	 	 	 	 	 	
Total current liabilities	  	 	1,899,125 	 	 	 	1,911,139 	 	
 	  	 	 	 	 	 	 	 	
Long-term debt	  	 	9,241,489 	 	 	 	8,782,798 	 	
 	  	 	 	 	 	 	 	 	
Deferred income taxes	  	 	704,725 	 	 	 	704,725 	 	
 	  	 	 	 	 	 	 	 	
Other long-term liabilities	  	 	998,984 	 	 	 	949,990 	 	
 	  	 	 	 	 	 	 	 	
Total liabilities	  	 	12,844,323 	 	 	 	12,348,652 	 	
 	  	 	 	 	 	 	 	 	
Redeemable noncontrolling interests in equity of consolidated subsidiaries	  	 	367,909 	 	 	 	395,743 	 	
 	  	 	 	 	 	 	 	 	
EQUITY	  	 	 	 	 	 	 	 	
Community Health Systems, Inc. stockholders’ equity	  	 	 	 	 	 	 	 	
Preferred stock, $.01 par value per share, 100,000,000 shares authorized; none issued	  	 	-	  	 	 	-	  	
Common stock, $.01 par value per share, 300,000,000 shares authorized; 91,917,432 shares issued and 90,941,883 shares outstanding at June 30, 2012, and 91,547,079 shares issued and 90,571,530 shares outstanding at December 31, 2011	  	 	919 	 	 	 	915 	 	
Additional paid-in capital	  	 	1,101,224 	 	 	 	1,086,008 	 	
Treasury stock, at cost, 975,549 shares at June 30, 2012 and December 31, 2011	  	 	(6,678)	  	 	 	(6,678)	  	
Accumulated other comprehensive loss	  	 	(159,546)	  	 	 	(184,479)	  	
Retained earnings	  	 	1,660,163 	 	 	 	1,501,330 	 	
 	  	 	 	 	 	 	 	 	
Total Community Health Systems, Inc. stockholders’ equity	  	 	2,596,082 	 	 	 	2,397,096 	 	
Noncontrolling interests in equity of consolidated subsidiaries	  	 	64,692 	 	 	 	67,349 	 	
 	  	 	 	 	 	 	 	 	
Total equity	  	 	2,660,774 	 	 	 	2,464,445 	 	
 	  	 	 	 	 	 	 	 	
Total liabilities and equity	  	$	        15,873,006 	 	 	$	15,208,840 	 	
 	  	 	 	 	 	 	 	 	
See accompanying notes to the condensed consolidated financial statements.
 
2

Table of Contents
COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(in thousands, except share and per share data)
(Unaudited)

 	  	        Three Months Ended         
June 30,	 	 	        Six Months Ended         
June 30,	 	
 	  	2012	 	 	2011	 	 	2012	 	 	2011	 	
 	 	 	 	 	
Operating revenues (net of contractual allowances and discounts)	  	$	3,746,428 	 	 	  $	3,433,829 	 	 	$	7,529,919 	 	 	  $	6,787,881 	 	
Provision for bad debts	  	 	503,454 	 	 	 	433,002 	 	 	 	989,910 	 	 	 	832,971 	 	
 	  	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Net operating revenues	  	 	3,242,974 	 	 	 	3,000,827 	 	 	 	6,540,009 	 	 	 	5,954,910 	 	

Operating costs and expenses:	  	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Salaries and benefits	  	 	1,497,446 	 	 	 	1,384,096 	 	 	 	3,022,421 	 	 	 	2,763,463 	 	
Supplies	  	 	489,729 	 	 	 	449,279 	 	 	 	988,308 	 	 	 	907,096 	 	
Other operating expenses	  	 	736,225 	 	 	 	654,737 	 	 	 	1,445,168 	 	 	 	1,269,530 	 	
Electronic health records incentive reimbursement	  	 	(16,802)	  	 	 	-	  	 	 	(42,970)	  	 	 	-	  	
Rent	  	 	66,463 	 	 	 	62,431 	 	 	 	133,687 	 	 	 	125,601 	 	
Depreciation and amortization	  	 	179,801 	 	 	 	161,376 	 	 	 	354,155 	 	 	 	319,531 	 	

Total operating costs and expenses	  	 	2,952,862 	 	 	 	2,711,919 	 	 	 	5,900,769 	 	 	 	5,385,221 	 	
 	  	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Income from operations	  	 	290,112 	 	 	 	288,908 	 	 	 	639,240 	 	 	 	569,689 	 	
Interest expense, net	  	 	151,607 	 	 	 	163,230 	 	 	 	303,782 	 	 	 	326,448 	 	
Loss from early extinguishment of debt	  	 	-	  	 	 	-	  	 	 	63,429 	 	 	 	-	  	
Equity in earnings of unconsolidated affiliates	  	 	(13,181)	  	 	 	(12,017)	  	 	 	(25,194)	  	 	 	(30,151)	  	
 	  	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Income from continuing operations before income taxes	  	 	151,686 	 	 	 	137,695 	 	 	 	297,223 	 	 	 	273,392 	 	
Provision for income taxes	  	 	49,519 	 	 	 	44,821 	 	 	 	95,338 	 	 	 	88,913 	 	
 	  	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Income from continuing operations	  	 	102,167 	 	 	 	92,874 	 	 	 	201,885 	 	 	 	184,479 	 	
 	  	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Discontinued operations, net of taxes:	  	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Income (loss) from operations of entities sold	  	 	-	  	 	 	235 	 	 	 	(466)	  	 	 	(1,443)	  	
Impairment of hospitals sold	  	 	-	  	 	 	(39,562)	  	 	 	-	  	 	 	(47,930)	  	
Loss on sale, net	  	 	-	  	 	 	-	  	 	 	-	  	 	 	(3,234)	  	
 	  	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Loss from discontinued operations, net of taxes	  	 	-	  	 	 	(39,327)	  	 	 	(466)	  	 	 	(52,607)	  	
 	  	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Net income	  	 	102,167 	 	 	 	53,547 	 	 	 	201,419 	 	 	 	131,872 	 	
Less: Net income attributable to noncontrolling interests	  	 	18,808 	 	 	 	18,158 	 	 	 	42,586 	 	 	 	35,159 	 	
 	  	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Net income attributable to Community Health Systems, Inc.	  	$	83,359 	 	 	  $	35,389 	 	 	$	158,833 	 	 	  $	96,713 	 	

Basic earnings (loss) per share attributable to Community Health Systems, Inc. common stockholders(1):	  	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Continuing operations	  	$	0.94 	 	 	  $	0.82 	 	 	$	1.79 	 	 	  $	1.64 	 	
Discontinued operations	  	 	-	  	 	 	(0.43)	  	 	 	(0.01)	  	 	 	(0.58)	  	
 	  	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Net income	  	$	0.94 	 	 	  $	0.39 	 	 	$	1.79 	 	 	  $	1.06 	 	

Diluted earnings (loss) per share attributable to Community Health Systems, Inc. common stockholders(1):	  	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Continuing operations	  	$	0.93 	 	 	  $	0.81 	 	 	$	1.79 	 	 	  $	1.62 	 	
Discontinued operations	  	 	-	  	 	 	(0.43)	  	 	 	(0.01)	  	 	 	(0.57)	  	
 	  	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Net income	  	$	0.93 	 	 	  $	0.39 	 	 	$	1.78 	 	 	  $	1.05 	 	

Weighted-average number of shares outstanding:	  	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Basic	  	 	89,147,472 	 	 	 	91,130,672 	 	 	 	88,911,126 	 	 	 	91,069,876 	 	
 	  	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Diluted	  	 	89,530,639 	 	 	 	91,783,725 	 	 	 	89,191,651 	 	 	 	91,960,610 	 	
 	  	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
(1) Total per share amounts may not add due to rounding.
See accompanying notes to the condensed consolidated financial statements.
 
3

Table of Contents
COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(In thousands)
(Unaudited)

 	  	        Three Months Ended         
June 30,	 	 	        Six Months Ended         
June 30,	 	
 	  	2012	 	 	2011	 	 	2012	 	 	2011	 	
 	 	 	 	 	
Net income	  	$	102,167 	 	 	$	53,547 	 	 	$	201,419 	 	 	$	131,872 	 	
Other comprehensive income (loss), net of income taxes:	  	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Net change in fair value of interest rate swaps	  	 	9,976 	 	 	 	(8,969)	  	 	 	20,512 	 	 	 	27,477 	 	
Net change in fair value of available-for-sale securities	  	 	(527)	  	 	 	268 	 	 	 	2,140 	 	 	 	1,338 	 	
Amortization and recognition of unrecognized pension cost components	  	 	1,140 	 	 	 	807 	 	 	 	2,281 	 	 	 	1,579 	 	
 	  	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Other comprehensive income (loss)	  	 	10,589 	 	 	 	(7,894)	  	 	 	24,933 	 	 	 	30,394 	 	
 	  	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Comprehensive income	  	 	112,756 	 	 	 	45,653 	 	 	 	226,352 	 	 	 	162,266 	 	
Less: Comprehensive income attributable to noncontrolling interests	  	 	18,808 	 	 	 	18,158 	 	 	 	42,586 	 	 	 	35,159 	 	
 	  	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Comprehensive income attributable to Community Health Systems, Inc.	  	$	93,948 	 	 	$	27,495 	 	 	$	183,766 	 	 	$	127,107 	 	
 	  	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
See accompanying notes to the condensed consolidated financial statements.
 
4

Table of Contents
COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
(Unaudited)

 	  	        Six Months Ended June 30,         	 	
 	  	2012	 	 	2011	 	
 	 	 	
Cash flows from operating activities	  	 	 	 	 	 	 	 	
Net income	  	$	201,419 	 	 	$	131,872 	 	
Adjustments to reconcile net income to net cash provided by operating activities:	  	 	 	 	 	 	 	 	
Depreciation and amortization	  	 	354,155 	 	 	 	324,367 	 	
Stock-based compensation expense	  	 	20,624 	 	 	 	20,732 	 	
Loss on sale, net	  	 	-	  	 	 	3,234 	 	
Impairment of hospitals sold	  	 	-	  	 	 	47,930 	 	
Loss from early extinguishment of debt	  	 	63,429 	 	 	 	-	  	
Excess tax benefit relating to stock-based compensation	  	 	(1,037)	  	 	 	(4,659)	  	
Other non-cash expenses, net	  	 	16,461 	 	 	 	4,313 	 	
Changes in operating assets and liabilities, net of effects of acquisitions and divestitures:	  	 	 	 	 	 	 	 	
Patient accounts receivable	  	 	(199,383)	  	 	 	(83,082)	  	
Supplies, prepaid expenses and other current assets	  	 	(39,920)	  	 	 	9,374 	 	
Accounts payable, accrued liabilities and income taxes	  	 	51,843 	 	 	 	129,518 	 	
Other	  	 	15,336 	 	 	 	1,086 	 	
 	  	 	 	 	 	 	 	 	
Net cash provided by operating activities	  	 	482,927 	 	 	 	584,685 	 	

Cash flows from investing activities	  	 	 	 	 	 	 	 	
Acquisitions of facilities and other related equipment	  	 	(245,227)	  	 	 	(204,264)	  	
Purchases of property and equipment	  	 	(386,461)	  	 	 	(351,383)	  	
Proceeds from disposition of ancillary operations	  	 	-	  	 	 	18,464 	 	
Proceeds from sale of property and equipment	  	 	3,437 	 	 	 	8,034 	 	
Increase in other investments	  	 	(162,316)	  	 	 	(75,211)	  	
 	  	 	 	 	 	 	 	 	
Net cash used in investing activities	  	 	(790,567)	  	 	 	(604,360)	  	

Cash flows from financing activities	  	 	 	 	 	 	 	 	
Proceeds from exercise of stock options	  	 	1,269 	 	 	 	18,831 	 	
Repurchase of restricted stock shares for payroll tax withholding requirements	  	 	(9,074)	  	 	 	-	  	
Deferred financing costs	  	 	(63,986)	  	 	 	(234)	  	
Excess tax benefit relating to stock-based compensation	  	 	1,037 	 	 	 	4,659 	 	
Stock buy-back	  	 	-	  	 	 	(50,002)	  	
Proceeds from noncontrolling investors in joint ventures	  	 	637 	 	 	 	863 	 	
Redemption of noncontrolling investments in joint ventures	  	 	(35,888)	  	 	 	(3,303)	  	
Distributions to noncontrolling investors in joint ventures	  	 	(34,590)	  	 	 	(30,078)	  	
Borrowings under credit agreements	  	 	5,244,263 	 	 	 	-	  	
Issuance of long-term debt	  	 	1,025,000 	 	 	 	-	  	
Proceeds from receivables facility	  	 	300,000 	 	 	 	-	  	
Repayments of long-term indebtedness	  	 	(6,135,784)	  	 	 	(28,798)	  	
 	  	 	 	 	 	 	 	 	
Net cash provided by (used in) financing activities	  	 	292,884 	 	 	 	(88,062)	  	

Net change in cash and cash equivalents	  	 	(14,756)	  	 	 	(107,737)	  	
Cash and cash equivalents at beginning of period	  	 	129,865 	 	 	 	299,169 	 	
 	  	 	 	 	 	 	 	 	
Cash and cash equivalents at end of period	  	$	115,109 	 	 	$	191,432 	 	

Supplemental disclosure of cash flow information:	  	 	 	 	 	 	 	 	
Interest payments	  	$	331,161 	 	 	$	327,717 	 	
 	  	 	 	 	 	 	 	 	
Income tax paid (refunds received), net	  	$	22,028 	 	 	$	(25,697)	  	
 	  	 	 	 	 	 	 	 	
See accompanying notes to the condensed consolidated financial statements.
 
5

Table of Contents
COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
1.  BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES
The unaudited condensed consolidated financial statements of Community Health Systems, Inc. and its subsidiaries (the “Company”) as of June 30, 2012 and December 31, 2011 and for the three-month and six-month periods ended June 30, 2012 and June 30, 2011, have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). In the opinion of management, such information contains all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of the results for such periods. All intercompany transactions and balances have been eliminated. The results of operations for the three and six months ended June 30, 2012, are not necessarily indicative of the results to be expected for the full fiscal year ending December 31, 2012. Certain information and disclosures normally included in the notes to consolidated financial statements have been condensed or omitted as permitted by the rules and regulations of the Securities and Exchange Commission (the “SEC”). The Company believes the disclosures are adequate to make the information presented not misleading. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto for the year ended December 31, 2011, contained in the Company’s Annual Report on Form 10-K.
Noncontrolling interests in less-than-wholly-owned consolidated subsidiaries of the parent are presented as a component of total equity on the condensed consolidated balance sheets to distinguish between the interests of the parent company and the interests of the noncontrolling owners. Noncontrolling interests that are redeemable or may become redeemable at a fixed or determinable price at the option of the holder or upon the occurrence of an event outside of the control of the Company are presented in mezzanine equity on the condensed consolidated balance sheets.
Allowance for Doubtful Accounts. In July 2011, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2011-07, which requires healthcare organizations that perform services for patients for which the ultimate collection of all or a portion of the amounts billed or billable cannot be determined at the time services are rendered to present all bad debt expense associated with patient service revenue as an offset to the patient service revenue line item in the statement of operations. The ASU also requires qualitative disclosures about the Company’s policy for recognizing revenue and bad debt expense for patient service transactions and quantitative information about the effects of changes in the assessment of collectibility of patient service revenue. This ASU was adopted by the Company on January 1, 2012. Upon adoption, the Company’s provision for bad debts was presented as a reduction of operating revenues after contractual adjustments and discounts. The condensed consolidated statement of income for the three and six months ended June 30, 2011 has been restated to present the provision for bad debts as a reduction of operating revenues for comparative purposes with the June 30, 2012 presentation.
Accounts receivable are reduced by an allowance for amounts that could become uncollectible in the future. Substantially all of the Company’s receivables are related to providing healthcare services to its hospitals’ patients.
The Company estimates the allowance for doubtful accounts by reserving a percentage of all self-pay accounts receivable without regard to aging category, based on collection history, adjusted for expected recoveries and, if present, anticipated changes in trends. For all other non-self-pay payor categories, the Company reserves 100% of all accounts aging over 365 days from the date of discharge. The percentage used to reserve for all self-pay accounts is based on the Company’s collection history. The Company collects substantially all of its third-party insured receivables, which include receivables from governmental agencies.
Collections are impacted by the economic ability of patients to pay and the effectiveness of the Company’s collection efforts. Significant changes in payor mix, business office operations, economic conditions or trends in federal and state governmental healthcare coverage could affect the Company’s collection of accounts receivable and the estimates of the collectability of future accounts receivable. The process of estimating the allowance for doubtful accounts requires the Company to estimate the collectability of self-pay accounts receivable, which is primarily based on its collection history, adjusted for expected recoveries and, if available, anticipated changes in collection trends. The Company also continually reviews its overall reserve adequacy by monitoring historical cash collections as a percentage of trailing net revenue less provision for bad debts, as well as by analyzing current period net revenue and admissions by payor classification, aged accounts receivable by payor, days revenue outstanding, and the impact of recent acquisitions and dispositions.
 
6

Table of Contents
COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) – (Continued)
 
Operating revenues, net of contractual allowances and discounts (but before the provision for bad debts), recognized during the three and six months ended June 30, 2012 and 2011, were as follows (in thousands):

 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
 	  	        Three Months Ended         
June 30,	 	  	        Six Months Ended         
June 30,	 	
 	  	2012	 	  	2011	 	  	2012	 	  	2011	 	
Medicare	  	$	950,887    	  	  	$	918,669    	  	  	$	2,015,043    	  	  	$	1,842,533    	  	
Medicaid	  	 	396,566    	  	  	 	348,232    	  	  	 	711,657    	  	  	 	669,757    	  	
Managed Care and other third-party payors	  	 	1,911,861    	  	  	 	1,751,817    	  	  	 	3,818,350    	  	  	 	3,451,677    	  	
Self-pay	  	 	487,114    	  	  	 	415,111    	  	  	 	984,869    	  	  	 	823,914    	  	
 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Total	  	$	  3,746,428    	  	  	$	  3,433,829    	  	  	$	    7,529,919    	  	  	$	    6,787,881    	  	
 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Electronic Health Records Incentive Reimbursement. The American Recovery and Reinvestment Act of 2009 included provisions for implementing health information technology under the Health Information Technology for Economic and Clinical Health Act (“HITECH”). These provisions were designed to increase the use of electronic health records (“EHR”) technology and establish the requirements for a Medicare and Medicaid incentive payments program beginning in 2011 for eligible hospitals and providers that adopt and meaningfully use certified EHR technology. Eligibility for annual Medicare incentive payments is dependent on providers demonstrating meaningful use of EHR technology in each period over a four-year period. Initial Medicaid incentive payments are available to providers that adopt, implement or upgrade certified EHR technology; but providers must demonstrate meaningful use of such technology in subsequent years to qualify for additional incentive payments. Medicaid EHR incentive payments are fully funded by the federal government and administered by the states; however, the states are not required to offer EHR incentive payments to providers.
During the three and six months ended June 30, 2012, the Company recognized approximately $16.8 million and $43.0 million, respectively, of incentive reimbursement for HITECH incentives from Medicare and Medicaid related to certain of the Company’s hospitals and from Medicare and Medicaid for certain of the Company’s employed physicians that have demonstrated meaningful use of certified EHR technology or have completed attestations to their adoption or implementation of certified EHR technology. These incentive reimbursements were presented as a reduction of operating expenses on the condensed consolidated statement of income. During the three and six months ended June 30, 2012, the Company received cash related to the incentive reimbursement for HITECH incentives of approximately $22.6 million and $28.8 million, respectively. No incentive reimbursements were recognized during the three-month and six-month periods ended June 30, 2011.
Reimbursement Settlements. Included in net operating revenues for the six months ended June 30, 2012 is approximately $101.8 million of net operating revenues from an industry-wide settlement with the United States Department of Health and Human Services and Centers for Medicare and Medicaid Services, based on a claim that acute-care hospitals in the U.S. were underpaid from the Medicare inpatient prospective payment system in federal fiscal years 1999 through 2011. The underpayments resulted from calculations related to the rural floor budget neutrality adjustments implemented in connection with the Balanced Budget Act of 1997. Also included in net operating revenues for the six months ended June 30, 2012 is an unfavorable adjustment of approximately $21.0 million related to the newly issued Supplemental Security Income ratios for federal fiscal years 2006 through 2009 utilized for calculating Medicare Disproportionate Share Hospital reimbursements.
Throughout these notes to the condensed consolidated financial statements, Community Health Systems, Inc. (the “Parent”), and its consolidated subsidiaries are referred to on a collective basis as the “Company.” This drafting style is not meant to indicate that the publicly-traded Parent or any subsidiary of the Parent owns or operates any asset, business, or property. The hospitals, operations and businesses described in this filing are owned and operated, and management services provided, by distinct and indirect subsidiaries of Community Health Systems, Inc.
2.  ACCOUNTING FOR STOCK-BASED COMPENSATION
Stock-based compensation awards are granted under the Community Health Systems, Inc. Amended and Restated 2000 Stock Option and Award Plan, amended and restated as of March 24, 2009 (the “2000 Plan”), and the Community Health Systems, Inc. 2009 Stock Option and Award Plan, amended and restated as of March 18, 2011 (the “2009 Plan”).
 
7

Table of Contents
COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) – (Continued)
 
The 2000 Plan allows for the grant of incentive stock options intended to qualify under Section 422 of the Internal Revenue Code (the “IRC”), as well as stock options which do not so qualify, stock appreciation rights, restricted stock, restricted stock units, performance-based shares or units and other share awards. Prior to being amended in 2009, the 2000 Plan also allowed for the grant of phantom stock. Persons eligible to receive grants under the 2000 Plan include the Company’s directors, officers, employees and consultants. To date, all options granted under the 2000 Plan have been “nonqualified” stock options for tax purposes. Generally, vesting of these granted options occurs in one-third increments on each of the first three anniversaries of the award date. Options granted prior to 2005 have a 10-year contractual term, options granted in 2005 through 2007 have an eight-year contractual term and options granted in 2008 or later have a 10-year contractual term. As of June 30, 2012, 446,221 shares of unissued common stock were reserved for future grants under the 2000 Plan.
The 2009 Plan provides for the grant of incentive stock options intended to qualify under Section 422 of the IRC and for the grant of stock options which do not so qualify, stock appreciation rights, restricted stock, restricted stock units, performance-based shares or units and other share awards. Persons eligible to receive grants under the 2009 Plan include the Company’s directors, officers, employees and consultants. To date, all options granted under the 2009 Plan have been “nonqualified” stock options for tax purposes. Options granted in 2011 have a 10-year contractual term. As of June 30, 2012, 1,627,477 shares of unissued common stock were reserved for future grants under the 2009 Plan.
The exercise price of all options granted is equal to the fair value of the Company’s common stock on the option grant date.
The following table reflects the impact of total compensation expense related to stock-based equity plans on the reported operating results for the respective periods (in thousands):

 	  	        Three Months Ended         
June 30,	 	  	        Six Months Ended         
June 30,	 	
 	  	2012	 	  	2011	 	  	2012	 	  	2011	 	
Effect on income from continuing operations before income taxes	  	$	      (10,129)	  	  	$	      (10,814)	  	  	$	      (20,624)	  	  	$	      (20,732)	  	
 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Effect on net income	  	$	(6,432)	  	  	$	(6,867)	  	  	$	(13,096)	  	  	$	(13,165)	  	
 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
At June 30, 2012, $54.9 million of unrecognized stock-based compensation expense was expected to be recognized over a weighted-average period of 21 months. Of that amount, $11.0 million related to outstanding unvested stock options was expected to be recognized over a weighted-average period of 20 months and $43.9 million related to outstanding unvested restricted stock and restricted stock units was expected to be recognized over a weighted-average period of 21 months. There were no modifications to awards during the three-month and six-month periods ended June 30, 2012.
The fair value of stock options was estimated using the Black Scholes option pricing model with the following assumptions and weighted-average fair values during the three and six months ended June 30, 2012 and 2011:

 	  	Three Months Ended
June  30,	 	  	Six Months Ended
June  30,	 	
 	  	        2012        	 	  	        2011        	 	  	        2012        	 	  	        2011        	 	
Expected volatility	  	 	59.9 %	  	  	 	38.1 %	  	  	 	57.8 %	  	  	 	31.5%	  	
Expected dividends	  	 	-     	  	  	 	-     	  	  	 	-     	  	  	 	-     	  	
Expected term	  	 	4 years     	  	  	 	4 years     	  	  	 	4.1 years     	  	  	 	4 years     	  	
Risk-free interest rate	  	 	0.6 %	  	  	 	1.4 %	  	  	 	0.7 %	  	  	 	1.7 %	  	
 
8

Table of Contents
COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) – (Continued)
 
In determining the expected term, the Company examined concentrations of option holdings and historical patterns of option exercises and forfeitures, as well as forward-looking factors, in an effort to determine if there were any discernable employee populations. From this analysis, the Company identified two primary employee populations, one consisting of certain senior executives and the other one consisting of substantially all other recipients.
The expected volatility rate was estimated based on historical volatility. In determining expected volatility, the Company also reviewed the market-based implied volatility of actively traded options of its common stock and determined that historical volatility utilized to estimate the expected volatility rate did not differ significantly from the implied volatility.
The expected term computation is based on historical exercise and cancellation patterns and forward-looking factors, where present, for each population identified. The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of the grant. The pre-vesting forfeiture rate is based on historical rates and forward-looking factors for each population identified. The Company adjusts the estimated forfeiture rate to its actual experience.
Options outstanding and exercisable under the 2000 Plan and the 2009 Plan as of June 30, 2012, and changes during each of the three-month periods following December 31, 2011, were as follows (in thousands, except share and per share data):

 	  	        Shares        	 	  	Weighted-Average
Exercise Price	 	  	Weighted-
Average
Remaining
Contractual Term	  	Aggregate
Intrinsic
Value as of
    June 30, 2012     	 	
Outstanding at December 31, 2011	  	 	8,389,142 	  	  	$	32.83 	  	  	 	  	 	 	 	
Granted	  	 	246,500 	  	  	 	21.07 	  	  	 	  	 	 	 	
Exercised	  	 	(17,244)	  	  	 	17.88 	  	  	 	  	 	 	 	
Forfeited and cancelled	  	 	(130,475)	  	  	 	32.27 	  	  	 	  	 	 	 	
 	  	 	 	 	  	 	 	 	  	 	  	 	 	 	
Outstanding at March 31, 2012	  	 	8,487,923 	  	  	 	32.53 	  	  	 	  	 	 	 	
Granted	  	 	4,000 	  	  	 	21.91 	  	  	 	  	 	 	 	
Exercised	  	 	(50,018)	  	  	 	19.20 	  	  	 	  	 	 	 	
Forfeited and cancelled	  	 	(103,448)	  	  	 	33.38 	  	  	 	  	 	 	 	
 	  	 	 	 	  	 	 	 	  	 	  	 	 	 	
Outstanding at June 30, 2012	  	 	8,338,457 	  	  	$	32.59 	  	  	4.8 years	  	$	    15,756            	  	
 	  	 	 	 	  	 	 	 	  	 	  	 	 	 	
Exercisable at June 30, 2012	  	 	6,732,861 	  	  	$	32.67 	  	  	3.9 years	  	$	12,670            	  	
 	  	 	 	 	  	 	 	 	  	 	  	 	 	 	
The weighted-average grant date fair value of stock options granted during the three months ended June 30, 2012 and 2011 was $10.01 and $8.89, respectively, and $9.16 and $10.29 during the six months ended June 30, 2012 and 2011, respectively. The aggregate intrinsic value (the number of in-the-money stock options multiplied by the difference between the Company’s closing stock price on the last trading day of the reporting period ($28.03) and the exercise price of the respective stock options) in the table above represents the amount that would have been received by the option holders had all option holders exercised their options on June 30, 2012. This amount changes based on the market value of the Company’s common stock. The aggregate intrinsic value of options exercised during the three months ended June 30, 2012 and 2011 was $0.3 million and $0.2 million, respectively. The aggregate intrinsic value of options exercised during the six months ended June 30, 2012 and 2011 was $0.4 million and $6.1 million, respectively. The aggregate intrinsic value of options vested and expected to vest approximates that of the outstanding options.
The Company has also awarded restricted stock under the 2000 Plan and the 2009 Plan to its directors and employees of certain subsidiaries. The restrictions on these shares generally lapse in one-third increments on each of the first three anniversaries of the award date. Certain of the restricted stock awards granted to the Company’s senior executives contain a performance objective that must be met in addition to any vesting requirements. If the performance objective is not attained, the awards will be forfeited in their entirety. Once the performance objective has been attained, restrictions will lapse in one-third increments on each of the first three anniversaries of the award date. Notwithstanding the above-mentioned performance objectives and vesting requirements, the restrictions will lapse earlier in the event of death, disability or termination of employment by the Company for any reason other than for cause of the holder of the restricted stock, or change in control of the Company. Restricted stock awards subject to performance standards are not considered outstanding for purposes of determining earnings per share until the performance objectives have been satisfied.
 
9

Table of Contents
COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) – (Continued)
 
Restricted stock outstanding under the 2000 Plan and the 2009 Plan as of June 30, 2012, and changes during each of the three-month periods following December 31, 2011, were as follows:

 	  	        Shares        	 	 	    Weighted-Average    
Grant
Date Fair Value	 	
Unvested at December 31, 2011	  	 	2,207,612 	  	 	$	32.95 	  	
Granted	  	 	660,500 	  	 	 	21.07 	  	
Vested	  	 	(1,082,821)	  	 	 	29.67 	  	
Forfeited	  	 	(1,000)	  	 	 	37.96 	  	
 	  	 	 	 	 	 	 	 	
Unvested at March 31, 2012	  	 	1,784,291 	  	 	 	30.54 	  	
Granted	  	 	8,000 	  	 	 	21.91 	  	
Vested	  	 	(7,001)	  	 	 	29.78 	  	
Forfeited	  	 	(7,000)	  	 	 	31.39 	  	
 	  	 	 	 	 	 	 	 	
Unvested at June 30, 2012	  	 	1,778,290 	  	 	 	30.50 	  	
 	  	 	 	 	 	 	 	 	
Phantom stock and restricted stock units (“RSUs”) have been granted to the Company’s outside directors under the 2000 Plan and the 2009 Plan. On February 25, 2009, each of the Company’s outside directors received a grant under the 2000 Plan of 7,151 shares of phantom stock. On May 19, 2009, the newly elected outside director received a grant under the 2000 Plan of 7,151 RSUs. On February 24, 2010, six of the Company’s seven outside directors each received a grant under the 2000 Plan of 4,130 RSUs and one outside director, who did not stand for reelection in 2010, did not receive such a grant. On February 23, 2011, each of the Company’s outside directors received a grant under the 2009 Plan of 3,688 RSUs. On February 16, 2012, each of the Company’s outside directors received a grant under the 2009 Plan of 6,645 RSUs. Vesting of these shares of phantom stock and RSUs occurs in one-third increments on each of the first three anniversaries of the award date. Restricted stock units and phantom stock outstanding under the 2000 Plan and the 2009 Plan as of June 30, 2012, and changes during each of the three-month periods following December 31, 2011, were as follows:

 	  	        Shares        	 	 	    Weighted-Average    
Grant
Date Fair Value	 	
Unvested at December 31, 2011	  	 	52,956 	  	 	$	31.67 	  	
RSUs Granted February 16, 2012	  	 	39,870 	  	 	 	21.07 	  	
Vested	  	 	(27,556)	  	 	 	28.19 	  	
Forfeited	  	 	- 	  	 	 	- 	  	
 	  	 	 	 	 	 	 	 	
Unvested at March 31, 2012	  	 	65,270 	  	 	 	26.67 	  	
RSUs Granted	  	 	- 	  	 	 	- 	  	
Vested	  	 	(2,384)	  	 	 	25.27 	  	
Forfeited	  	 	- 	  	 	 	- 	  	
 	  	 	 	 	 	 	 	 	
Unvested at June 30, 2012	  	 	62,886 	  	 	 	26.72 	  	

10

Table of Contents
COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) – (Continued)
 
Under the Directors’ Fees Deferral Plan, the Company’s outside directors may elect to receive share equivalent units in lieu of cash for their directors’ fees. These share equivalent units are held in the plan until the director electing to receive the share equivalent units retires or otherwise terminates his/her directorship with the Company. Share equivalent units are converted to shares of common stock of the Company at the time of distribution based on the closing market price of the Company’s common stock on that date. The following table represents the amount of directors’ fees which were deferred during each of the respective periods, and the number of share equivalent units into which such directors’ fees would have converted had each of the directors who had deferred such fees retired or terminated his/her directorship with the Company as of the end of the respective periods (in thousands, except share equivalent units):

 	  	            Three Months Ended             
June 30,	 	 	            Six Months Ended             
June 30,	 	
 	  	        2012        	 	 	        2011        	 	 	        2012        	 	 	        2011        	 	
Directors’ fees earned and deferred into plan	  	$	28 	  	 	$	55 	  	 	$	55 	  	 	$	110 	  	
 	  	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Share equivalent units	  	 	1,237 	  	 	 	2,142 	  	 	 	2,218 	  	 	 	3,517 	  	
 	  	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
At June 30, 2012, a total of 30,993 share equivalent units were deferred in the plan with an aggregate fair value of $0.9 million, based on the closing market price of the Company’s common stock at June 30, 2012 of $28.03.
3.  COST OF REVENUE
Substantially all of the Company’s operating costs and expenses are “cost of revenue” items. Operating costs that could be classified as general and administrative by the Company would include the Company’s corporate office costs at its Franklin, Tennessee office, which were $56.6 million and $47.8 million for the three months ended June 30, 2012 and 2011, respectively, and $104.2 million and $89.5 million for the six months ended June 30, 2012 and 2011, respectively. Included in these amounts is stock-based compensation expense of $10.1 million and $10.8 million for the three months ended June 30, 2012 and 2011, respectively, and $20.6 million and $20.7 million for the six months ended June 30, 2012 and 2011, respectively.
4.  USE OF ESTIMATES
The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements. Actual results could differ from these estimates under different assumptions or conditions.
5.  ACQUISITIONS AND DIVESTITURES
Acquisitions
The Company accounts for all transactions that represent business combinations after January 1, 2009 using the acquisition method of accounting, where the identifiable assets acquired, the liabilities assumed and any noncontrolling interest in the acquired entity are recognized and measured at their fair values on the date the Company obtains control in the acquiree. Such fair values that are not finalized for reporting periods following the acquisition date are estimated and recorded as provisional amounts. Adjustments to these provisional amounts during the measurement period (defined as the date through which all information required to identify and measure the consideration transferred, the assets acquired, the liabilities assumed and any noncontrolling interests has been obtained, limited to one year from the acquisition date) are recorded as of the date of acquisition. Any material impact to comparative information for periods after acquisition, but before the period in which adjustments are identified, is reflected in those prior periods as if the adjustments were considered as of the acquisition date. Goodwill is determined as the excess of the fair value of the consideration conveyed in the acquisition over the fair value of the net assets acquired.
 
11

Table of Contents
COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) – (Continued)
 
Effective March 5, 2012, one or more subsidiaries of the Company completed a merger with Diagnostic Clinic of Longview, P.A., which is a multi-specialty clinic serving residents of Longview, Texas and surrounding East Texas communities. This merger was accounted for as a purchase business combination. The total cash consideration paid for the business, including net working capital, was approximately $52.3 million, with additional consideration of $12.7 million assumed in liabilities, for a total consideration of $65.0 million. Based upon the Company’s preliminary purchase price allocation relating to this acquisition as of June 30, 2012, approximately $41.8 million of goodwill has been recorded. The preliminary allocation of the purchase price has been determined by the Company based on available information and is subject to settling amounts related to purchased working capital. Adjustments to the purchase price allocation are not expected to be material.
Effective March 1, 2012, one or more subsidiaries of the Company completed the acquisition of MetroSouth Medical Center (330 licensed beds) located in Blue Island, Illinois. The total cash consideration paid for fixed assets was approximately $39.3 million with additional consideration of $11.5 million assumed in liabilities as well as a credit applied at closing of $0.9 million for negative acquired working capital, for a total consideration of $49.9 million. Based upon the Company’s preliminary purchase price allocation relating to this acquisition as of June 30, 2012, no goodwill has been recorded. The preliminary allocation of the purchase price has been determined by the Company based on available information and is subject to settling amounts related to purchased working capital and final appraisals of tangible and intangible assets. Adjustments to the purchase price allocation are not expected to be material.
Effective January 1, 2012, one or more subsidiaries of the Company completed the acquisition of Moses Taylor Healthcare System based in Scranton, Pennsylvania, which is a healthcare system comprised of two acute care hospitals and other healthcare providers. This healthcare system includes Moses Taylor Hospital (217 licensed beds) located in Scranton, Pennsylvania, and Mid-Valley Hospital (25 licensed beds) located in Peckville, Pennsylvania. The total cash consideration paid for fixed assets and working capital was approximately $151.1 million and $9.2 million, respectively, with additional consideration of $13.5 million assumed in liabilities, for a total consideration of $173.8 million. Based upon the Company’s preliminary purchase price allocation relating to this acquisition as of June 30, 2012, approximately $54.9 million of goodwill has been recorded. The preliminary allocation of the purchase price has been determined by the Company based on available information and is subject to settling amounts related to purchased working capital and final appraisals of tangible and intangible assets. Adjustments to the purchase price allocation are not expected to be material.
Effective October 1, 2011, one or more subsidiaries of the Company completed the acquisition of Tomball Regional Hospital (358 licensed beds) located in Tomball, Texas. The total cash consideration paid for fixed assets and working capital was approximately $192.0 million and $17.5 million, respectively, with additional consideration of $15.9 million assumed in liabilities, for a total consideration of $225.4 million. Based upon the Company’s final purchase price allocation relating to this acquisition, as of June 30, 2012, approximately $32.4 million of goodwill has been recorded.
Effective May 1, 2011, one or more subsidiaries of the Company completed the acquisition of Mercy Health Partners based in Scranton, Pennsylvania, which is a healthcare system comprised of two acute care hospitals, a long-term acute care facility and other healthcare providers. This healthcare system includes Regional Hospital of Scranton (198 licensed beds) located in Scranton, Pennsylvania, and Tyler Memorial Hospital (48 licensed beds) located in Tunkhannock, Pennsylvania. This healthcare system also includes a long-term acute care facility, Special Care Hospital (67 licensed beds) located in Nanticoke, Pennsylvania, as well as several outpatient clinics and other ancillary facilities. The total cash consideration paid for fixed assets was approximately $150.8 million, with additional consideration of $12.3 million assumed in liabilities as well as a credit applied at closing of $2.1 million for negative acquired working capital, for a total consideration of $161.0 million. Based upon the Company’s final purchase price allocation relating to this acquisition, as of June 30, 2012, approximately $43.1 million of goodwill has been recorded.
Additionally, during the six months ended June 30, 2012, the Company paid approximately $13.2 million to acquire the operating assets and related businesses of certain physician practices, clinics and other ancillary businesses that operate within the communities served by its hospitals. In connection with these acquisitions, the Company allocated approximately $3.4 million of the consideration paid to property and equipment, $0.3 million to net working capital, and the remainder, approximately $9.5 million consisting of intangible assets that do not qualify for separate recognition, was allocated to goodwill. These acquisition transactions were accounted for as purchase business combinations.
Approximately $2.3 million and $5.3 million of acquisition costs related to prospective and closed acquisitions were expensed during the three months ended June 30, 2012 and 2011, respectively, and $6.6 million and $8.7 million for the six months ended June 30, 2012 and 2011, respectively.
 
12

Table of Contents
COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) – (Continued)
 
Discontinued Operations
Effective February 1, 2011, the Company sold Willamette Community Medical Group, which is a physician clinic operating as Oregon Medical Group, located in Springfield, Oregon, to Oregon Healthcare Resources, LLC, for $14.6 million in cash; this business had a carrying amount of net assets, including an allocation of reporting unit goodwill, of $19.7 million.
Effective September 1, 2011, the Company sold SouthCrest Hospital, located in Tulsa, Oklahoma, Claremore Regional Hospital, located in Claremore, Oklahoma, and other related healthcare assets affiliated with those hospitals to Hillcrest Healthcare System, part of Ardent Health Services, for approximately $154.2 million in cash. The carrying amount of the net assets sold in this transaction, including an allocation of reporting unit goodwill, was approximately $193.0 million.
Effective October 22, 2011, the Company sold Cleveland Regional Medical Center, located in Cleveland, Texas, and other related healthcare assets affiliated with the hospital to New Directions Health Systems, LLC for approximately $0.9 million in cash. The carrying amount of the net assets sold in this transaction, including an allocation of reporting unit goodwill, was approximately $14.2 million.
The Company has classified the results of operations for Oregon Medical Group, SouthCrest Hospital, Claremore Regional Hospital and Cleveland Regional Hospital as discontinued operations in the accompanying condensed consolidated statements of income for the three and six months ended June 30, 2012 and 2011.
Net operating revenues and loss from discontinued operations for the respective periods are as follows (in thousands):

 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
 	  	Three Months Ended
June 30,	 	 	Six Months Ended
June 30,	 	
 	  	        2012        	 	 	    2011    	 	 	        2012        	 	 	    2011        	 	

Net operating revenues	  	$	- 	  	 	$	68,479 	  	 	$	- 	  	 	$	140,563 	  	
 	  	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Income (loss) from operations of entities sold before income taxes	  	 	- 	  	 	 	392 	  	 	 	(729)	  	 	 	(2,280)	  	
Impairment of hospitals sold	  	 	- 	  	 	 	(38,600)	  	 	 	- 	  	 	 	(51,695)	  	
Loss on sale, net	  	 	- 	  	 	 	- 	  	 	 	- 	  	 	 	(5,061)	  	
 	  	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Loss from discontinued operations, before taxes	  	 	- 	  	 	 	(38,208)	  	 	 	(729)	  	 	 	(59,036)	  	
Income tax expense (benefit)	  	 	- 	  	 	 	1,119 	  	 	 	(263)	  	 	 	(6,429)	  	
 	  	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Loss from discontinued operations, net of taxes	  	$	- 	  	 	$	(39,327)	  	 	$	(466)	  	 	$	(52,607)	  	
 	  	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Interest expense was allocated to discontinued operations based on sale proceeds available for debt repayment.
6.  INCOME TAXES
The total amount of unrecognized benefit that would affect the effective tax rate, if recognized, was approximately $2.0 million as of June 30, 2012. During the six months ended June 30, 2012, the Company increased liabilities for uncertain tax positions by $1.0 million and increased interest and penalties by approximately $0.3 million. A total of approximately $0.5 million of interest and penalties is included in the amount of the liability for uncertain tax positions at June 30, 2012. It is the Company’s policy to recognize interest and penalties related to unrecognized benefits in its condensed consolidated statements of income as income tax expense.
It is possible the amount of unrecognized tax benefit could change in the next twelve months as a result of a lapse of the statute of limitations and settlements with taxing authorities; however, the Company does not anticipate the change will have a material impact on its consolidated results of operations or consolidated financial position.
The Company, or one of its subsidiaries, files income tax returns in the United States federal jurisdiction and various state jurisdictions. The Company has extended the federal statute of limitations for Triad Hospitals, Inc. (“Triad”) for the tax periods ended December 31, 1999, December 31, 2000, April 30, 2001, June 30, 2001, December 31, 2001, December 31, 2002 and December 31, 2003. The Internal Revenue Service (the “IRS”) has concluded its examination of the federal tax return of Triad for the tax periods ended December 31, 2004, December 31, 2005, December 31, 2006 and July 25, 2007, and the statutes of limitations for those years will close on December 31, 2012. With few exceptions, the Company is no longer subject to state income tax examinations for years prior to 2008 and federal
 
13

Table of Contents
COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) – (Continued)
 
income tax examinations with respect to Community Health Systems, Inc. federal returns for years prior to 2007. The Company’s federal income tax returns for the 2007, 2008, 2009 and 2010 tax years are currently under examination by the IRS. The Company believes the results of this examination will not be material to its consolidated results of operations or consolidated financial position. In connection with the Company’s 2007 and 2008 IRS examinations, the IRS has taken exception to the timing of the Company’s malpractice expense deductions. Management believes that the Company’s deduction timing is appropriate, and will work to resolve this item over the next 24 months. If management is unable to sustain the current timing of the Company’s deduction, then it would be subject to interest and penalty costs. Management does not consider this matter to have met the recognition criteria to be considered an uncertain tax position for which a reserve is necessary.
Cash paid for income taxes, net of refunds received, resulted in net cash paid of $22.1 million and a net cash refund of $25.0 million for the three months ended June 30, 2012 and 2011, respectively. Cash paid for income taxes, net of refunds received, resulted in net cash paid of $22.0 million and a net cash refund of $25.7 million for the six months ended June 30, 2012 and 2011, respectively.
7.  GOODWILL AND OTHER INTANGIBLE ASSETS
The changes in the carrying amount of goodwill for the six months ended June 30, 2012, are as follows (in thousands):

Balance as of December 31, 2011	  	$	4,264,845 	  	
Goodwill acquired as part of acquisitions during 2012	  	 	106,189 	  	
Consideration adjustments and purchase price allocation adjustments for prior year’s acquisitions	  	 	1,959 	  	
 	  	 	 	 	
Balance as of June 30, 2012	  	$	            4,372,993 	  	
 	  	 	 	 	
Goodwill is allocated to each identified reporting unit, which is defined as an operating segment or one level below the operating segment (referred to as a component of the entity). Management has determined that the Company’s operating segments meet the criteria to be classified as reporting units. At June 30, 2012, the hospital operations reporting unit, the home care agency operations reporting unit, and the hospital management services reporting unit had approximately $4.3 billion, $40.5 million and $33.3 million, respectively, of goodwill.
Goodwill is evaluated for impairment at the same time every year and when an event occurs or circumstances change that, more likely than not, reduce the fair value of the reporting unit below its carrying value. There is a two-step method for determining goodwill impairment. Step one is to compare the fair value of the reporting unit with the unit’s carrying amount, including goodwill. If this test indicates the fair value is less than the carrying value, then step two is required to compare the implied fair value of the reporting unit’s goodwill with the carrying value of the reporting unit’s goodwill. The Company has selected September 30 as its annual testing date. The Company performed its last annual goodwill evaluation as of September 30, 2011, which evaluation took place during the fourth quarter of 2011. No impairment was indicated by this evaluation.
The Company estimates the fair value of the related reporting units using both a discounted cash flow model as well as an EBITDA multiple model. The cash flow forecasts are adjusted by an appropriate discount rate based on the Company’s estimate of a market participant’s weighted-average cost of capital. These models are both based on the Company’s best estimate of future revenues and operating costs and are reconciled to the Company’s consolidated market capitalization, with consideration of the amount a potential acquirer would be required to pay, in the form of a control premium, in order to gain sufficient ownership to set policies, direct operations and control management decisions.
 
14

Table of Contents
COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) – (Continued)
 
The gross carrying amount of the Company’s other intangible assets subject to amortization was $61.8 million at June 30, 2012 and $60.0 million at December 31, 2011, and the net carrying amount was $29.6 million at June 30, 2012 and $30.6 million at December 31, 2011. The carrying amount of the Company’s other intangible assets not subject to amortization was $47.3 million at June 30, 2012 and $46.9 million at December 31, 2011. Other intangible assets are included in other assets, net on the Company’s condensed consolidated balance sheets. Substantially all of the Company’s intangible assets are contract-based intangible assets related to operating licenses, management contracts, or non-compete agreements entered into in connection with prior acquisitions.
The weighted-average amortization period for the intangible assets subject to amortization is approximately eight years. There are no expected residual values related to these intangible assets. Amortization expense on these intangible assets was $1.9 million and $2.3 million during the three months ended June 30, 2012 and 2011, respectively, and $3.7 million and $4.2 million during the six months ended June 30, 2012 and 2011, respectively. Amortization expense on intangible assets is estimated to be $4.4 million for the remainder of 2012, $5.5 million in 2013, $3.5 million in 2014, $3.2 million in 2015, $2.4 million in 2016, $2.2 million in 2017 and $8.4 million thereafter.
The gross carrying amount of capitalized software for internal use was approximately $544.5 million and $451.0 million at June 30, 2012 and December 31, 2011, respectively, and the net carrying amount considering accumulated amortization was approximately $294.2 million and $241.3 million at June 30, 2012 and December 31, 2011, respectively. The estimated amortization period for capitalized internal-use software is generally three years, except for capitalized costs related to significant system conversions, which is generally eight years. There is no expected residual value for capitalized internal-use software. At June 30, 2012, there was approximately $171.9 million of capitalized costs for internal-use software that is currently in the development stage and will begin amortization once the software project is complete and ready for its intended use. Amortization expense on capitalized internal-use software was $21.7 million and $16.7 million during the three months ended June 30, 2012 and 2011, respectively, and $41.4 million and $34.7 million during the six months ended June 30, 2012 and 2011, respectively. Amortization expense on capitalized internal-use software is estimated to be $48.8 million for the remainder of 2012, $97.7 million in 2013, $60.4 million in 2014, $26.7 million in 2015, $19.4 million in 2016, $16.2 million in 2017 and $25.0 million thereafter.
 
15

Table of Contents
COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) – (Continued)
 
8.  EARNINGS PER SHARE
The following table sets forth the components of the numerator and denominator for the computation of basic and diluted earnings per share for income from continuing operations, discontinued operations and net income attributable to Community Health Systems, Inc. common stockholders (in thousands, except share data):

 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
 	  	        Three Months Ended         
June 30,	 	  	        Six Months Ended         
June 30,	 	
 	  	2012	 	  	2011	 	  	2012	 	  	2011	 	
Numerator:	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Income from continuing operations, net of taxes	  	$	102,167 	  	  	$	92,874 	  	  	$	201,885 	  	  	$	184,479 	  	
Less: Income from continuing operations attributable to noncontrolling interests, net of taxes	  	 	18,808 	  	  	 	18,158 	  	  	 	42,586 	  	  	 	35,159 	  	
 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Income from continuing operations attributable to Community Health Systems, Inc. common stockholders — basic and diluted	  	$	83,359 	  	  	$	74,716 	  	  	$	159,299 	  	  	$	149,320 	  	

Loss from discontinued operations, net of taxes	  	$	- 	  	  	$	(39,327)	  	  	$	(466)	  	  	$	(52,607)	  	
Less: Loss from discontinued operations attributable to noncontrolling interests, net of taxes	  	 	- 	  	  	 	- 	  	  	 	- 	  	  	 	- 	  	
 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Loss from discontinued operations attributable to Community Health Systems, Inc. common stockholders — basic and diluted	  	$	- 	  	  	$	(39,327)	  	  	$	(466)	  	  	$	(52,607)	  	

Denominator:	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Weighted-average number of shares outstanding — basic	  	 	89,147,472 	  	  	 	91,130,672 	  	  	 	88,911,126 	  	  	 	91,069,876 	  	
Effect of dilutive securities:	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Restricted stock awards	  	 	160,211 	  	  	 	263,876 	  	  	 	90,722 	  	  	 	258,871 	  	
Employee stock options	  	 	214,353 	  	  	 	381,632 	  	  	 	180,876 	  	  	 	623,662 	  	
Other equity-based awards	  	 	8,603 	  	  	 	7,545 	  	  	 	8,927 	  	  	 	8,201 	  	

Weighted-average number of shares outstanding — diluted	  	 	89,530,639 	  	  	 	91,783,725 	  	  	 	89,191,651 	  	  	 	91,960,610 	  	

 	  	        Three Months Ended         
June 30,	 	  	        Six Months Ended         
June 30,	 	
 	  	2012	 	  	2011	 	  	2012	 	  	2011	 	
 	 	 	 	 	
Dilutive securities outstanding not included in the computation of earnings per share because their effect is antidilutive:	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Employee stock options	  	 	6,774,748 	  	  	 	6,726,417 	  	  	 	6,895,140 	  	  	 	5,560,855 	  	

16

Table of Contents
COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) – (Continued)
 
9.  STOCKHOLDERS’ EQUITY
Authorized capital shares of the Company include 400,000,000 shares of capital stock consisting of 300,000,000 shares of common stock and 100,000,000 shares of preferred stock. Each of the aforementioned classes of capital stock has a par value of $0.01 per share. Shares of preferred stock, none of which were outstanding as of June 30, 2012, may be issued in one or more series having such rights, preferences and other provisions as determined by the Board of Directors without approval by the holders of common stock.
On December 14, 2011, the Company adopted a new open market repurchase program for up to 4,000,000 shares of the Company’s common stock, not to exceed $100 million in repurchases. The new repurchase program will conclude at the earliest of three years from the commencement date, when the maximum number of shares has been repurchased, or when the maximum dollar amount of repurchases has been expended. Through June 30, 2012, no shares have been purchased and retired under this program.
On September 15, 2010, the Company commenced an open market repurchase program for up to 4,000,000 shares of the Company’s common stock, not to exceed $100 million in repurchases. This program will conclude at the earliest of three years from the commencement date, when the maximum number of shares has been repurchased or when the maximum dollar amount of repurchases has been expended. During the three and six months ended June 30, 2012, the Company did not repurchase any shares under this program. During the three and six months ended June 30, 2011, the Company repurchased and retired 1,763,566 shares at a weighted average price of $28.31 under this program. The cumulative number of shares that have been repurchased and retired under this program through June 30, 2012 is 3,921,138 shares at a weighted-average price of $25.39 per share.
The Company’s Credit Facility (as discussed below) limits the Company’s ability to pay dividends and/or repurchase stock to an amount not to exceed $50 million in the aggregate plus the aggregate amount of proceeds from the exercise of stock options. The indentures governing the 8  7 / 8 % Senior Notes due 2015 and the 8% Senior Notes due 2019 (collectively, the “Senior Notes”) also limit the Company’s ability to pay dividends and/or repurchase stock. As of June 30, 2012, under the most restrictive test under these agreements, the Company has approximately $81.3 million remaining available with which to pay permitted dividends and/or repurchase shares of stock or its Senior Notes.
 
17

Table of Contents
COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) – (Continued)
 
The following schedule presents the reconciliation of the carrying amount of total equity, equity attributable to the Company, and equity attributable to the noncontrolling interests for the six-month period ended June 30, 2012 (in thousands):

 	 	 	 	 	Community Health Systems, Inc. Stockholders	 	 	 	 	 	 	 	
 	 	 	 	 	 	 	 	 	
 	 	Redeemable
   Noncontrolling  
Interest	 	 	  Common
Stock	 	 	Additional
Paid-In
Capital	 	 	  Treasury  
Stock	 	 	Accumulated
Other
Comprehensive
Income (Loss)	 	 	    Retained    
Earnings	 	 	Noncontrolling
Interest	 	 	Total
Stockholders’
Equity	 	
Balance, December 31, 2011	 	$	395,743 	 	 	$	  915 	 	 	$	    1,086,008 	 	 	$	(6,678)	  	 	$	(184,479)	  	 	$	1,501,330 	 	 	$	67,349 	 	 	$	    2,464,445 	 	
 
Comprehensive income	 	 	30,698 	 	 	 	-	  	 	 	-	  	 	 	-	  	 	 	24,933 	 	 	 	158,833 	 	 	 	11,888 	 	 	 	195,654 	 	
 
Distributions to noncontrolling interests, net of contributions	 	 	(20,390)	  	 	 	-	  	 	 	-	  	 	 	-	  	 	 	-	  	 	 	-	  	 	 	(13,563)	  	 	 	(13,563)	  	

Purchase of subsidiary shares from noncontrolling interests	 	 	(16,681)	  	 	 	-	  	 	 	(18,848)	  	 	 	-	  	 	 	-	  	 	 	-	  	 	 	(359)	  	 	 	(19,207)	  	
 
Other reclassifications of noncontrolling interests	 	 	1,625 	 	 	 	-	  	 	 	-	  	 	 	-	  	 	 	-	  	 	 	-	  	 	 	(623)	  	 	 	(623)	  	
 
Adjustment to redemption value of redeemable noncontrolling interests	 	 	(23,086)	  	 	 	-	  	 	 	23,086 	 	 	 	-	  	 	 	-	  	 	 	-	  	 	 	-	  	 	 	23,086 	 	
 
Issuance of common stock in connection with the exercise of stock options	 	 	-	  	 	 	-	  	 	 	1,269 	 	 	 	-	  	 	 	-	  	 	 	-	  	 	 	-	  	 	 	1,269 	 	
 
Cancellation of restricted stock for tax withholdings on vested shares	 	 	-	  	 	 	(3)	  	 	 	(9,074)	  	 	 	-	  	 	 	-	  	 	 	-	  	 	 	-	  	 	 	(9,077)	  	
 
Excess tax benefit from exercise of stock options	 	 	-	  	 	 	-	  	 	 	(1,841)	  	 	 	-	  	 	 	-	  	 	 	-	  	 	 	-	  	 	 	(1,841)	  	
 
Share-based compensation	 	 	-	  	 	 	7 	 	 	 	20,624 	 	 	 	-	  	 	 	-	  	 	 	-	  	 	 	-	  	 	 	20,631 	 	

Balance, June 30, 2012	 	$	367,909 	 	 	$	919 	 	 	$	1,101,224 	 	 	$	(6,678)	  	 	$	(159,546)	  	 	$	1,660,163 	 	 	$	64,692 	 	 	$	2,660,774 	 	

The following schedule discloses the effects of changes in the Company’s ownership interest in its less-than-wholly-owned subsidiaries on Community Health Systems, Inc. stockholders’ equity (in thousands):

 	  	        Six Months Ended         
June 30, 2012	 	
Net income attributable to Community Health Systems, Inc.	  	$	158,833 	  	
Transfers to the noncontrolling interests:	  	 	 	 	
Net decrease in Community Health Systems, Inc. paid-in capital for purchase of subsidiary partnership interests	  	 	(18,848)	  	
 	  	 	 	 	
Net transfers to the noncontrolling interests	  	 	(18,848)	  	
 	  	 	 	 	
Change to Community Health Systems, Inc. stockholders’ equity from net income attributable to Community Health Systems, Inc. and transfers to noncontrolling interests	  	$	139,985 	  	

18

Table of Contents
COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) – (Continued)
 
10.  EQUITY INVESTMENTS
As of June 30, 2012, the Company owned equity interests of 27.5% in four hospitals in Las Vegas, Nevada, and 26.1% in one hospital in Las Vegas, Nevada, in which Universal Health Systems, Inc. owns the majority interest, and an equity interest of 38.0% in three hospitals in Macon, Georgia, in which HCA Inc. owns the majority interest.
Summarized combined financial information for the three and six months ended June 30, 2012 and 2011, for these unconsolidated entities in which the Company owns an equity interest is as follows (in thousands):

 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
 	  	        Three Months Ended         
June 30,	 	  	        Six Months Ended         
June 30,	 	
 	  	2012	 	  	2011	 	  	2012	 	  	2011	 	
Revenues	  	$	315,106 	  	  	$	307,453 	  	  	$	632,423 	  	  	$	628,293 	  	
Operating costs and expenses	  	 	274,303 	  	  	 	268,777 	  	  	 	551,559 	  	  	 	535,013 	  	
Income from continuing operations before taxes	  	 	40,781 	  	  	 	38,645 	  	  	 	80,816 	  	  	 	93,229 	  	
The summarized financial information for the three and six months ended June 30, 2012 and 2011 was derived from the unaudited financial information provided to the Company by those unconsolidated entities.
The Company’s investment in all of its unconsolidated affiliates was $432.3 million and $422.2 million at June 30, 2012 and December 31, 2011, respectively, and is included in other assets, net in the accompanying condensed consolidated balance sheets. Included in the Company’s results of operations is the Company’s equity in pre-tax earnings from all of its investments in unconsolidated affiliates, which was $13.2 million and $12.0 million for the three months ended June 30, 2012 and 2011, respectively, and $25.2 million and $30.2 million for the six months ended June 30, 2012 and 2011, respectively.
11.  LONG-TERM DEBT
Long-term debt consists of the following (in thousands):

 	 	        June 30,        
2012	 	 	        December 31,         
2011	 	
Credit Facility:	 	 	 	 	 	 	 	 	
Term loan A	 	  $	750,000 	  	 	  $	- 	  	
Term loan B	 	 	5,219,062 	  	 	 	5,949,383 	  	
Revolving credit loans	 	 	5,000 	  	 	 	30,000 	  	
8 7/8% Senior Notes due 2015	 	 	931,235 	  	 	 	1,777,617 	  	
8% Senior Notes due 2019	 	 	2,023,955 	  	 	 	1,000,000 	  	
Receivables Facility	 	 	300,000 	  	 	 	- 	  	
Capital lease obligations	 	 	47,539 	  	 	 	48,361 	  	
Other	 	 	48,575 	  	 	 	41,143 	  	
 	 	 	 	 	 	 	 	 	
Total debt	 	 	9,325,366 	  	 	 	8,846,504 	  	
Less current maturities	 	 	(83,877)	  	 	 	(63,706)	  	
 	 	 	 	 	 	 	 	 	
Total long-term debt	 	  $	        9,241,489 	  	 	  $	8,782,798 	  	

19

Table of Contents
COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) – (Continued)
 
Credit Facility
In connection with the consummation of the acquisition of Triad in July 2007, the Company’s wholly-owned subsidiary CHS/Community Health Systems, Inc. (“CHS”) obtained approximately $7.2 billion of senior secured financing under a new credit facility (the “Credit Facility”) with a syndicate of financial institutions led by Credit Suisse, as administrative agent and collateral agent, and issued approximately $3.0 billion aggregate principal amount of 8  7 / 8 % senior notes due 2015 (the “8  7 / 8 % Senior Notes”). The Company used the net proceeds of $3.0 billion from the 8  7 / 8 % Senior Notes offering and the net proceeds of approximately $6.1 billion of term loans under the Credit Facility to acquire the outstanding shares of Triad, to refinance certain of Triad’s indebtedness and the Company’s indebtedness, to complete certain related transactions, to pay certain costs and expenses of the transactions and for general corporate uses. Specifically, the Company repaid its outstanding debt under the previously outstanding credit facility, the 6.50% senior subordinated notes due 2012 and certain of Triad’s existing indebtedness.
The Credit Facility consisted of an approximately $6.1 billion funded term loan facility with a maturity of seven years, a $400 million delayed draw term loan facility with a maturity of seven years and a $750 million revolving credit facility with a maturity of six years. As of December 31, 2007, the $400 million delayed draw term loan facility had been reduced to $300 million at the request of CHS. During the fourth quarter of 2008, $100 million of the delayed draw term loan was drawn by CHS, reducing the delayed draw term loan availability to $200 million at December 31, 2008. In January 2009, CHS drew down the remaining $200 million of the delayed draw term loan. The revolving credit facility also includes a subfacility for letters of credit and a swingline subfacility. The Credit Facility requires quarterly amortization payments of each term loan facility equal to 0.25% of the outstanding amount of the term loans.
On November 5, 2010, CHS entered into an amendment and restatement of the Credit Facility. The amendment extended by two and a half years, until January 25, 2017, the maturity date of $1.5 billion of the existing term loans under the Credit Facility and increased the pricing on these term loans to LIBOR plus 350 basis points. If more than $50 million of the 8  7 / 8 % Senior Notes remain outstanding on April 15, 2015, without having been refinanced, then the maturity date for the extended term loans will be accelerated to April 15, 2015. The amendment also increased CHS’s ability to issue additional indebtedness under the uncommitted incremental facility to $1.0 billion from $600 million, permitted CHS to issue term loan A loans under the incremental facility, and provided up to $2.0 billion of borrowing capacity from receivable transactions, an increase of $0.5 billion, of which $1.7 billion would be required to be used for repayment of existing term loans. In addition, effective February 2, 2012, the Company completed a second amendment and restatement of the Credit Facility, which extended by two and a half years, until January 25, 2017, the maturity date of an additional $1.6 billion of the existing non-extended term loans under the Credit Facility and increased the pricing on these term loans to LIBOR plus 350 basis points. The maturity date of the balance of the term loans of approximately $2.9 billion remained unchanged at July 25, 2014.
Effective March 6, 2012, the Company obtained a new $750 million senior secured revolving credit facility (the “Replacement Revolver Facility”) and a new $750 million incremental term loan A facility (the “Incremental Term Loan”) subject to the terms and conditions set forth in the Credit Facility. The Replacement Revolver Facility replaced in full the existing revolving credit facility under the Credit Facility. The net proceeds of the Incremental Term Loan were used to repay the same amount of the existing term loans under the Credit Facility. The execution of these agreements resulted in a loss from early extinguishment of debt of $8.5 million with an after-tax impact of $5.3 million recorded in continuing operations for the six months ended June 30, 2012. Both the Replacement Revolver Facility and the Incremental Term Loan have a maturity date of October 25, 2016, subject to customary acceleration events and to the repayment, extension or refinancing with longer maturity debt of substantially all of the Company’s outstanding term loans maturing July 25, 2014 and the 8  7 / 8 % Senior Notes. The pricing on each of the Replacement Revolver Facility and the Incremental Term Loan initially is LIBOR plus a margin of 250 basis points, subject to adjustment based on the Company’s leverage ratio. The Incremental Term Loan amortizes at 5% in year one, 10% in years two and three, 15% in year four and 60% in year five.
The term loan facility must be prepaid in an amount equal to (1) 100% of the net cash proceeds of certain asset sales and dispositions by the Company and its subsidiaries, subject to certain exceptions and reinvestment rights, (2) 100% of the net cash proceeds of issuances of certain debt obligations or receivables-based financing by the Company and its subsidiaries, subject to certain exceptions, and (3) 50%, subject to reduction to a lower percentage based on the Company’s leverage ratio (as defined in the Credit Facility generally as the ratio of total debt on the date of determination to the Company’s EBITDA, as defined, for the four quarters most recently ended prior to such date), of excess cash flow (as defined) for any year, commencing in 2008, subject to certain exceptions. Voluntary prepayments and commitment reductions are permitted in whole or in part, without any premium or penalty, subject to minimum prepayment or reduction requirements.
 
20

Table of Contents
COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) – (Continued)
 
The obligor under the Credit Facility is CHS. All of the obligations under the Credit Facility are unconditionally guaranteed by the Company and certain of its existing and subsequently acquired or organized domestic subsidiaries. All obligations under the Credit Facility and the related guarantees are secured by a perfected first priority lien or security interest in substantially all of the assets of the Company, CHS and each subsidiary guarantor, including equity interests held by the Company, CHS or any subsidiary guarantor, but excluding, among others, the equity interests of non-significant subsidiaries, syndication subsidiaries, securitization subsidiaries and joint venture subsidiaries.
The loans under the Credit Facility bear interest on the outstanding unpaid principal amount at a rate equal to an applicable percentage plus, at CHS’s option, either (a) an Alternate Base Rate (as defined) determined by reference to the greater of (1) the Prime Rate (as defined) announced by Credit Suisse or (2) the Federal Funds Effective Rate (as defined) plus 0.50% or (3) the adjusted London Interbank Offered Rate (“LIBOR”) on such day for a three-month interest period commencing on the second business day after such day plus 1%, or (b) a reserve adjusted LIBOR for dollars (Eurodollar rate) (as defined). The applicable percentage for Alternate Base Rate loans is 1.25% for term loans due 2014 and is 2.25% for term loans due 2017 and the Incremental Term Loan. The applicable percentage for Eurodollar rate loans is 2.25% for term loans due 2014 and 3.50% for term loans due 2017 and the Incremental Term Loan. The applicable percentage for revolving loans is 1.50% for Alternate Base Rate revolving loans and 2.50% for Eurodollar revolving loans, in each case subject to reduction based on the Company’s leverage ratio. Loans under the swingline subfacility bear interest at the rate applicable to Alternate Base Rate loans under the revolving credit facility.
CHS has agreed to pay letter of credit fees equal to the applicable percentage then in effect with respect to Eurodollar rate loans under the revolving credit facility times the maximum aggregate amount available to be drawn under all letters of credit outstanding under the subfacility for letters of credit. The issuer of any letter of credit issued under the subfacility for letters of credit will also receive a customary fronting fee and other customary processing charges. CHS is obligated to pay commitment fees of 0.50% per annum (subject to reduction based upon the Company’s leverage ratio) on the unused portion of the revolving credit facility. For purposes of this calculation, swingline loans are not treated as usage of the revolving credit facility. With respect to the delayed draw term loan facility, CHS was also obligated to pay commitment fees of 0.50% per annum for the first nine months after the closing of the Credit Facility, 0.75% per annum for the next three months after such nine-month period and thereafter, 1% per annum. In each case, the commitment fee was paid on the unused amount of the delayed draw term loan facility. After the draw down of the remaining $200 million of the delayed draw term loan in January 2009, CHS no longer pays any commitment fees for the delayed draw term loan facility. CHS paid arrangement fees on the closing of the Credit Facility and pays an annual administrative agent fee.
The Credit Facility contains customary representations and warranties, subject to limitations and exceptions, and customary covenants restricting the Company’s and its subsidiaries’ ability, subject to certain exceptions, to, among other things (1) declare dividends, make distributions or redeem or repurchase capital stock, (2) prepay, redeem or repurchase other debt, (3) incur liens or grant negative pledges, (4) make loans and investments and enter into acquisitions and joint ventures, (5) incur additional indebtedness or provide certain guarantees, (6) make capital expenditures, (7) engage in mergers, acquisitions and asset sales, (8) conduct transactions with affiliates, (9) alter the nature of the Company’s businesses, (10) grant certain guarantees with respect to physician practices, (11) engage in sale and leaseback transactions or (12) change the Company’s fiscal year. The Company is also required to comply with specified financial covenants (consisting of a leverage ratio and an interest coverage ratio) and various affirmative covenants.
Events of default under the Credit Facility include, but are not limited to, (1) CHS’s failure to pay principal, interest, fees or other amounts under the credit agreement when due (taking into account any applicable grace period), (2) any representation or warranty proving to have been materially incorrect when made, (3) covenant defaults subject, with respect to certain covenants, to a grace period, (4) bankruptcy events, (5) a cross default to certain other debt, (6) certain undischarged judgments (not paid within an applicable grace period), (7) a change of control, (8) certain ERISA-related defaults and (9) the invalidity or impairment of specified security interests, guarantees or subordination provisions in favor of the administrative agent or lenders under the Credit Facility.
As of June 30, 2012, the availability for additional borrowings under the Credit Facility was $750 million pursuant to the Replacement Revolver Facility, of which $37.7 million was set aside for outstanding letters of credit and $5.0 million was outstanding at June 30, 2012. CHS has the ability to amend the Credit Facility to provide for one or more tranches of term loans in an aggregate principal amount of $1.0 billion, which CHS has not yet accessed. As of June 30, 2012, the weighted-average interest rate under the Credit Facility, excluding swaps, was 3.5%.
 
21

Table of Contents
COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) – (Continued)
 
8 7/8% Senior Notes due 2015
The 8 7/8% Senior Notes were issued by CHS in connection with the Triad acquisition in the principal amount of approximately $3.0 billion. The 8  7 / 8 % Senior Notes will mature on July 15, 2015. The 8  7 / 8 % Senior Notes bear interest at the rate of 8.875% per annum, payable semiannually in arrears on January 15 and July 15, commencing January 15, 2008. Interest on the 8  7 / 8 % Senior Notes accrues from the date of original issuance. Interest is calculated on the basis of a 360-day year comprised of twelve 30-day months.
On December 7, 2011, CHS completed the cash tender offer for $1.0 billion of the then $2.8 billion aggregate outstanding principal amount of the 8  7 / 8 % Senior Notes. This resulted in a loss from early extinguishment of debt of $66.0 million with an after-tax impact of $42.0 million recorded in continuing operations for the year ended December 31, 2011.
On March 21, 2012, CHS completed the cash tender offer for $850 million of the then $1.8 billion aggregate outstanding principal amount of the 8  7 / 8 % Senior Notes. This resulted in a loss from early extinguishment of debt of $54.9 million with an after-tax impact of $34.3 million recorded in continuing operations for the six months ended June 30, 2012.
After July 15, 2011, CHS is entitled, at its option, to redeem all or a portion of the 8 7/8% Senior Notes upon not less than 30 nor more than 60 days’ notice, at the redemption prices (expressed as a percentage of principal amount on the redemption date), plus accrued and unpaid interest, if any, to the redemption date (subject to the right of holders of record on the relevant record date to receive interest due on the relevant interest payment date), if redeemed during the 12-month period commencing on July 15 of the years set forth below:

Period	 	        Redemption        
Price	 	
2011	 	 	104.438 %    	  	
2012	 	 	102.219 %    	  	
2013 and thereafter	 	 	100.000 %    	  	
Pursuant to a registration rights agreement entered into at the time of the issuance of the 8 7/8% Senior Notes, as a result of an exchange offer made by CHS, substantially all of the 8  7 / 8 % Senior Notes issued in July 2007 were exchanged in November 2007 for new notes (the “8  7 / 8 % Exchange Notes”) having terms substantially identical in all material respects to the 8  7 / 8 % Senior Notes (except that the 8  7 / 8 % Exchange Notes were issued under a registration statement pursuant to the 1933 Act). References to the 8  7 / 8 % Senior Notes shall also be deemed to include the 8  7 / 8 % Exchange Notes unless the context provides otherwise.
8% Senior Notes due 2019
On November 22, 2011, CHS completed its offering of $1.0 billion aggregate principal amount of 8% Senior Notes due 2019 (the “8% Senior Notes”), which were issued in a private placement. The net proceeds from this issuance, together with available cash on hand, were used to finance the purchase of $1.0 billion aggregate principal amount of CHS’ outstanding 8  7 / 8 % Senior Notes due 2015 and related fees and expenses. On March 21, 2012, CHS completed the secondary offering of $1.0 billion aggregate principal amount of 8% Senior Notes due 2019, which were issued in a private placement (at a premium of 102.5%). The net proceeds from this issuance were used to finance the purchase of $850 million aggregate principal amount of CHS’ outstanding 8  7 / 8 % Senior Notes due 2015, to pay related fees and expenses and for general corporate purposes. The 8% Senior Notes bear interest at 8% per annum, payable semiannually in arrears on May 15 and November 15, commencing May 15, 2012. Interest on the 8% Senior Notes accrues from the date of original issuance. Interest is calculated on the basis of a 360-day year comprised of twelve 30-day months.
Except as set forth below, CHS is not entitled to redeem the 8% Senior Notes prior to November 15, 2015.
 
22

Table of Contents
COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) – (Continued)
 
On and after November 15, 2015, CHS is entitled, at its option, to redeem all or a portion of the 8% Senior Notes upon not less than 30 nor more than 60 days’ notice, at the redemption prices (expressed as a percentage of principal amount on the redemption date), plus accrued and unpaid interest, if any, to the redemption date (subject to the right of holders of record on the relevant record date to receive interest due on the relevant interest payment date), if redeemed during the 12-month period commencing on November 15 of the years set forth below:

Period	 	        Redemption        
Price	 	
2015	 	 	104.000 %    	  	
2016	 	 	102.000 %    	  	
2017 and thereafter	 	 	100.000 %    	  	
Pursuant to a registration rights agreement entered into at the time of the issuance of the 8% Senior Notes, as a result of an exchange offer made by CHS, substantially all of the 8% Senior Notes issued in November 2011 and March 2012 were exchanged in May 2012 for new notes (the “8% Exchange Notes”) having terms substantially identical in all material respects to the 8% Senior Notes (except that the 8% Exchange Notes were issued under a registration statement pursuant to the 1933 Act). References to the 8% Senior Notes shall also be deemed to include the 8% Exchange Notes unless the context provides otherwise.
Receivables Facility
On March 21, 2012, the Company and certain of its subsidiaries entered into an accounts receivables loan agreement (the “Receivables Facility”) with a group of conduit lenders and liquidity banks, Credit Agricolé Corporate and Investment Bank, as a managing agent and as the administrative agent, and The Bank of Nova Scotia, as a managing agent. The existing and future patient-related accounts receivable (the “Receivables”) for certain of the Company’s hospitals serve as collateral for the outstanding borrowings under the Receivables Facility. The interest rate on the borrowings is based on the commercial paper rate plus an applicable interest rate spread. Unless earlier terminated or subsequently extended pursuant to its terms, the Receivables Facility will expire on March 21, 2014, subject to customary termination events that could cause an early termination date. The Company maintains effective control over the Receivables because, pursuant to the terms of the Receivables Facility, the Receivables are sold from certain of the Company’s subsidiaries to the Company, which then sells or contributes the Receivables to a special-purpose entity that is wholly-owned by the Company. The wholly-owned special-purpose entity in turn grants security interests in the Receivables in exchange for borrowings obtained from the group of third-party conduit lenders and liquidity banks of up to $300 million outstanding from time to time based on the availability of eligible Receivables and other customary factors. The group of third-party conduit lenders and liquidity banks do not have recourse to the Company or its subsidiaries beyond the assets of the wholly-owned special-purpose entity that collateralizes the loan. The Receivables and other assets of the wholly-owned special-purpose entity will be available first and foremost to satisfy the claims of the creditors of such entity. The outstanding borrowings pursuant to the Receivables Facility at June 30, 2012 totaled $300.0 million and are classified as long-term debt on the condensed consolidated balance sheet. At June 30, 2012, the carrying amount of Receivables included in the Receivables Facility totaled approximately $888.0 million and are included in patient accounts receivable on the condensed consolidated balance sheet.
The Company paid interest of $170.0 million and $101.6 million on borrowings during the three months ended June 30, 2012 and 2011, respectively, and $331.2 million and $327.7 million during the six months ended June 30, 2012 and 2011, respectively.
 
23

Table of Contents
COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) – (Continued)
 
12.   FAIR VALUE OF FINANCIAL INSTRUMENTS
The fair value of financial instruments has been estimated by the Company using available market information as of June 30, 2012 and December 31, 2011, and valuation methodologies considered appropriate. The estimates presented are not necessarily indicative of amounts the Company could realize in a current market exchange (in thousands):

 	 	June 30, 2012	 	 	December 31, 2011	 	
 	 	        Carrying        
Amount	 	 	Estimated
         Fair Value        	 	 	        Carrying        
Amount	 	 	Estimated
         Fair Value        	 	
Assets:	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Cash and cash equivalents	 	$	115,109  	  	 	$	115,109  	  	 	$	129,865  	  	 	$	129,865  	  	
Available-for-sale securities	 	 	33,943  	  	 	 	33,943  	  	 	 	31,582  	  	 	 	31,582  	  	
Trading securities	 	 	34,946  	  	 	 	34,946  	  	 	 	30,486  	  	 	 	30,486  	  	
Liabilities:	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Credit Facility	 	 	5,974,062  	  	 	 	5,870,228  	  	 	 	5,979,383  	  	 	 	5,780,877  	  	
8 7/8% Senior Notes	 	 	931,235  	  	 	 	961,193  	  	 	 	1,777,617  	  	 	 	1,842,322  	  	
8% Senior Notes	 	 	2,023,955  	  	 	 	2,065,000  	  	 	 	1,000,000  	  	 	 	995,000  	  	
Other debt	 	 	348,575  	  	 	 	348,575  	  	 	 	41,143  	  	 	 	41,143  	  	
The estimated fair value is determined using the methodologies discussed below in accordance with accounting standards related to the determination of fair value based on the U.S. GAAP fair value hierarchy as discussed in Note 13. The estimated fair value for financial instruments with a fair value that does not equal its carrying value is considered a Level 2 valuation. The Company utilizes the market approach and obtains indicative pricing from the administrative agent to the Credit Facility to determine fair values, which are validated through subscription services such as Bloomberg where relevant.
Cash and cash equivalents.  The carrying amount approximates fair value due to the short-term maturity of these instruments (less than three months).
Available-for-sale securities.  Estimated fair value is based on closing price as quoted in public markets.
Trading securities.  Estimated fair value is based on closing price as quoted in public markets.
Credit Facility.  Estimated fair value is based on information from the Company’s bankers regarding relevant pricing for trading activity among the Company’s lending institutions.
8 7/8% Senior Notes.  Estimated fair value is based on the average bid and ask price as quoted by the bank who served as underwriters in the sale of these notes.
8% Senior Notes.  Estimated fair value is based on the average bid and ask price as quoted by the bank who served as underwriters in the sale of these notes.
Other debt.  The carrying amount of all other debt approximates fair value due to the nature of these obligations.
Interest rate swaps.  The fair value of interest rate swap agreements is the amount at which they could be settled, based on estimates calculated by the Company using a discounted cash flow analysis based on observable market inputs and validated by comparison to estimates obtained from the counterparty. The Company incorporates credit valuation adjustments (“CVAs”) to appropriately reflect both its own nonperformance or credit risk and the respective counterparty’s nonperformance or credit risk in the fair value measurements. In adjusting the fair value of its interest rate swap agreements for the effect of nonperformance or credit risk, the Company has considered the impact of any netting features included in the agreements.
 
24

Table of Contents
COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) – (Continued)
 
The Company assesses the effectiveness of its hedge instruments on a quarterly basis. For the three and six months ended June 30, 2012 and 2011, the Company completed an assessment of the cash flow hedge instruments and determined the hedges to be highly effective. The Company has also determined that the ineffective portion of the hedges do not have a material effect on the Company’s consolidated financial position, operations or cash flows. The counterparties to the interest rate swap agreements expose the Company to credit risk in the event of nonperformance. However, at June 30, 2012, each swap agreement entered into by the Company was in a net liability position so that the Company would be required to make the net settlement payments to the counterparties; the Company does not anticipate nonperformance by those counterparties. The Company does not hold or issue derivative financial instruments for trading purposes.
Interest rate swaps consisted of the following at June 30, 2012:

            Swap #             	 	Notional
Amount
         (in 000’s)        	 	 	Fixed
         Interest        
Rate	 	 	            Termination             
Date	 	 	Fair Value of
  Liability (in 000’s)  	 	
1	 	$	200,000 	  	 	 	4.685 %  	  	 	 	September 11, 2012	  	 	$	1,679 	  	
2	 	 	100,000 	  	 	 	3.352 %  	  	 	 	October 23, 2012	  	 	 	908 	  	
3	 	 	125,000 	  	 	 	4.375 %  	  	 	 	November 23, 2012	  	 	 	1,953 	  	
4	 	 	75,000 	  	 	 	4.380 %  	  	 	 	November 23, 2012	  	 	 	1,174 	  	
5	 	 	150,000 	  	 	 	5.020 %  	  	 	 	November 30, 2012	  	 	 	2,862 	  	
6	 	 	200,000 	  	 	 	2.242 %  	  	 	 	February 28, 2013	  	 	 	2,347 	  	
7	 	 	100,000 	  	 	 	5.023 %  	  	 	 	May 30, 2013	  	 	 	4,144 	  	
8	 	 	300,000 	  	 	 	5.242 %  	  	 	 	August 6, 2013	  	 	 	15,631 	  	
9	 	 	100,000 	  	 	 	5.038 %  	  	 	 	August 30, 2013	  	 	 	5,276 	  	
10	 	 	50,000 	  	 	 	3.586 %  	  	 	 	October 23, 2013	  	 	 	2,013 	  	
11	 	 	50,000 	  	 	 	3.524 %  	  	 	 	October 23, 2013	  	 	 	1,972 	  	
12	 	 	100,000 	  	 	 	5.050 %  	  	 	 	November 30, 2013	  	 	 	6,383 	  	
13	 	 	200,000 	  	 	 	2.070 %  	  	 	 	December 19, 2013	  	 	 	4,540 	  	
14	 	 	100,000 	  	 	 	5.231 %  	  	 	 	July 25, 2014	  	 	 	9,511 	  	
15	 	 	100,000 	  	 	 	5.231 %  	  	 	 	July 25, 2014	  	 	 	9,511 	  	
16	 	 	200,000 	  	 	 	5.160 %  	  	 	 	July 25, 2014	  	 	 	18,734 	  	
17	 	 	75,000 	  	 	 	5.041 %  	  	 	 	July 25, 2014	  	 	 	6,843 	  	
18	 	 	125,000 	  	 	 	5.022 %  	  	 	 	July 25, 2014	  	 	 	11,357 	  	
19	 	 	100,000 	  	 	 	2.621 %  	  	 	 	July 25, 2014	  	 	 	4,216 	  	
20	 	 	100,000 	  	 	 	3.110 %  	  	 	 	July 25, 2014	  	 	 	5,208 	  	
21	 	 	100,000 	  	 	 	3.258 %  	  	 	 	July 25, 2014	  	 	 	5,508 	  	
22	 	 	200,000 	  	 	 	2.693 %  	  	 	 	October 26, 2014	  	 	 	9,682 	  	
23	 	 	300,000 	  	 	 	3.447 %  	  	 	 	August 8, 2016	  	 	 	30,536 	  	
24	 	 	200,000 	  	 	 	3.429 %  	  	 	 	August 19, 2016	  	 	 	20,306 	  	
25	 	 	100,000 	  	 	 	3.401 %  	  	 	 	August 19, 2016	  	 	 	10,048 	  	
26	 	 	200,000 	  	 	 	3.500 %  	  	 	 	August 30, 2016	  	 	 	20,957 	  	
27	 	 	100,000 	  	 	 	3.005 %  	  	 	 	November 30, 2016	  	 	 	8,828 	  	
 
25

Table of Contents
COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) – (Continued)
 
The Company is exposed to certain risks relating to its ongoing business operations. The risk managed by using derivative instruments is interest rate risk. Interest rate swaps are entered into to manage interest rate fluctuation risk associated with the term loans in the Credit Facility. Companies are required to recognize all derivative instruments as either assets or liabilities at fair value in the condensed consolidated statement of financial position. The Company designates its interest rate swaps as cash flow hedges. For derivative instruments that are designated and qualify as cash flow hedges, the effective portion of the gain or loss on the derivative is reported as a component of OCI and reclassified into earnings in the same period or periods during which the hedged transactions affect earnings. Gains and losses on the derivative representing either hedge ineffectiveness or hedge components excluded from the assessment of effectiveness are recognized in current earnings.
Assuming no change in June 30, 2012 interest rates, approximately $111.3 million of interest expense resulting from the spread between the fixed and floating rates defined in each interest rate swap agreement will be recognized during the next 12 months. If interest rate swaps do not remain highly effective as a cash flow hedge, the derivatives’ gains or losses resulting from the change in fair value reported through OCI will be reclassified into earnings.
The following tabular disclosure provides the amount of pre-tax loss recognized as a component of OCI during the three and six months ended June 30, 2012 and 2011 (in thousands):

 	  	Amount of Pre-Tax Loss Recognized in OCI (Effective  Portion)	 	
Derivatives in Cash Flow
Hedging Relationships	  	Three Months Ended
June  30,	 	  	Six Months Ended
June 30,	 	
 	  	        2012        	 	  	        2011        	 	  	        2012        	 	  	        2011        	 	
Interest rate swaps	  	$	(21,704)	  	  	$	(67,685)	  	  	$	(44,826)	  	  	$	(63,572)	  	
The following tabular disclosure provides the location of the effective portion of the pre-tax loss reclassified from accumulated other comprehensive loss (“AOCL”) into interest expense on the condensed consolidated statements of income during the three and six months ended June 30, 2012 and 2011 (in thousands):

 	  	  Amount of Pre-Tax Loss Reclassified from AOCL  into Income (Effective Portion)  	 	
Location of Loss Reclassified from
AOCL into Income (Effective Portion)	  	Three Months Ended
June  30,	 	  	Six Months Ended
June 30,	 	
 	  	        2012        	 	  	        2011        	 	  	        2012        	 	  	        2011        	 	
Interest expense, net	  	$	37,316 	  	  	$	53,649 	  	  	$	76,926 	  	  	$	106,573 	  	
The fair values of derivative instruments in the condensed consolidated balance sheets as of June 30, 2012 and December 31, 2011 were as follows (in thousands):

 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
 	  	Asset Derivatives	 	  	Liability Derivatives	 	
 	  	June 30, 2012	 	  	December 31, 2011	 	  	June 30, 2012	 	  	December 31, 2011	 	
 	  	Balance
Sheet
  Location  	  	Fair Value	 	  	Balance
Sheet
  Location  	  	Fair Value	 	  	Balance
Sheet
  Location  	  	Fair Value	 	  	Balance
Sheet
  Location  	  	Fair Value	 	
Derivatives designated as hedging instruments	  	Other
assets, net	  	$	-  	  	  	Other
assets, net	  	$	-  	  	  	Other long-
term
liabilities	  	$	  222,127  	  	  	Other long-
term
liabilities	  	$	  254,228  	  	
 
26

Table of Contents
COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) – (Continued)
 
13.   FAIR VALUE
Fair Value Hierarchy
Fair value is a market-based measurement, not an entity-specific measurement. Therefore, a fair value measurement should be determined based on the assumptions that market participants would use in pricing the asset or liability. As a basis for considering market participant assumptions in fair value measurements, the Company utilizes the U.S. GAAP fair value hierarchy that distinguishes between market participant assumptions based on market data obtained from sources independent of the reporting entity (observable inputs that are classified within Levels 1 and 2 of the hierarchy) and the reporting entity’s own assumption about market participant assumptions (unobservable inputs classified within Level 3 of the hierarchy).
The inputs used to measure fair value are classified into the following fair value hierarchy:

Level 1:	  	Quoted market prices in active markets for identical assets or liabilities.	
 	 	
Level 2:	  	Observable market-based inputs or unobservable inputs that are corroborated by market data.	
 	 	
Level 3:	  	Unobservable inputs that are supported by little or no market activity and are significant to the fair value of the assets or liabilities. Level 3 includes values determined using pricing models, discounted cash flow methodologies, or similar techniques reflecting the Company’s own assumptions.	
In instances where the determination of the fair value hierarchy measurement is based on inputs from different levels of the fair value hierarchy, the level in the fair value hierarchy within which the entire fair value measurement falls is based on the lowest level input that is significant to the fair value measurement in its entirety. The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment of factors specific to the asset or liability.
The following table sets forth, by level within the fair value hierarchy, the financial assets and liabilities recorded at fair value on a recurring basis as of June 30, 2012 and December 31, 2011 (in thousands):

 	  	    June 30,    
2012	 	  	    Level 1    	 	  	    Level 2    	 	  	    Level 3    	 	
Available-for-sale securities	  	$	33,943 	  	  	$	33,943 	  	  	$	- 	  	  	$	- 	  	
Trading securities	  	 	34,946 	  	  	 	34,946 	  	  	 	- 	  	  	 	- 	  	
 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Total assets	  	$	68,889 	  	  	$	68,889 	  	  	$	- 	  	  	$	- 	  	

Fair value of interest rate swap agreements	  	$	222,127 	  	  	$	- 	  	  	$	222,127 	  	  	$	- 	  	
 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Total liabilities	  	$	222,127 	  	  	$	- 	  	  	$	222,127 	  	  	$	- 	  	

 	  	  December 31,  
2011	 	  	Level 1	 	  	Level 2	 	  	Level 3	 	
Available-for-sale securities	  	$	31,582 	  	  	$	31,582 	  	  	$	- 	  	  	$	- 	  	
Trading securities	  	 	30,486 	  	  	 	30,486 	  	  	 	- 	  	  	 	- 	  	
 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Total assets	  	$	62,068 	  	  	$	62,068 	  	  	$	- 	  	  	$	- 	  	

Fair value of interest rate swap agreements	  	$	254,228 	  	  	$	- 	  	  	$	254,228 	  	  	$	- 	  	
 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Total liabilities	  	$	254,228 	  	  	$	- 	  	  	$	254,228 	  	  	$	- 	  	

27

Table of Contents
COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) – (Continued)
 
Available-for-sale securities and trading securities classified as Level 1 are measured using quoted market prices.
The valuation of the Company’s interest rate swap agreements is determined using market valuation techniques, including discounted cash flow analysis on the expected cash flows of each agreement. This analysis reflects the contractual terms of the agreement, including the period to maturity, and uses observable market-based inputs, including forward interest rate curves. The fair value of interest rate swap agreements are determined by netting the discounted future fixed cash payments and the discounted expected variable cash receipts. The variable cash receipts are based on the expectation of future interest rates based on observable market forward interest rate curves and the notional amount being hedged.
The Company incorporates CVAs to appropriately reflect both its own nonperformance or credit risk and the respective counterparty’s nonperformance or credit risk in the fair value measurements. In adjusting the fair value of its interest rate swap agreements for the effect of nonperformance or credit risk, the Company has considered the impact of any netting features included in the agreements. The CVA on the Company’s interest rate swap agreements at June 30, 2012 resulted in a decrease in the fair value of the related liability of $9.7 million and an after-tax adjustment of $6.2 million to OCI. The CVA on the Company’s interest rate swap agreements at December 31, 2011 resulted in a decrease in the fair value of the related liability of $21.7 million and an after-tax adjustment of $13.9 million to OCI.
The majority of the inputs used to value its interest rate swap agreements, including the forward interest rate curves and market perceptions of the Company’s credit risk used in the CVAs, are observable inputs available to a market participant. As a result, the Company has determined that the interest rate swap valuations are classified in Level 2 of the fair value hierarchy.
14. RECENT ACCOUNTING PRONOUNCEMENTS
In September 2011, the FASB issued ASU 2011-08, which modifies how entities test goodwill for impairment. Previous guidance required an entity to perform a two-step goodwill impairment test at least annually by comparing the fair value of a reporting unit with its carrying amount, including goodwill, and recording an impairment loss if the fair value is less than the carrying amount. This ASU allows an entity to first assess qualitative factors to determine whether the existence of events or circumstances leads to a determination that it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If an entity determines after that assessment that it is not more likely than not that the fair value of a reporting unit is less than its carrying amount, then performing the two-step impairment test is not required. This ASU is required to be applied to interim and annual goodwill impairment tests performed for fiscal years beginning after December 15, 2011, and was adopted by the Company on January 1, 2012. The adoption of this ASU did not impact the Company’s consolidated financial position, results of operations or cash flows.
15.  SEGMENT INFORMATION
The Company operates in three distinct operating segments, represented by hospital operations (which includes its general acute care hospitals and related healthcare entities that provide inpatient and outpatient healthcare services), home care agency operations (which provide in-home outpatient care), and hospital management services (which provides executive management and consulting services to non-affiliated acute care hospitals). Only the hospital operations segment meets the criteria as a separate reportable segment. The financial information for the home care agencies and hospital management services segments do not meet the quantitative thresholds for a separate identifiable reportable segment and are combined into the corporate and all other reportable segment.
 
28

Table of Contents
COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) – (Continued)
 
The distribution between reportable segments of the Company’s net operating revenues and income from continuing operations before income taxes is summarized in the following tables (in thousands):

 	  	Three Months Ended
June 30,	 	  	Six Months Ended
June 30,	 	
 	  	        2012        	 	  	        2011        	 	  	        2012        	 	  	        2011        	 	
Net operating revenues:	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Hospital operations	  	$	3,178,229 	  	  	$	2,929,038 	  	  	$	6,401,326 	  	  	$	5,813,368 	  	
Corporate and all other	  	 	64,745 	  	  	 	71,789 	  	  	 	138,683 	  	  	 	141,542 	  	
 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Total	  	$	3,242,974 	  	  	$	3,000,827 	  	  	$	6,540,009 	  	  	$	5,954,910 	  	

Income from continuing operations before income taxes:	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Hospital operations	  	$	220,242 	  	  	$	184,426 	  	  	$	420,550 	  	  	$	362,539 	  	
Corporate and all other	  	 	(68,556)	  	  	 	(46,731)	  	  	 	(123,327)	  	  	 	(89,147)	  	
 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Total	  	$	151,686 	  	  	$	137,695 	  	  	$	297,223 	  	  	$	273,392 	  	
 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
16.  CONTINGENCIES
The Company is a party to various legal proceedings incidental to its business. In the opinion of management, any ultimate liability with respect to these actions will not have a material adverse effect on the Company’s consolidated financial position, cash flows or results of operations. With respect to all litigation matters, the Company considers the likelihood of a negative outcome. If the Company determines the likelihood of a negative outcome is probable and the amount of the loss can be reasonably estimated, the Company records an estimated loss for the expected outcome of the litigation and discloses that fact together with the amount accrued, if it was estimable. If the likelihood of a negative outcome is reasonably possible and the Company is able to determine an estimate of the possible loss or a range of loss, the Company discloses that fact together with the estimate of the possible loss or range of loss. However, it is difficult to predict the outcome or estimate a possible loss or range of loss in some instances because litigation is subject to significant uncertainties.
Reasonably Possible Contingencies
For the legal matter below, the Company believes that a negative outcome is reasonably possible, but the Company is unable to determine an estimate of the possible loss or a range of loss.
On February 10, 2006, the Company received a letter from the Civil Division of the Department of Justice requesting documents in an investigation it was conducting involving the Company. The inquiry related to the way in which different state Medicaid programs apply to the federal government for matching or supplemental funds that are ultimately used to pay for a small portion of the services provided to Medicaid and indigent patients. These programs are referred to by different names, including “intergovernmental payments,” “upper payment limit programs,” and “Medicaid disproportionate share hospital payments.” The February 2006 letter focused on the Company’s hospitals in three states: Arkansas, New Mexico, and South Carolina. On August 31, 2006, the Company received a follow up letter from the Department of Justice requesting additional documents relating to the programs in New Mexico and the payments to the Company’s three hospitals in that state. Through the beginning of 2009, the Company provided the Department of Justice with requested documents, met with its personnel on numerous occasions, and otherwise cooperated in its investigation. During the course of the investigation, the Civil Division notified the Company that it believed that the Company and its three New Mexico hospitals caused the State of New Mexico to submit improper claims for federal funds, in violation of the Federal False Claims Act. At one point, the Civil Division calculated that the three hospitals received ineligible federal participation payments from August 2000 to June 2006 of approximately $27.5 million and said that if it proceeded to trial, it would seek treble damages plus an appropriate penalty for each of the violations of the Federal False Claims Act. This investigation has culminated in the federal government’s intervention in a qui tam lawsuit styled U.S. ex rel. Baker vs. Community Health Systems, Inc., pending in the United States District Court for the District of New Mexico. The federal government filed its complaint in intervention on June 30, 2009. The relator filed a second amended complaint on July 1, 2009. Both of these complaints expand the time period during which alleged improper payments were made. The Company filed motions to dismiss all of the federal government’s and the relator’s claims on August 28, 2009. On March 19, 2010, the court granted in part and denied in part the Company’s motion to dismiss as to the relator’s complaint. On July 7, 2010, the court denied the Company’s motion to dismiss the federal government’s complaint in intervention. On July 21, 2010, the Company filed its answer and pretrial discovery began. On June 2,
 
29

Table of Contents
COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) – (Continued)
 
2011, the relator filed a Third Amended Complaint adding subsidiaries Community Health Systems Professional Services Corporation and CHS/Community Health Systems, Inc. as defendants. On June 6, 2011, the government filed its First Amended Complaint in intervention adding Community Health Systems Professional Services Corporation as a defendant. Discovery is closed. Motions for Summary Judgment were filed on March 27, 2012 and there is currently no hearing date on the motions nor has a trial date been set. On March 30, 2012, the court denied the Company’s motion to exclude Plaintiffs’ expert witness testimony, which the Company believes fails to follow the controlling Medicaid statute and regulations and results in an exaggeration of the damages estimate by fourfold. The Company has the opportunity to challenge the methodology employed at trial. The Company is vigorously defending this action.
Matters for which an Outcome Cannot be Assessed
For all of the legal matters below, the Company cannot at this time assess what the outcome may be and is further unable to determine any estimate of loss or range of loss. Because the investigations are at a very preliminary stage, there are not sufficient facts available to make these assessments.
On April 8, 2011, the Company received a document subpoena, dated March 31, 2011, from the United States Department of Health and Human Services, Office of Inspector General (the “OIG”), in connection with an investigation of possible improper claims submitted to Medicare and Medicaid. The subpoena, issued from the OIG’s Chicago, Illinois office, requested documents from all of the Company’s hospitals and appears to concern emergency department processes and procedures, including the Company’s hospitals’ use of the Pro-MED Clinical Information System, which is a third-party software system that assists with the management of patient care and provides operational support and data collection for emergency department management and has the ability to track discharge, transfer and admission recommendations of emergency department physicians. The subpoena also requested other information about the Company’s relationships with emergency department physicians, including financial arrangements. The subpoena’s requests were very similar to those contained in the Civil Investigative Demands received by the Company’s Texas hospitals from the Office of the Attorney General of the State of Texas on November 15, 2010. This investigation is being led by the Department of Justice. The Company is continuing to cooperate with the government including detailing a process for a medical necessity review by clinical reviewers and physicians of a sampling of medical records at a small number of hospitals.
On April 22, 2011, a joint motion was filed by the relator and the United States Department of Justice in the case styled United States ex rel. and Reuille vs. Community Health Systems Professional Services Corporation and Lutheran Musculoskeletal Center, LLC d/b/a Lutheran Hospital, in the United States District Court for the Northern District of Indiana, Fort Wayne Division. The lawsuit was originally filed under seal on January 7, 2009. The suit is brought under the False Claims Act and alleges that Lutheran Hospital of Indiana billed the Medicare program for (a) false 23 hour observation after outpatient surgeries and procedures, and (b) intentional assignment of inpatient status to one-day stays for cases that do not meet Medicare criteria for inpatient intensity of service or severity of illness. The relator had worked in the case management department of Lutheran Hospital of Indiana but was reassigned to another department in the fall of 2006. This facility was acquired by the Company as part of the July 25, 2007 merger transaction with Triad. The complaint also includes allegations of age discrimination in Ms. Reuille’s 2006 reassignment and retaliation in connection with her resignation on October 1, 2008. The Company had cooperated fully with the government in its investigation of this matter, but had been unaware of the exact nature of the allegations in the complaint. On December 27, 2010, the government filed a notice that it declined to intervene in this suit. The April 22, 2011 motion contained additional information about how the government intended to proceed with an investigation regarding “allegations of improper billing for inpatient care at other hospitals associated with Community Health Systems, Inc. . . . asserted in other qui tam complaints in other jurisdictions.” The motion stated that the Department of Justice has “consolidated its investigations” of the Company and other related entities and that “the Civil Division of the Department of Justice, multiple United States Attorneys’ offices, and the Office of Inspector General for the Department of Health and Human Services (the “HHS”) are now closely coordinating their investigation of these overlapping allegations. The Attorney General of Texas has initiated an investigation; the United States intends to work cooperatively with Texas and any other States investigating these allegations.” The motion also stated that the Office of Audit Services for the Office of Investigations for HHS has been engaged to conduct a national audit of certain of the Company’s Medicare claims. The government confirmed that it considers the allegations made in the complaint styled Tenet Healthcare Corporation vs. Community Health Systems, Inc., et al. filed in the United States District Court for the Northern District of Texas, Dallas Division on April 11, 2011 to be related to the allegations in the qui tam and to what the government is now describing as a consolidated investigation. (Because qui tam suits are filed “under seal,” no one but the relator and the government knows that the suit has been filed or what allegations are being made by the relator on behalf of the government. Initially, the government has 60 days to make a determination about whether to intervene in a case and to act as the plaintiff or to decline to intervene and allow the relator to act as the plaintiff in the suit, but extensions of time are frequently granted to allow the government additional time to investigate the allegations. Even if, in the course of an investigation, the court partially unseals a complaint to allow the government and a defendant to work to a resolution of the complaint’s allegations, the defendant is prohibited from revealing to anyone even that the partial unsealing has occurred. As the investigation proceeds, the Company may learn of additional qui tam suits filed against the Company or its affiliated hospitals or related entities, or that contact letters, document requests, or medical record requests the Company has received in the past
 
30

Table of Contents
COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) – (Continued)
 
from various governmental agencies are generated from qui tam cases filed under seal.) The motion filed on April 22, 2011 concluded by requesting a stay of the litigation in the Reuille case for 180 days, and on April 25, 2011, the court granted the motion. The Company’s management company subsidiary, Community Health Systems Professional Services Corporation, the defendant in the Reuille case, consented to the request for the stay. On October 19, 2011, the government filed an application to transfer the Reuille case to the Middle District of Tennessee or for an extension of the stay for an additional 180 days. The Company agreed that a stay for an additional, but shorter period of time, 90 days, was appropriate, but did not consent to the transfer of the case. The Company’s response setting forth the Company’s legal arguments was filed on October 24, 2011. On November 1, 2011, the court denied the motion to transfer the matter and extended the stay until April 30, 2012. On April 26, 2012, the Company joined the government and the relator in a motion to extend the stay in this case for an additional 180 days. As noted in that filing, the Company is working with the government on a probe audit of medical records (described above with respect to the April 2011 subpoena). The stay has been extended until October 29, 2012. The Company is cooperating fully with the government in its investigations.
Three purported class action shareholder federal securities cases have been filed in the United States District Court for the Middle District of Tennessee; namely, Norfolk County Retirement System v. Community Health Systems, Inc., Wayne T. Smith and W. Larry Cash, filed May 5, 2011; De Zheng v. Community Health Systems, Inc., Wayne T. Smith and W. Larry Cash, filed May 12, 2011; and Minneapolis Firefighters Relief Association v. Community Health Systems, Inc., Wayne T. Smith, W. Larry Cash and Thomas Mark Buford, filed June 2, 2011. All three seek class certification on behalf of purchasers of the Company’s common stock between July 27, 2006 and April 11, 2011 and allege that misleading statements resulted in artificially inflated prices for the Company’s common stock. On September 20, 2011, all three were assigned to the same judge as related cases. On December 28, 2011, the court consolidated all three shareholder cases for pretrial purposes, selected NYC Funds as lead plaintiffs, and selected NYC Funds’ counsel as lead plaintiffs’ counsel. The parties negotiated operative dates for these consolidated shareholder federal securities actions. An operative consolidated complaint was filed on July 13, 2012 and a responsive pleading is due September 11, 2012.
Three purported shareholder derivative actions have also been filed in the United States District Court for the Middle District of Tennessee; Plumbers and Pipefitters Local Union No. 630 Pension Annuity Trust Fund v. Wayne T. Smith, W. Larry Cash, T. Mark Buford, John A. Clerico, James S. Ely III, John A. Fry, William Norris Jennings, Julia B. North and H. Mitchell Watson, Jr., filed May 24, 2011; Roofers Local No. 149 Pension Fund v. Wayne T. Smith, W. Larry Cash, John A. Clerico, James S. Ely, III, John A. Fry, William Norris Jennings, Julia B. North and H. Mitchell Watson, Jr., filed June 21, 2011; and Lambert Sweat v. Wayne T. Smith, W. Larry Cash, T. Mark Buford, John A. Clerico, James S. Ely, III, John A. Fry, William Norris Jennings, Julia B. North, H. Mitchell Watson, Jr. and Community Health Systems, Inc., filed October 5, 2011. These three cases allege breach of fiduciary duty arising out of allegedly improper inpatient admission practices, mismanagement, waste and unjust enrichment. On September 28, 2011, the court ordered that the Plumbers and Pipefitters Local Union No. 630 Pension Annuity Trust Fund action and the Roofers Local No. 149 Pension Fund action be consolidated for pretrial purposes, and appointed the derivative plaintiffs’ lead counsel. On November 29, 2011, the court ordered that the Lambert Sweat action be consolidated with the Plumbers and Roofers consolidated derivative actions. The Plaintiffs filed an operative amended derivative complaint in these three consolidated actions on March 15, 2012. A motion to dismiss was filed on May 14, 2012 and Plaintiffs’ response was filed on July 13, 2012. A reply is due on August 27, 2012. The Company believes all of these matters are without merit and will vigorously defend them.
On May 2, 2012, suit was filed in the matter styled Daniel Eagle v. Community Health Systems, Inc., Chancery Court, State of Delaware. Suit was filed under Section 220 of the Delaware General Corporation Law to inspect certain of the Company’s books and records pertaining to matters concerning alleged improper admissions practices. An answer was filed on June 25, 2012 and the matter is set for a hearing on September 27, 2012. The Company is vigorously defending this action.
During the six months ended June 30, 2012, the Company met the deductible for its directors and officers insurance policy as it relates to the legal costs for the Tenet acquisition lawsuit and shareholder lawsuits of possible improper claims submitted to Medicare and Medicaid. As a result, the majority of future legal costs incurred related to these claims, covered by the directors and officers insurance policy, will be offset by insurance recoveries. The Company incurred the following pre-tax charges in connection with these legal matters and the government investigations, net of insurance recoveries, during the three and six months ending June 30, 2012 and 2011 (in thousands):

 	 	 	 	 	Three Months Ended
June  30,	 	 	 	 	 	Six Months Ended
June  30,	 	
 	 	 	 	 	        2012        	 	 	 	 	 	        2011        	 	 	 	 	 	        2012        	 	 	 	 	 	        2011        	 	
Professional fees and other related costs	 	$	 	  	 	 	(454)	  	 	$	 	  	 	 	6,174 	  	 	$	 	  	 	 	1,448 	  	 	$	 	  	 	 	6,174 	  	

31

Table of Contents
COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) – (Continued)
 
Probable Contingencies
In addition to the cases described above, there are a number of legal matters for which, based on information currently available, the Company believes that a negative outcome is known or is probable. In the aggregate, an estimate of these losses has been accrued in the amount of $20.4 million at June 30, 2012. Due to the uncertainties and difficulty in predicting the ultimate resolution of these contingencies, the actual amount could differ from the estimated amount; however, the Company does not believe the ultimate outcome of any of these matters would be material.
17.  SUBSEQUENT EVENTS
The Company evaluated all material events occurring subsequent to the balance sheet date for events requiring disclosure or recognition in the condensed consolidated financial statements.
Effective July 1, 2012, one or more subsidiaries of the Company completed the acquisition of Memorial Health Systems in York, Pennsylvania. This healthcare system includes Memorial Hospital (100 licensed beds), the Surgical Center of York, and other outpatient and ancillary services. The total cash consideration paid at closing for long-lived assets was $45.0 million and for preliminary net working capital was approximately $2.6 million. As part of this purchase agreement, the Company has agreed to spend at least $75.0 million to build a replacement hospital within five years of the closing date.
On July 3, 2012, CHS commenced a cash tender offer for any and all of the approximately $934 million outstanding principal amount of the 8 7/8% Senior Notes. The total consideration payable for each $1,000 principal amount of the 8  7 / 8 % Senior Notes validly tendered and not validly withdrawn prior to the consent expiration date of July 17, 2012 is $1,026, which includes a consent payment of $20 per $1,000 principal amount of notes. On July 18, 2012, CHS purchased approximately $639.7 million of the 8  7 / 8 % Senior Notes pursuant to the cash tender offer and notified holders of its intent to redeem all such remaining 8  7 / 8 % Senior Notes on August 17, 2012. The total consideration to be paid for each $1,000 principal amount of the 8  7 / 8 % Senior Notes validly tendered and not validly withdrawn after July 17, 2012 is $1,006 for each $1,000 principal amount of notes. The tender offer is scheduled to expire on August 1, 2012, unless extended or earlier terminated.
In addition, on July 18, 2012, CHS completed an offering to issue and sell $1.2 billion of 7 1/8% Senior Notes due 2020. The Company used the proceeds of the offering to purchase approximately $639.7 million of the 8  7 / 8 % Senior Notes that were validly tendered and not validly withdrawn in the cash tender offer commenced on July 3, 2012, to pay for consents delivered in connection therewith and to pay related fees and expenses. The Company intends to use the remaining proceeds to redeem any remaining 8  7 / 8 % Senior Notes and, to the extent any proceeds remain, for general corporate purposes.
18.  SUPPLEMENTAL CONDENSED CONSOLIDATING FINANCIAL INFORMATION
In 2007, CHS issued the 8 7/8% Senior Notes in the aggregate principal amount of approximately $3.0 billion. In 2011, CHS issued the 8% Senior Notes in the aggregate principal amount of $1.0 billion, the proceeds from which were used to purchase $1.0 billion of the 8  7 / 8 % Senior Notes. In addition, CHS issued an additional $1.0 billion of 8% Senior Notes in March 2012, the proceeds from which were used to purchase $850 million of 8  7 / 8 % Senior Notes. The 8  7 / 8 % Senior Notes and 8% Senior Notes are senior unsecured obligations of CHS and are guaranteed on a senior basis by the Company and by certain of its existing and subsequently acquired or organized 100% owned domestic subsidiaries.
Both the 8 7/8% Senior Notes and the 8% Senior Notes are guaranteed on a joint and several basis, with limited exceptions considered customary for such guarantees, including the release of the guarantee when a subsidiary’s assets used in operations are sold. The following condensed consolidating financial statements present Community Health Systems, Inc. (as parent guarantor), CHS (as the issuer), the subsidiary guarantors, the subsidiary non-guarantors and eliminations. These condensed consolidating financial statements have been prepared and presented in accordance with SEC Regulation S-X Rule 3-10 “Financial Statements of Guarantors and Issuers of Guaranteed Securities Registered or Being Registered.”
The accounting policies used in the preparation of this financial information are consistent with those elsewhere in the consolidated financial statements of the Company, except as noted below:
 
 	•	 	Intercompany receivables and payables are presented gross in the supplemental condensed consolidating balance sheets.	
 
32

Table of Contents
COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) – (Continued)
 
 	•	 	Cash flows from intercompany transactions are presented in cash flows from financing activities, as changes in intercompany balances with affiliates, net.	
 
 	•	 	Income tax expense is allocated from the parent guarantor to the income producing operations (other guarantors and non-guarantors) and the issuer through stockholders’ equity. As this approach represents an allocation, the income tax expense allocation is considered non-cash for statement of cash flow purposes.	
 
 	•	 	Interest expense, net has been presented to reflect net interest expense and interest income from outstanding long-term debt and intercompany balances.	
The Company’s intercompany activity consists primarily of daily cash transfers for purposes of cash management, the allocation of certain expenses and expenditures paid for by the parent on behalf of its subsidiaries, and the push down of investment in its subsidiaries. This activity also includes the intercompany transactions between consolidated entities as part of the Receivables Facility that is further discussed in Note 11. The Company’s subsidiaries generally do not purchase services from one another; thus, the intercompany transactions do not represent revenue generating transactions. All intercompany transactions eliminate in consolidation.
From time to time, the Company sells and/or repurchases noncontrolling interests in consolidated subsidiaries, which may change subsidiaries between guarantors and non-guarantors. Amounts for prior periods are restated to reflect the status of guarantors or non-guarantors as of June 30, 2012.
 
33

Table of Contents
COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) – (Continued)
 
Condensed Consolidating Balance Sheet
June 30, 2012

 	  	Parent
Guarantor	 	  	Issuer	 	  	Other
Guarantors	 	  	Non -
Guarantors	 	  	Eliminations	 	  	Consolidated	 	
 	  	(In thousands)	 	
 	
ASSETS	  	
 	 	 	 	 	 	 	
Current assets:	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Cash and cash equivalents	  	  $	-	  	  	  $	-	  	  	  $	12,722	  	  	  $	102,387	  	  	  $	-	  	  	  $	115,109	  	
Patient accounts receivable, net of allowance for doubtful accounts	  	 	-	  	  	 	-	  	  	 	617,545	  	  	 	1,437,747	  	  	 	-	  	  	 	2,055,292	  	
Supplies	  	 	-	  	  	 	-	  	  	 	239,339	  	  	 	119,258	  	  	 	-	  	  	 	358,597	  	
Deferred income taxes	  	 	89,797	  	  	 	-	  	  	 	-	  	  	 	-	  	  	 	-	  	  	 	89,797	  	
Prepaid expenses and taxes	  	 	16,721	  	  	 	18	  	  	 	96,300	  	  	 	30,565	  	  	 	-	  	  	 	143,604	  	
Other current assets	  	 	-	  	  	 	-	  	  	 	159,736	  	  	 	75,028	  	  	 	-	  	  	 	234,764	  	
 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Total current assets	  	 	106,518	  	  	 	18	  	  	 	1,125,642	  	  	 	1,764,985	  	  	 	-	  	  	 	2,997,163	  	
Intercompany receivable	  	 	1,262,531	  	  	 	9,700,772	  	  	 	3,165,271	  	  	 	2,202,583	  	  	 	(16,331,157)	  	  	 	-	  	
Property and equipment, net	  	 	-	  	  	 	-	  	  	 	4,696,549	  	  	 	2,351,676	  	  	 	-	  	  	 	7,048,225	  	
Goodwill	  	 	-	  	  	 	-	  	  	 	2,511,192	  	  	 	1,861,801	  	  	 	-	  	  	 	4,372,993	  	
Other assets, net of accumulated amortization	  	 	-	  	  	 	127,205	  	  	 	665,677	  	  	 	661,743	  	  	 	-	  	  	 	1,454,625	  	
Net investment in subsidiaries	  	 	1,942,226	  	  	 	6,677,251	  	  	 	3,679,952	  	  	 	-	  	  	 	(12,299,429)	  	  	 	-	  	
 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Total assets	  	  $	    3,311,275	  	  	  $	    16,505,246	  	  	  $	    15,844,283	  	  	  $	    8,842,788	  	  	  $	    (28,630,586)	  	  	  $	    15,873,006	  	

LIABILITIES AND EQUITY	  	
 	 	 	 	 	 	 	
Current liabilities:	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Current maturities of long-term debt	  	  $	-	  	  	  $	61,250	  	  	  $	19,095	  	  	  $	3,532	  	  	  $	-	  	  	  $	83,877	  	
Accounts payable	  	 	-	  	  	 	26	  	  	 	571,967	  	  	 	198,457	  	  	 	-	  	  	 	770,450	  	
Accrued interest	  	 	-	  	  	 	82,295	  	  	 	125	  	  	 	322	  	  	 	-	  	  	 	82,742	  	
Accrued liabilities	  	 	7,580	  	  	 	-	  	  	 	631,145	  	  	 	323,331	  	  	 	-	  	  	 	962,056	  	
 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Total current liabilities	  	 	7,580	  	  	 	143,571	  	  	 	1,222,332	  	  	 	525,642	  	  	 	-	  	  	 	1,899,125	  	
Long-term debt	  	 	-	  	  	 	8,868,681	  	  	 	53,652	  	  	 	319,156	  	  	 	-	  	  	 	9,241,489	  	
Intercompany payable	  	 	-	  	  	 	5,330,843	  	  	 	11,663,052	  	  	 	7,131,049	  	  	 	(24,124,944)	  	  	 	-	  	
Deferred income taxes	  	 	704,725	  	  	 	-	  	  	 	-	  	  	 	-	  	  	 	-	  	  	 	704,725	  	
Other long-term liabilities	  	 	2,888	  	  	 	219,930	  	  	 	591,168	  	  	 	184,998	  	  	 	-	  	  	 	998,984	  	
 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Total liabilities	  	 	715,193	  	  	 	14,563,025	  	  	 	13,530,204	  	  	 	8,160,845	  	  	 	(24,124,944)	  	  	 	12,844,323	  	
Redeemable noncontrolling interests in equity of consolidated subsidiaries	  	 	-	  	  	 	-	  	  	 	-	  	  	 	367,909	  	  	 	-	  	  	 	367,909	  	
 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Equity:	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Community Health Systems, Inc. stockholders’ equity:	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Preferred stock	  	 	-	  	  	 	-	  	  	 	-	  	  	 	-	  	  	 	-	  	  	 	-	  	
Common stock	  	 	919	  	  	 	-	  	  	 	1	  	  	 	2	  	  	 	(3)	  	  	 	919	  	
Additional paid-in capital	  	 	1,101,224	  	  	 	792,366	  	  	 	878,917	  	  	 	94,001	  	  	 	(1,765,284)	  	  	 	1,101,224	  	
Treasury stock, at cost	  	 	(6,678)	  	  	 	-	  	  	 	-	  	  	 	-	  	  	 	-	  	  	 	(6,678)	  	
Accumulated other comprehensive (loss) income	  	 	(159,546)	  	  	 	(159,546)	  	  	 	(17,267)	  	  	 	-	  	  	 	176,813	  	  	 	(159,546)	  	
Retained earnings	  	 	1,660,163	  	  	 	1,309,401	  	  	 	1,452,428	  	  	 	155,339	  	  	 	(2,917,168)	  	  	 	1,660,163	  	
 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Total Community Health Systems, Inc. stockholders’ equity	  	 	2,596,082	  	  	 	1,942,221	  	  	 	2,314,079	  	  	 	249,342	  	  	 	(4,505,642)	  	  	 	2,596,082	  	
Noncontrolling interests in equity of consolidated subsidiaries	  	 	-	  	  	 	-	  	  	 	-	  	  	 	64,692	  	  	 	-	  	  	 	64,692	  	
 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Total equity	  	 	2,596,082	  	  	 	1,942,221	  	  	 	2,314,079	  	  	 	314,034	  	  	 	(4,505,642)	  	  	 	2,660,774	  	
 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Total liabilities and equity	  	  $	3,311,275	  	  	  $	16,505,246	  	  	  $	15,844,283	  	  	  $	8,842,788	  	  	  $	(28,630,586)	  	  	  $	15,873,006	  	

34

Table of Contents
COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) – (Continued)
 
Condensed Consolidating Balance Sheet
December 31, 2011

 	  	Parent
Guarantor	 	  	Issuer	 	  	Other
Guarantors	 	  	Non -
Guarantors	 	  	Eliminations	 	  	Consolidated	 	
 	  	(In thousands)	 	
 	
ASSETS	  	
 	 	 	 	 	 	 	
Current assets:	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Cash and cash equivalents	  	  $	-	  	  	  $	-	  	  	  $	12,289 	 	  	  $	117,576 	 	  	  $	-	  	  	  $	129,865 	 	
Patient accounts receivable, net of allowance for doubtful accounts	  	 	-	  	  	 	-	  	  	 	1,135,909 	 	  	 	698,258 	 	  	 	-	  	  	 	1,834,167 	 	
Supplies	  	 	-	  	  	 	-	  	  	 	227,864 	 	  	 	118,747 	 	  	 	-	  	  	 	346,611 	 	
Deferred income taxes	  	 	89,797 	 	  	 	-	  	  	 	-	  	  	 	-	  	  	 	-	  	  	 	89,797 	 	
Prepaid expenses and taxes	  	 	101,389 	 	  	 	117 	 	  	 	86,368 	 	  	 	26,128 	 	  	 	-	  	  	 	214,002 	 	
Other current assets	  	 	-	  	  	 	10,235 	 	  	 	145,446 	 	  	 	75,966 	 	  	 	-	  	  	 	231,647 	 	
 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Total current assets	  	 	191,186 	 	  	 	10,352 	 	  	 	1,607,876 	 	  	 	1,036,675 	 	  	 	-	  	  	 	2,846,089 	 	
Intercompany receivable	  	 	1,160,785 	 	  	 	9,294,295 	 	  	 	1,735,734 	 	  	 	1,672,003 	 	  	 	(13,862,817)	  	  	 	-	  	
Property and equipment, net	  	 	-	  	  	 	-	  	  	 	4,524,901 	 	  	 	2,331,075 	 	  	 	-	  	  	 	6,855,976 	 	
Goodwill	  	 	-	  	  	 	-	  	  	 	2,412,517 	 	  	 	1,852,328 	 	  	 	-	  	  	 	4,264,845 	 	
Other assets, net of accumulated amortization	  	 	-	  	  	 	99,521 	 	  	 	508,066 	 	  	 	634,343 	 	  	 	-	  	  	 	1,241,930 	 	
Net investment in subsidiaries	  	 	1,758,458 	 	  	 	6,457,992 	 	  	 	2,412,694 	 	  	 	-	  	  	 	(10,629,144)	  	  	 	-	  	
 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Total assets	  	  $	    3,110,429 	 	  	  $	    15,862,160 	 	  	  $	    13,201,788 	 	  	  $	    7,526,424 	 	  	  $	    (24,491,961)	  	  	  $	    15,208,840 	 	

LIABILITIES AND EQUITY	  	
 	 	 	 	 	 	 	
Current liabilities:	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Current maturities of long-term debt	  	  $	-	  	  	  $	49,954 	 	  	  $	10,087 	 	  	  $	3,665 	 	  	  $	-	  	  	  $	63,706 	 	
Accounts payable	  	 	-	  	  	 	345 	 	  	 	526,255 	 	  	 	222,397 	 	  	 	-	  	  	 	748,997 	 	
Accrued interest	  	 	-	  	  	 	109,984 	 	  	 	131 	 	  	 	6 	 	  	 	-	  	  	 	110,121 	 	
Accrued liabilities	  	 	7,580 	 	  	 	567 	 	  	 	677,229 	 	  	 	302,939 	 	  	 	-	  	  	 	988,315 	 	
 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Total current liabilities	  	 	7,580 	 	  	 	160,850 	 	  	 	1,213,702 	 	  	 	529,007 	 	  	 	-	  	  	 	1,911,139 	 	
Long-term debt	  	 	-	  	  	 	8,707,805 	 	  	 	54,628 	 	  	 	20,365 	 	  	 	-	  	  	 	8,782,798 	 	
Intercompany payable	  	 	-	  	  	 	4,980,822 	 	  	 	9,385,406 	 	  	 	6,084,097 	 	  	 	(20,450,325)	  	  	 	-	  	
Deferred income taxes	  	 	704,725 	 	  	 	-	  	  	 	-	  	  	 	-	  	  	 	-	  	  	 	704,725 	 	
Other long-term liabilities	  	 	1,028 	 	  	 	254,228 	 	  	 	433,452 	 	  	 	261,282 	 	  	 	-	  	  	 	949,990 	 	
 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Total liabilities	  	 	713,333 	 	  	 	14,103,705 	 	  	 	11,087,188 	 	  	 	6,894,751 	 	  	 	(20,450,325)	  	  	 	12,348,652 	 	
Redeemable noncontrolling interests in equity of consolidated subsidiaries	  	 	-	  	  	 	-	  	  	 	-	  	  	 	395,743 	 	  	 	-	  	  	 	395,743 	 	
 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Equity:	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Community Health Systems, Inc. stockholders’ equity:	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Preferred stock	  	 	-	  	  	 	-	  	  	 	-	  	  	 	-	  	  	 	-	  	  	 	-	  	
Common stock	  	 	915 	 	  	 	-	  	  	 	1 	 	  	 	2 	 	  	 	(3)	  	  	 	915 	 	
Additional paid-in capital	  	 	1,086,008 	 	  	 	701,399 	 	  	 	771,199 	 	  	 	60,857 	 	  	 	(1,533,455)	  	  	 	1,086,008 	 	
Treasury stock, at cost	  	 	(6,678)	  	  	 	-	  	  	 	-	  	  	 	-	  	  	 	-	  	  	 	(6,678)	  	
Accumulated other comprehensive (loss) income	  	 	(184,479)	  	  	 	(184,479)	  	  	 	(21,687)	  	  	 	-	  	  	 	206,166 	 	  	 	(184,479)	  	
Retained earnings	  	 	1,501,330 	 	  	 	1,241,535 	 	  	 	1,365,087 	 	  	 	107,722 	 	  	 	(2,714,344)	  	  	 	1,501,330 	 	
 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Total Community Health Systems, Inc. stockholders’ equity	  	 	2,397,096 	 	  	 	1,758,455 	 	  	 	2,114,600 	 	  	 	168,581 	 	  	 	(4,041,636)	  	  	 	2,397,096 	 	
Noncontrolling interests in equity of consolidated subsidiaries	  	 	-	  	  	 	-	  	  	 	-	  	  	 	67,349 	 	  	 	-	  	  	 	67,349 	 	
 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Total equity	  	 	2,397,096 	 	  	 	1,758,455 	 	  	 	2,114,600 	 	  	 	235,930 	 	  	 	(4,041,636)	  	  	 	2,464,445 	 	
 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Total liabilities and equity	  	  $	3,110,429 	 	  	  $	15,862,160 	 	  	  $	13,201,788 	 	  	  $	7,526,424 	 	  	  $	(24,491,961)	  	  	  $	15,208,840 	 	

35

Table of Contents
COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) – (Continued)
 
Condensed Consolidating Statement of Income
Three Months Ended June 30, 2012

 	  	Parent
Guarantor	 	  	Issuer	 	  	Other
Guarantors	 	  	Non -
Guarantors	 	  	  Eliminations  	 	  	Consolidated	 	
 	  	(In thousands)	 	
 	 	 	 	 	 	 	
Operating revenues (net of contractual allowances and discounts)	  	  $	-	  	  	  $	(2,666)	  	  	  $	2,328,946 	 	  	  $	1,420,148 	 	  	  $	-	  	  	  $	3,746,428 	 	
Provision for bad debts	  	 	-	  	  	 	-	  	  	 	316,982 	 	  	 	186,472 	 	  	 	-	  	  	 	503,454 	 	
 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Net operating revenues	  	 	-	  	  	 	(2,666)	  	  	 	2,011,964 	 	  	 	1,233,676 	 	  	 	-	  	  	 	3,242,974 	 	
Operating costs and expenses:	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Salaries and benefits	  	 	-	  	  	 	-	  	  	 	886,435 	 	  	 	611,011 	 	  	 	-	  	  	 	1,497,446 	 	
Supplies	  	 	-	  	  	 	-	  	  	 	325,281 	 	  	 	164,448 	 	  	 	-	  	  	 	489,729 	 	
Other operating expenses	  	 	-	  	  	 	20 	 	  	 	447,530 	 	  	 	288,675 	 	  	 	-	  	  	 	736,225 	 	
Electronic health records incentive reimbursement	  	 	-	  	  	 	-	  	  	 	(6,313)	  	  	 	(10,489)	  	  	 	-	  	  	 	(16,802)	  	
Rent	  	 	-	  	  	 	-	  	  	 	36,692 	 	  	 	29,771 	 	  	 	-	  	  	 	66,463 	 	
Depreciation and amortization	  	 	-	  	  	 	-	  	  	 	119,422 	 	  	 	60,379 	 	  	 	-	  	  	 	179,801 	 	
 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Total operating costs and expenses	  	 	-	  	  	 	20 	 	  	 	    1,809,047 	 	  	 	    1,143,795 	 	  	 	-	  	  	 	    2,952,862 	 	
 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Income from operations	  	 	-	  	  	 	(2,686)	  	  	 	202,917 	 	  	 	89,881 	 	  	 	-	  	  	 	290,112 	 	
Interest expense, net	  	 	-	  	  	 	17,588 	 	  	 	123,132 	 	  	 	10,887 	 	  	 	-	  	  	 	151,607 	 	
Loss from early extinguishment of debt	  	 	-	  	  	 	-	  	  	 	-	  	  	 	-	  	  	 	-	  	  	 	-	  	
Equity in earnings of unconsolidated affiliates	  	 	    (83,359)	  	  	 	(84,540)	  	  	 	(50,097)	  	  	 	-	  	  	 	204,815 	 	  	 	(13,181)	  	
 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Income from continuing operations before income taxes	  	 	83,359 	 	  	 	64,266 	 	  	 	129,882 	 	  	 	78,994 	 	  	 	(204,815)	  	  	 	151,686 	 	
Provision for (benefit from) income taxes	  	 	-	  	  	 	    (19,093)	  	  	 	46,887 	 	  	 	21,725 	 	  	 	-	  	  	 	49,519 	 	
 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Income from continuing operations	  	 	83,359 	 	  	 	83,359 	 	  	 	82,995 	 	  	 	57,269 	 	  	 	(204,815)	  	  	 	102,167 	 	
Discontinued operations, net of taxes:	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Income (loss) from operations of entities sold	  	 	-	  	  	 	-	  	  	 	-	  	  	 	-	  	  	 	-	  	  	 	-	  	
Impairment of hospitals sold	  	 	-	  	  	 	-	  	  	 	-	  	  	 	-	  	  	 	-	  	  	 	-	  	
Loss on sale, net	  	 	-	  	  	 	-	  	  	 	-	  	  	 	-	  	  	 	-	  	  	 	-	  	
 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Loss from discontinued operations, net of taxes	  	 	-	  	  	 	-	  	  	 	-	  	  	 	-	  	  	 	-	  	  	 	-	  	
 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Net income	  	 	83,359 	 	  	 	83,359 	 	  	 	82,995 	 	  	 	57,269 	 	  	 	(204,815)	  	  	 	102,167 	 	
Less: Net income attributable to noncontrolling interests	  	 	-	  	  	 	-	  	  	 	-	  	  	 	18,808 	 	  	 	-	  	  	 	18,808 	 	
 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Net income attributable to Community Health Systems, Inc.	  	  $	83,359 	 	  	  $	83,359 	 	  	  $	82,995 	 	  	  $	38,461 	 	  	  $	    (204,815)	  	  	  $	83,359 	 	

36

Table of Contents
COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) – (Continued)
 
Condensed Consolidating Statement of Income
Three Months Ended June 30, 2011

 	  	Parent
Guarantor	 	  	Issuer	 	  	Other
Guarantors	 	  	Non -
Guarantors	 	  	  Eliminations  	 	  	Consolidated	 	
 	  	(In thousands)	 	
 	 	 	 	 	 	 	
Operating revenues (net of contractual allowances and discounts)	  	  $	-	  	  	  $	-	  	  	  $	    2,166,347 	 	  	  $	    1,267,482 	 	  	  $	-	  	  	  $	    3,433,829 	 	
Provision for bad debts	  	 	-	  	  	 	-	  	  	 	279,173 	 	  	 	153,829 	 	  	 	-	  	  	 	433,002 	 	
 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Net operating revenues	  	 	-	  	  	 	-	  	  	 	1,887,174 	 	  	 	1,113,653 	 	  	 	-	  	  	 	3,000,827 	 	
Operating costs and expenses:	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Salaries and benefits	  	 	-	  	  	 	-	  	  	 	820,221 	 	  	 	563,875 	 	  	 	-	  	  	 	1,384,096 	 	
Supplies	  	 	-	  	  	 	-	  	  	 	296,768 	 	  	 	152,511 	 	  	 	-	  	  	 	449,279 	 	
Other operating expenses	  	 	-	  	  	 	-	  	  	 	432,436 	 	  	 	222,301 	 	  	 	-	  	  	 	654,737 	 	
Electronic health records incentive reimbursement	  	 	-	  	  	 	-	  	  	 	-	  	  	 	-	  	  	 	-	  	  	 	-	  	
Rent	  	 	-	  	  	 	-	  	  	 	33,683 	 	  	 	28,748 	 	  	 	-	  	  	 	62,431 	 	
Depreciation and amortization	  	 	-	  	  	 	-	  	  	 	103,613 	 	  	 	57,763 	 	  	 	-	  	  	 	161,376 	 	
 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Total operating costs and expenses	  	 	-	  	  	 	-	  	  	 	1,686,721 	 	  	 	1,025,198 	 	  	 	-	  	  	 	2,711,919 	 	
 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Income from operations	  	 	-	  	  	 	-	  	  	 	200,453 	 	  	 	88,455 	 	  	 	-	  	  	 	288,908 	 	
Interest expense, net	  	 	-	  	  	 	22,212 	 	  	 	120,921 	 	  	 	20,097 	 	  	 	-	  	  	 	163,230 	 	
Loss from early extinguishment of debt	  	 	-	  	  	 	-	  	  	 	-	  	  	 	-	  	  	 	-	  	  	 	-	  	
Equity in earnings of unconsolidated affiliates	  	 	    (35,389)	  	  	 	    (54,818)	  	  	 	(2,180)	  	  	 	-	  	  	 	80,370 	 	  	 	(12,017)	  	
 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Income from continuing operations before income taxes	  	 	35,389 	 	  	 	32,606 	 	  	 	81,712 	 	  	 	68,358 	 	  	 	(80,370)	  	  	 	137,695 	 	
Provision for (benefit from) income taxes	  	 	-	  	  	 	(2,783)	  	  	 	29,498 	 	  	 	18,106 	 	  	 	-	  	  	 	44,821 	 	
 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Income from continuing operations	  	 	35,389 	 	  	 	35,389 	 	  	 	52,214 	 	  	 	50,252 	 	  	 	(80,370)	  	  	 	92,874 	 	
Discontinued operations, net of taxes:	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Income (loss) from operations of entities sold	  	 	-	  	  	 	-	  	  	 	-	  	  	 	235 	 	  	 	-	  	  	 	235 	 	
Impairment of hospitals sold	  	 	-	  	  	 	-	  	  	 	-	  	  	 	(39,562)	  	  	 	-	  	  	 	(39,562)	  	
Loss on sale, net	  	 	-	  	  	 	-	  	  	 	-	  	  	 	-	  	  	 	-	  	  	 	-	  	
 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Loss from discontinued operations, net of taxes	  	 	-	  	  	 	-	  	  	 	-	  	  	 	(39,327)	  	  	 	-	  	  	 	(39,327)	  	
 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Net income	  	 	35,389 	 	  	 	35,389 	 	  	 	52,214 	 	  	 	10,925 	 	  	 	(80,370)	  	  	 	53,547 	 	
Less: Net income attributable to noncontrolling interests	  	 	-	  	  	 	-	  	  	 	-	  	  	 	18,158 	 	  	 	-	  	  	 	18,158 	 	
 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Net income attributable to Community Health Systems, Inc.	  	  $	35,389 	 	  	  $	35,389 	 	  	  $	52,214 	 	  	  $	(7,233)	  	  	  $	    (80,370)	  	  	  $	35,389 	 	

37

Table of Contents
COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) – (Continued)
 
Condensed Consolidating Statement of Income
Six Months Ended June 30, 2012

 	  	Parent
    Guarantor    	 	  	    Issuer    	 	  	Other
Guarantors	 	  	Non -
Guarantors	 	  	  Eliminations  	 	  	Consolidated	 	
 	  	(In thousands)	 	
 	 	 	 	 	 	 	
Operating revenues (net of contractual allowances and discounts)	  	  $	-	  	  	  $	(4,430)	  	  	  $	    4,626,438 	 	  	  $	    2,907,911 	 	  	  $	-	  	  	  $	    7,529,919 	 	
Provision for bad debts	  	 	-	  	  	 	-	  	  	 	640,525 	 	  	 	349,385 	 	  	 	-	  	  	 	989,910 	 	
 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Net operating revenues	  	 	-	  	  	 	(4,430)	  	  	 	3,985,913 	 	  	 	2,558,526 	 	  	 	-	  	  	 	6,540,009 	 	
Operating costs and expenses:	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Salaries and benefits	  	 	-	  	  	 	-	  	  	 	1,737,847 	 	  	 	1,284,574 	 	  	 	-	  	  	 	3,022,421 	 	
Supplies	  	 	-	  	  	 	-	  	  	 	626,609 	 	  	 	361,699 	 	  	 	-	  	  	 	988,308 	 	
Other operating expenses	  	 	-	  	  	 	334 	 	  	 	893,402 	 	  	 	551,432 	 	  	 	-	  	  	 	1,445,168 	 	
Electronic health records incentive reimbursement	  	 	-	  	  	 	-	  	  	 	(24,392)	  	  	 	(18,578)	  	  	 	-	  	  	 	(42,970)	  	
Rent	  	 	-	  	  	 	-	  	  	 	71,497 	 	  	 	62,190 	 	  	 	-	  	  	 	133,687 	 	
Depreciation and amortization	  	 	-	  	  	 	-	  	  	 	230,554 	 	  	 	123,601 	 	  	 	-	  	  	 	354,155 	 	
 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Total operating costs and expenses	  	 	-	  	  	 	334 	 	  	 	3,535,517 	 	  	 	2,364,918 	 	  	 	-	  	  	 	5,900,769 	 	
 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Income from operations	  	 	-	  	  	 	(4,764)	  	  	 	450,396 	 	  	 	193,608 	 	  	 	-	  	  	 	639,240 	 	
Interest expense, net	  	 	-	  	  	 	33,325 	 	  	 	246,550 	 	  	 	23,907 	 	  	 	-	  	  	 	303,782 	 	
Loss from early extinguishment of debt	  	 	-	  	  	 	63,429 	 	  	 	-	  	  	 	-	  	  	 	-	  	  	 	63,429 	 	
Equity in earnings of unconsolidated affiliates	  	 	(158,833)	  	  	 	(199,603)	  	  	 	(101,412)	  	  	 	-	  	  	 	434,654 	 	  	 	(25,194)	  	
 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Income from continuing operations before income taxes	  	 	158,833 	 	  	 	98,085 	 	  	 	305,258 	 	  	 	169,701 	 	  	 	(434,654)	  	  	 	297,223 	 	
Provision for (benefit from) income taxes	  	 	-	  	  	 	(60,748)	  	  	 	110,198 	 	  	 	45,888 	 	  	 	-	  	  	 	95,338 	 	
 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Income from continuing operations	  	 	158,833 	 	  	 	158,833 	 	  	 	195,060 	 	  	 	123,813 	 	  	 	(434,654)	  	  	 	201,885 	 	
Discontinued operations, net of taxes:	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Income (loss) from operations of entities sold	  	 	-	  	  	 	-	  	  	 	-	  	  	 	(466)	  	  	 	-	  	  	 	(466)	  	
Impairment of hospitals sold	  	 	-	  	  	 	-	  	  	 	-	  	  	 	-	  	  	 	-	  	  	 	-	  	
Loss on sale, net	  	 	-	  	  	 	-	  	  	 	-	  	  	 	-	  	  	 	-	  	  	 	-	  	
 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Loss from discontinued operations, net of taxes	  	 	-	  	  	 	-	  	  	 	-	  	  	 	(466)	  	  	 	-	  	  	 	(466)	  	
 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Net income	  	 	158,833 	 	  	 	158,833 	 	  	 	195,060 	 	  	 	123,347 	 	  	 	(434,654)	  	  	 	201,419 	 	
Less: Net income attributable to noncontrolling interests	  	 	-	  	  	 	-	  	  	 	-	  	  	 	42,586 	 	  	 	-	  	  	 	42,586 	 	
 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Net income attributable to Community Health Systems, Inc.	  	  $	158,833 	 	  	  $	        158,833 	 	  	  $	195,060 	 	  	  $	80,761 	 	  	  $	(434,654)	  	  	  $	158,833 	 	

38

Table of Contents
COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) – (Continued)
 
Condensed Consolidating Statement of Income
Six Months Ended June 30, 2011

 	  	Parent
    Guarantor    	 	  	    Issuer    	 	  	Other
Guarantors	 	  	Non -
Guarantors	 	  	  Eliminations  	 	  	Consolidated	 	
 	  	(In thousands)	 	
 	 	 	 	 	 	 	
Operating revenues (net of contractual allowances and discounts)	  	  $	-	  	  	  $	-	  	  	  $	    4,131,437 	 	  	  $	    2,656,444 	 	  	  $	-	  	  	  $	    6,787,881 	 	
Provision for bad debts	  	 	-	  	  	 	-	  	  	 	524,706 	 	  	 	308,265 	 	  	 	-	  	  	 	832,971 	 	
 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Net operating revenues	  	 	-	  	  	 	-	  	  	 	3,606,731 	 	  	 	2,348,179 	 	  	 	-	  	  	 	5,954,910 	 	
Operating costs and expenses:	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Salaries and benefits	  	 	-	  	  	 	-	  	  	 	1,574,209 	 	  	 	1,189,254 	 	  	 	-	  	  	 	2,763,463 	 	
Supplies	  	 	-	  	  	 	-	  	  	 	565,371 	 	  	 	341,725 	 	  	 	-	  	  	 	907,096 	 	
Other operating expenses	  	 	-	  	  	 	-	  	  	 	783,105 	 	  	 	486,425 	 	  	 	-	  	  	 	1,269,530 	 	
Electronic health records incentive reimbursement	  	 	-	  	  	 	-	  	  	 	-	  	  	 	-	  	  	 	-	  	  	 	-	  	
Rent	  	 	-	  	  	 	-	  	  	 	65,172 	 	  	 	60,429 	 	  	 	-	  	  	 	125,601 	 	
Depreciation and amortization	  	 	-	  	  	 	-	  	  	 	199,169 	 	  	 	120,362 	 	  	 	-	  	  	 	319,531 	 	
 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Total operating costs and expenses	  	 	-	  	  	 	-	  	  	 	3,187,026 	 	  	 	2,198,195 	 	  	 	-	  	  	 	5,385,221 	 	
 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Income from operations	  	 	-	  	  	 	-	  	  	 	419,705 	 	  	 	149,984 	 	  	 	-	  	  	 	569,689 	 	
Interest expense, net	  	 	-	  	  	 	50,315 	 	  	 	240,279 	 	  	 	35,854 	 	  	 	-	  	  	 	326,448 	 	
Loss from early extinguishment of debt	  	 	-	  	  	 	-	  	  	 	-	  	  	 	-	  	  	 	-	  	  	 	-	  	
Equity in earnings of unconsolidated affiliates	  	 	(96,713)	  	  	 	(134,254)	  	  	 	(23,278)	  	  	 	-	  	  	 	224,094 	 	  	 	(30,151)	  	
 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Income from continuing operations before income taxes	  	 	96,713 	 	  	 	83,939 	 	  	 	202,704 	 	  	 	114,130 	 	  	 	(224,094)	  	  	 	273,392 	 	
Provision for (benefit from) income taxes	  	 	-	  	  	 	(12,774)	  	  	 	73,176 	 	  	 	28,511 	 	  	 	-	  	  	 	88,913 	 	
 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Income from continuing operations	  	 	96,713 	 	  	 	96,713 	 	  	 	129,528 	 	  	 	85,619 	 	  	 	(224,094)	  	  	 	184,479 	 	
Discontinued operations, net of taxes:	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Income (loss) from operations of entities sold	  	 	-	  	  	 	-	  	  	 	-	  	  	 	(1,443)	  	  	 	-	  	  	 	(1,443)	  	
Impairment of hospitals sold	  	 	-	  	  	 	-	  	  	 	-	  	  	 	(47,930)	  	  	 	-	  	  	 	(47,930)	  	
Loss on sale, net	  	 	-	  	  	 	-	  	  	 	-	  	  	 	(3,234)	  	  	 	-	  	  	 	(3,234)	  	
 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Loss from discontinued operations, net of taxes	  	 	-	  	  	 	-	  	  	 	-	  	  	 	(52,607)	  	  	 	-	  	  	 	(52,607)	  	
 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Net income	  	 	96,713 	 	  	 	96,713 	 	  	 	129,528 	 	  	 	33,012 	 	  	 	(224,094)	  	  	 	131,872 	 	
Less: Net income attributable to noncontrolling interests	  	 	-	  	  	 	-	  	  	 	-	  	  	 	35,159 	 	  	 	-	  	  	 	35,159 	 	
 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Net income attributable to Community Health Systems, Inc.	  	  $	96,713 	 	  	  $	        96,713 	 	  	  $	129,528 	 	  	  $	(2,147)	  	  	  $	(224,094)	  	  	  $	96,713 	 	

39

Table of Contents
COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) – (Continued)
 
Condensed Consolidating Statement of Comprehensive Income
Three Months Ended June 30, 2012

 	  	Parent
   Guarantor   	 	  	      Issuer      	 	  	Other
  Guarantors  	 	  	Non -
  Guarantors  	 	  	  Eliminations  	 	  	  Consolidated  	 	
 	  	(In thousands)
 	 	
Net income	  	  $	    83,359 	 	  	  $	    83,359 	 	  	  $	    82,995 	 	  	  $	    57,269 	 	  	  $	(204,815)	  	  	  $	    102,167 	 	
Other comprehensive income (loss), net of taxes	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Net change in fair value of interest rate swaps	  	 	9,976 	 	  	 	9,976 	 	  	 	-	  	  	 	-	  	  	 	(9,976)	  	  	 	9,976 	 	
Net change in fair value of available-for-sale securities	  	 	(527)	  	  	 	(527)	  	  	 	(527)	  	  	 	-	  	  	 	1,054 	 	  	 	(527)	  	
Amortization and recognition of unrecognized pension cost components	  	 	1,140 	 	  	 	1,140 	 	  	 	1,140 	 	  	 	-	  	  	 	(2,280)	  	  	 	1,140 	 	
 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Other comprehensive income (loss)	  	 	10,589 	 	  	 	10,589 	 	  	 	613 	 	  	 	-	  	  	 	(11,202)	  	  	 	10,589 	 	
 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Comprehensive income	  	 	93,948 	 	  	 	93,948 	 	  	 	83,608 	 	  	 	57,269 	 	  	 	(216,017)	  	  	 	112,756 	 	
Less: Comprehensive income attributable to noncontrolling interests	  	 	-	  	  	 	-	  	  	 	-	  	  	 	18,808 	 	  	 	-	  	  	 	18,808 	 	
 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Comprehensive income attributable to Community Health Systems, Inc.	  	  $	93,948 	 	  	  $	        93,948 	 	  	  $	83,608 	 	  	  $	38,461 	 	  	  $	(216,017)	  	  	  $	93,948 	 	

 
Condensed Consolidating Statement of Comprehensive Income
Three Months Ended June 30, 2011

 	  	Parent
   Guarantor   	 	  	      Issuer      	 	  	Other
  Guarantors  	 	  	Non -
  Guarantors  	 	  	  Eliminations  	 	  	  Consolidated  	 	
 	  	(In thousands)
 	 	
Net income	  	  $	    35,389 	 	  	  $	    35,389 	 	  	  $	    52,214 	 	  	  $	    10,925 	 	  	  $	(80,370)	  	  	  $	    53,547 	 	
Other comprehensive income (loss), net of taxes	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Net change in fair value of interest rate swaps	  	 	(8,969)	  	  	 	(8,969)	  	  	 	-	  	  	 	-	  	  	 	8,969 	 	  	 	(8,969)	  	
Net change in fair value of available-for-sale securities	  	 	268 	 	  	 	268 	 	  	 	268 	 	  	 	-	  	  	 	(536)	  	  	 	268 	 	
Amortization and recognition of unrecognized pension cost components	  	 	807 	 	  	 	807 	 	  	 	807 	 	  	 	-	  	  	 	(1,614)	  	  	 	807 	 	
 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Other comprehensive income (loss)	  	 	(7,894)	  	  	 	(7,894)	  	  	 	1,075 	 	  	 	-	  	  	 	6,819 	 	  	 	(7,894)	  	
 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Comprehensive income	  	 	27,495 	 	  	 	27,495 	 	  	 	53,289 	 	  	 	10,925 	 	  	 	(73,551)	  	  	 	45,653 	 	
Less: Comprehensive income attributable to noncontrolling interests	  	 	-	  	  	 	-	  	  	 	-	  	  	 	18,158 	 	  	 	-	  	  	 	18,158 	 	
 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Comprehensive income attributable to Community Health Systems, Inc.	  	  $	27,495 	 	  	  $	        27,495 	 	  	  $	53,289 	 	  	  $	(7,233)	  	  	  $	(73,551)	  	  	  $	27,495 	 	

40

Table of Contents
COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) – (Continued)
 
Condensed Consolidating Statement of Comprehensive Income
Six Months Ended June 30, 2012

 	  	Parent
   Guarantor   	 	  	      Issuer      	 	  	Other
  Guarantors  	 	  	Non -
  Guarantors  	 	  	  Eliminations  	 	  	  Consolidated  	 	
 	  	(In thousands)
 	 	
Net income	  	  $	    158,833 	 	  	  $	    158,833 	 	  	  $	    195,060 	 	  	  $	    123,347 	 	  	  $	(434,654)	  	  	  $	    201,419 	 	
Other comprehensive income (loss), net of taxes	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Net change in fair value of interest rate swaps	  	 	20,512 	 	  	 	20,512 	 	  	 	-	  	  	 	-	  	  	 	(20,512)	  	  	 	20,512 	 	
Net change in fair value of available-for-sale securities	  	 	2,140 	 	  	 	2,140 	 	  	 	2,140 	 	  	 	-	  	  	 	(4,280)	  	  	 	2,140 	 	
Amortization and recognition of unrecognized pension cost components	  	 	2,281 	 	  	 	2,281 	 	  	 	2,281 	 	  	 	-	  	  	 	(4,562)	  	  	 	2,281 	 	
 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Other comprehensive income (loss)	  	 	24,933 	 	  	 	24,933 	 	  	 	4,421 	 	  	 	-	  	  	 	(29,354)	  	  	 	24,933 	 	
 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Comprehensive income	  	 	183,766 	 	  	 	183,766 	 	  	 	199,481 	 	  	 	123,347 	 	  	 	(464,008)	  	  	 	226,352 	 	
Less: Comprehensive income attributable to noncontrolling interests	  	 	-	  	  	 	-	  	  	 	-	  	  	 	42,586 	 	  	 	-	  	  	 	42,586 	 	
 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Comprehensive income attributable to Community Health Systems, Inc.	  	  $	183,766 	 	  	  $	        183,766 	 	  	  $	199,481 	 	  	  $	80,761 	 	  	  $	(464,008)	  	  	  $	183,766 	 	

Condensed Consolidating Statement of Comprehensive Income
Six Months Ended June 30, 2011

 	  	Parent
   Guarantor   	 	  	      Issuer      	 	  	Other
  Guarantors  	 	  	Non -
  Guarantors  	 	  	  Eliminations  	 	  	  Consolidated  	 	
 	  	(In thousands)
 	 	
Net income	  	  $	    96,713 	 	  	  $	    96,713 	 	  	  $	    129,528 	 	  	  $	    33,012 	 	  	  $	(224,094)	  	  	  $	    131,872 	 	
Other comprehensive income (loss), net of taxes	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Net change in fair value of interest rate swaps	  	 	27,477 	 	  	 	27,477 	 	  	 	-	  	  	 	-	  	  	 	(27,477)	  	  	 	27,477 	 	
Net change in fair value of available-for-sale securities	  	 	1,338 	 	  	 	1,338 	 	  	 	1,338 	 	  	 	-	  	  	 	(2,676)	  	  	 	1,338 	 	
Amortization and recognition of unrecognized pension cost components	  	 	1,579 	 	  	 	1,579 	 	  	 	1,579 	 	  	 	-	  	  	 	(3,158)	  	  	 	1,579 	 	
 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Other comprehensive income (loss)	  	 	30,394 	 	  	 	30,394 	 	  	 	2,917 	 	  	 	-	  	  	 	(33,311)	  	  	 	30,394 	 	
 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Comprehensive income	  	 	127,107 	 	  	 	127,107 	 	  	 	132,445 	 	  	 	33,012 	 	  	 	(257,405)	  	  	 	162,266 	 	
Less: Comprehensive income attributable to noncontrolling interests	  	 	-	  	  	 	-	  	  	 	-	  	  	 	35,159 	 	  	 	-	  	  	 	35,159 	 	
 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Comprehensive income attributable to Community Health Systems, Inc.	  	  $	127,107 	 	  	  $	        127,107 	 	  	  $	132,445 	 	  	  $	(2,147)	  	  	  $	(257,405)	  	  	  $	127,107 	 	

41

Table of Contents
COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) – (Continued)
 
Condensed Consolidating Statement of Cash Flows
Six Months Ended June 30, 2012

 	  	Parent
   Guarantor   	 	  	      Issuer      	 	  	Other
  Guarantors  	 	  	Non -
  Guarantors  	 	  	  Eliminations  	 	  	  Consolidated  	 	
 	  	(In thousands)	 	
 	 	 	 	 	 	 	
Net cash (used in) provided by operating activities	  	  $	(23,273)	  	  	  $	      (59,325)	  	  	  $	341,175 	 	  	  $	224,350 	 	  	  $	-	  	  	  $	482,927 	 	

Cash flows from investing activities:	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Acquisitions of facilities and other related equipment	  	 	-	  	  	 	-	  	  	 	(237,543)	  	  	 	(7,684)	  	  	 	-	  	  	 	(245,227)	  	
Purchases of property and equipment	  	 	-	  	  	 	-	  	  	 	(252,067)	  	  	 	(134,394)	  	  	 	-	  	  	 	(386,461)	  	
Proceeds from disposition of ancillary operations	  	 	-	  	  	 	-	  	  	 	-	  	  	 	-	  	  	 	-	  	  	 	-	  	
Proceeds from sale of property and equipment	  	 	-	  	  	 	-	  	  	 	1,460 	 	  	 	1,977 	 	  	 	-	  	  	 	3,437 	 	
Increase in other investments	  	 	-	  	  	 	-	  	  	 	(116,339)	  	  	 	(45,977)	  	  	 	-	  	  	 	(162,316)	  	
 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Net cash used in investing activities	  	 	-	  	  	 	-	  	  	 	(604,489)	  	  	 	(186,078)	  	  	 	-	  	  	 	(790,567)	  	

Cash flows from financing activities:	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Proceeds from exercise of stock options	  	 	1,269 	 	  	 	-	  	  	 	-	  	  	 	-	  	  	 	-	  	  	 	1,269 	 	
Repurchase of restricted stock shares for payroll tax withholding requirements	  	 	(9,074)	  	  	 	-	  	  	 	-	  	  	 	-	  	  	 	-	  	  	 	(9,074)	  	
Deferred financing costs	  	 	-	  	  	 	(63,986)	  	  	 	-	  	  	 	-	  	  	 	-	  	  	 	(63,986)	  	
Excess tax benefit relating to stock-based compensation	  	 	1,037 	 	  	 	-	  	  	 	-	  	  	 	-	  	  	 	-	  	  	 	1,037 	 	
Stock buy-back	  	 	-	  	  	 	-	  	  	 	-	  	  	 	-	  	  	 	-	  	  	 	-	  	
Proceeds from noncontrolling investors in joint ventures	  	 	-	  	  	 	-	  	  	 	-	  	  	 	637 	 	  	 	-	  	  	 	637 	 	
Redemption of noncontrolling investments in joint ventures	  	 	-	  	  	 	-	  	  	 	-	  	  	 	(35,888)	  	  	 	-	  	  	 	(35,888)	  	
Distributions to noncontrolling investors in joint ventures	  	 	-	  	  	 	-	  	  	 	-	  	  	 	(34,590)	  	  	 	-	  	  	 	(34,590)	  	
Changes in intercompany balances with affiliates, net	  	 	30,041 	 	  	 	(16,362)	  	  	 	257,015 	 	  	 	(270,694)	  	  	 	-	  	  	 	-	  	
Borrowings under credit agreements	  	 	-	  	  	 	5,225,674 	 	  	 	18,589 	 	  	 	-	  	  	 	-	  	  	 	5,244,263 	 	
Issuance of long-term debt	  	 	-	  	  	 	1,025,000 	 	  	 	-	  	  	 	-	  	  	 	-	  	  	 	1,025,000 	 	
Proceeds from receivables facility	  	 	-	  	  	 	-	  	  	 	-	  	  	 	300,000 	 	  	 	-	  	  	 	300,000 	 	
Repayments of long-term indebtedness	  	 	-	  	  	 	(6,111,001)	  	  	 	(11,857)	  	  	 	(12,926)	  	  	 	-	  	  	 	(6,135,784)	  	
 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Net cash provided by (used in) financing activities	  	 	23,273 	 	  	 	59,325 	 	  	 	263,747 	 	  	 	(53,461)	  	  	 	-	  	  	 	292,884 	 	
 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Net change in cash and cash equivalents	  	 	-	  	  	 	-	  	  	 	433 	 	  	 	(15,189)	  	  	 	-	  	  	 	(14,756)	  	
Cash and cash equivalents at beginning of period	  	 	-	  	  	 	-	  	  	 	12,289 	 	  	 	117,576 	 	  	 	-	  	  	 	129,865 	 	
 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Cash and cash equivalents at end of period	  	  $	-	  	  	  $	-	  	  	  $	        12,722 	 	  	  $	        102,387 	 	  	  $	-	  	  	  $	115,109 	 	

42

Table of Contents
COMMUNITY HEALTH SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) – (Continued)
 
Condensed Consolidating Statement of Cash Flows
Six Months Ended June 30, 2011

 	  	Parent
   Guarantor   	 	  	      Issuer      	 	  	Other
  Guarantors  	 	  	Non -
  Guarantors  	 	  	  Eliminations  	 	  	  Consolidated  	 	
 	  	(In thousands)
 	 	
Net cash (used in) provided by operating activities	  	  $	1,490 	 	  	  $	      (37,658)	  	  	  $	430,903 	 	  	  $	189,950 	 	  	  $	-	  	  	  $	584,685 	 	

Cash flows from investing activities:	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Acquisitions of facilities and other related equipment	  	 	-	  	  	 	-	  	  	 	(162,692)	  	  	 	(41,572)	  	  	 	-	  	  	 	(204,264)	  	
Purchases of property and equipment	  	 	-	  	  	 	-	  	  	 	(189,425)	  	  	 	(161,958)	  	  	 	-	  	  	 	(351,383)	  	
Proceeds from disposition of ancillary operations	  	 	-	  	  	 	-	  	  	 	-	  	  	 	18,464 	 	  	 	-	  	  	 	18,464 	 	
Proceeds from sale of property and equipment	  	 	-	  	  	 	-	  	  	 	881 	 	  	 	7,153 	 	  	 	-	  	  	 	8,034 	 	
Increase in other investments	  	 	-	  	  	 	-	  	  	 	(58,120)	  	  	 	(17,091)	  	  	 	-	  	  	 	(75,211)	  	
 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Net cash used in investing activities	  	 	-	  	  	 	-	  	  	 	(409,356)	  	  	 	(195,004)	  	  	 	-	  	  	 	(604,360)	  	

Cash flows from financing activities:	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Proceeds from exercise of stock options	  	 	18,831 	 	  	 	-	  	  	 	-	  	  	 	-	  	  	 	-	  	  	 	18,831 	 	
Repurchase of restricted stock shares for payroll tax withholding requirements	  	 	-	  	  	 	-	  	  	 	-	  	  	 	-	  	  	 	-	  	  	 	-	  	
Deferred financing costs	  	 	-	  	  	 	(234)	  	  	 	-	  	  	 	-	  	  	 	-	  	  	 	(234)	  	
Excess tax benefit relating to stock-based compensation	  	 	4,659 	 	  	 	-	  	  	 	-	  	  	 	-	  	  	 	-	  	  	 	4,659 	 	
Stock buy-back	  	 	(50,002)	  	  	 	-	  	  	 	-	  	  	 	-	  	  	 	-	  	  	 	(50,002)	  	
Proceeds from noncontrolling investors in joint ventures	  	 	-	  	  	 	-	  	  	 	-	  	  	 	863 	 	  	 	-	  	  	 	863 	 	
Redemption of noncontrolling investments in joint ventures	  	 	-	  	  	 	-	  	  	 	-	  	  	 	(3,303)	  	  	 	-	  	  	 	(3,303)	  	
Distributions to noncontrolling investors in joint ventures	  	 	-	  	  	 	-	  	  	 	-	  	  	 	(30,078)	  	  	 	-	  	  	 	(30,078)	  	
Changes in intercompany balances with affiliates, net	  	 	25,022 	 	  	 	62,908 	 	  	 	(157,450)	  	  	 	69,520 	 	  	 	-	  	  	 	-	  	
Borrowings under credit agreements	  	 	-	  	  	 	-	  	  	 	5,975 	 	  	 	-	  	  	 	(5,975)	  	  	 	-	  	
Issuance of long-term debt	  	 	-	  	  	 	-	  	  	 	-	  	  	 	-	  	  	 	-	  	  	 	-	  	
Proceeds from receivables facility	  	 	-	  	  	 	-	  	  	 	-	  	  	 	-	  	  	 	-	  	  	 	-	  	
Repayments of long-term indebtedness	  	 	-	  	  	 	    (25,016)	  	  	 	(2,793)	  	  	 	(6,964)	  	  	 	5,975 	 	  	 	(28,798)	  	
 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Net cash provided by (used in) financing activities	  	 	(1,490)	  	  	 	37,658 	 	  	 	(154,268)	  	  	 	30,038 	 	  	 	-	  	  	 	(88,062)	  	
 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Net change in cash and cash equivalents	  	 	-	  	  	 	-	  	  	 	(132,721)	  	  	 	24,984 	 	  	 	-	  	  	 	(107,737)	  	
Cash and cash equivalents at beginning of period	  	 	-	  	  	 	-	  	  	 	213,117 	 	  	 	86,052 	 	  	 	-	  	  	 	299,169 	 	
 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Cash and cash equivalents at end of period	  	  $	-	  	  	  $	-	  	  	  $	        80,396 	 	  	  $	        111,036 	 	  	  $	-	  	  	  $	191,432 	 	

43

Table of Contents
Item 2.  Management’s Discussion and Analysis of Financial Condition and Results of Operations
You should read this discussion together with our unaudited condensed consolidated financial statements and accompanying notes included herein.
Throughout this Quarterly Report on Form 10-Q, Community Health Systems, Inc., the parent company, and its consolidated subsidiaries are referred to on a collective basis using words like “we,” “our,” “us” and the “Company”. This drafting style is not meant to indicate that the publicly-traded parent company or any subsidiary of the parent company owns or operates any asset, business, or property. The hospitals, operations and businesses described in this filing are owned and operated, and management services provided, by distinct and indirect subsidiaries of Community Health Systems, Inc.
Executive Overview
We are one of the largest publicly-traded operators of hospitals in the United States in terms of number of facilities and net operating revenues. We provide healthcare services through the hospitals that we own and operate in non-urban and selected urban markets. We generate revenues by providing a broad range of general and specialized hospital healthcare services to patients in the communities in which we are located. As of June 30, 2012, we owned or leased 134 hospitals comprised of 130 general acute care hospitals and four stand-alone rehabilitation or psychiatric hospitals. In addition, we own and operate home care agencies, located primarily in markets where we also operate a hospital, and through our wholly-owned subsidiary, Quorum Health Resources, LLC, or QHR, we provide management and consulting services to non-affiliated general acute care hospitals located throughout the United States. For the hospitals and home care agencies that we own and operate, we are paid for our services by governmental agencies, private insurers and directly by the patients we serve. For our management and consulting services, we are paid by the non-affiliated hospitals utilizing our services.
As further discussed in Recent Accounting Pronouncements, during the first quarter of 2012 we adopted the provisions of Accounting Standards Update, or ASU, No. 2011-07 of the Financial Accounting Standards Board, or FASB, which requires us to present revenues net of the provision for bad debts. Prior to the adoption of this ASU, our provision for bad debts was presented as a component of operating expenses. For all periods presented in this quarterly report, revenues and any related financial ratios or metrics have been updated to reflect the change in the presentation of net operating revenues. The adoption of this standard did not impact our financial position, results of operations or cash flows.
During the six months ended June 30, 2012, we continued the execution of our acquisition strategy by acquiring three hospitals located in Scranton, Pennsylvania; Peckville, Pennsylvania; and Blue Island, Illinois and a large physician practice located in Longview, Texas. On July 2, 2012, we announced that one or more of our subsidiaries have acquired substantially all of the assets of Memorial Health Systems in York, Pennsylvania. This acquisition was effective July 1, 2012.
During the six months ended June 30, 2012, we also entered into several agreements that extend the maturity date of a significant portion of our outstanding indebtedness. As further discussed in the Liquidity and Capital Resources section, we entered into an additional amendment and restatement of our Credit Facility, which extended by two and a half years, until January 25, 2017, the maturity date of $1.6 billion of our existing term loans. Additionally, we obtained a new $750 million senior secured revolving credit facility and a new $750 million incremental term loan A facility, both with a maturity date of October 25, 2016, subject to certain acceleration clauses, the net proceeds of which were used to repay the same amount of existing borrowings under the previous revolving credit facility and term loans under the Credit Facility. Finally, we completed a secondary offering of $1.0 billion aggregate principal amount of 8% Senior Notes due 2019 sold at a premium of 102.5%, the net proceeds of which were used to finance the purchase of $850 million aggregate principal amount of our outstanding 8  7 / 8 % Senior Notes due 2015, to pay fees and expenses and for general corporate purposes. Subsequent to June 30, 2012, we announced an additional offering of $1.2 billion aggregate principal amount of 7  1 / 8 % Senior Notes due 2020. In addition, on July 18, 2012, we used the proceeds of the offering to purchase $639.7 million of the 8  7 / 8 % Senior Notes that were validly tendered and not validly withdrawn in the cash tender offer commenced on July 3, 2012, to pay for consents delivered in connection therewith and to pay related fees and expenses. We intend to use the remaining proceeds to redeem any remaining 8  7 / 8 % Senior Notes and, to the extent any proceeds remain, for general corporate purposes.
Our net operating revenues for the three months ended June 30, 2012 increased to approximately $3.2 billion, as compared to approximately $3.0 billion for the three months ended June 30, 2011. Income from continuing operations, before noncontrolling interests, for the three months ended June 30, 2012 increased 10.0% over the three months ended June 30, 2011 to $102.2 million compared to $92.9 million. This increase in income from continuing operations during the three months ended June 30, 2012, as compared to the three months ended June 30, 2011, is due primarily to increased revenues at our same-store hospitals, income from electronic health records incentive reimbursements and reductions in interest expense. Total inpatient admissions for the three months ended June 30, 2012 increased 3.0%, compared to the three months ended June 30, 2011, and adjusted admissions for the three months ended June 30, 2012 increased 5.7%, compared to the three months ended June 30, 2011. On a same-store basis, admissions decreased 2.0% and adjusted admissions increased 0.5%, compared with the three months ended June 30, 2011.
 
44

Table of Contents
Our net operating revenues for the six months ended June 30, 2012 increased to approximately $6.5 billion, as compared to approximately $6.0 billion for the six months ended June 30, 2011. Income from continuing operations, before noncontrolling interests, for the six months ended June 30, 2012 increased 9.4% over the six months ended June 30, 2011 to $201.9 million compared to $184.5 million. Included in income from continuing operations for the six months ended June 30, 2012, is a $42.8 million after-tax benefit from the resolution of an industry-wide governmental settlement and a payment update related to prior periods, an $8.7 million after-tax charge to establish reserves for certain legal matters and a $39.5 million after-tax loss from the early extinguishment of debt. Excluding these one-time items, income from continuing operations, before noncontrolling interests, for the six months ended June 30, 2012 increased 12.4% over the six months ended June 30, 2011 to $207.3 million compared to $184.5 million. This increase in income from continuing operations during the six months ended June 30, 2012, as compared to the six months ended June 30, 2011, is due primarily to increased revenues at our same-store hospitals, income from electronic health records incentive reimbursements and reductions in interest expense. Total inpatient admissions for the six months ended June 30, 2012 increased 3.1%, compared to the six months ended June 30, 2011, and adjusted admissions for the six months ended June 30, 2012 increased 6.9%, compared to the six months ended June 30, 2011. On a same-store basis, admissions decreased 2.2% and adjusted admissions increased 1.5%, compared with the six months ended June 30, 2011.
Self-pay revenues represented approximately 13.0% and 12.1% of our operating revenues, net of contractual allowances and discounts (but before provision for bad debts) for the three months ended June 30, 2012 and 2011, respectively, and 13.2% and 12.1% of our operating revenues, net of contractual allowances and discounts (but before provision for bad debts) for the six months ended June 30, 2012 and 2011, respectively. The amount of foregone revenue related to providing charity care services as a percentage of net operating revenues was approximately 5.4% and 5.1% for the three months ended June 30, 2012 and 2011, respectively, and 5.1% of our net operating revenues for both of the six-month periods ended June 30, 2012 and 2011, respectively. Direct and indirect costs incurred by us in providing charity care services were approximately 1.0% of net operating revenues for both of the three-month periods ended June 30, 2012 and 2011, and 0.9% and 1.0% of our net operating revenues for the six months ended June 30, 2012 and 2011, respectively.
The Patient Protection and Affordable Care Act, or PPACA, was signed into law on March 23, 2010. In addition, the Health Care and Education Affordability Reconciliation Act of 2010, or Reconciliation Act, which contains a number of amendments to PPACA, was signed into law on March 30, 2010. These two healthcare acts, referred to collectively as the Reform Legislation, include a mandate that requires substantially all U.S. citizens to maintain medical insurance coverage which will ultimately increase the number of persons with access to health insurance in the United States. The Reform Legislation, as originally enacted, is expected to expand health insurance coverage to approximately 32 million additional individuals by 2016 and to approximately 34 million additional individuals by 2021 through a combination of public program expansion and private sector health insurance reforms. We believe the expansion of private sector and Medicaid coverage will, over time, increase our reimbursement related to providing services to individuals who were previously uninsured, which should reduce our expense from uncollectible accounts receivable. On the other hand, this legislation makes a number of other changes to Medicare and Medicaid, such as reductions to the Medicare annual market basket update for federal fiscal years 2010 through 2019, a productivity offset to the Medicare market basket update which began October 1, 2011, and a reduction to the Medicare and Medicaid disproportionate share payments, that could adversely impact the reimbursement received under these programs. The various provisions in the Reform Legislation that directly or indirectly affect reimbursement are scheduled to take effect over a number of years, and we cannot predict their impact at this time. Other provisions of the Reform Legislation, such as requirements related to employee health insurance coverage, should increase our operating costs.
Also included in the Reform Legislation are provisions aimed at reducing fraud, waste and abuse in the healthcare industry. These provisions allocate significant additional resources to federal enforcement agencies and expand the use of private contractors to recover potentially inappropriate Medicare and Medicaid payments. The Reform Legislation amends several existing federal laws, including the Medicare Anti-Kickback Statute and the False Claims Act, making it easier for government agencies and private plaintiffs to prevail in lawsuits brought against healthcare providers. These amendments also make it easier for potentially severe fines and penalties to be imposed on healthcare providers accused of violating applicable laws and regulations.
On June 28, 2012, the Supreme Court of the United States largely upheld the constitutionality of the Reform Legislation, though it overturned an aspect of the legislation that would have permitted the Federal government to withhold all Medicaid funding from a state if that state did not expand Medicaid coverage to the extent required by the Reform Legislation. The Supreme Court’s ruling instead held that only new incremental funding could be withheld from a state in such a situation. As a result, states will face less severe financial consequences if they refuse to expand Medicaid coverage to individuals with incomes below certain thresholds. Since the Supreme Court’s ruling, some states have suggested that, for budgetary and other reasons, they would not expand their Medicaid programs. If states refuse to expand their Medicaid programs, the number of uninsured patients at our hospitals will decline by a smaller margin as compared to our expectations when the Reform Legislation was first adopted. Because of the many variables involved, including the potential for changes to the law as a result of efforts to amend or repeal it, clarifications and modifications resulting from the rule-making process, the
 
45

Table of Contents
development of agency guidance and future judicial interpretations, whether and how many states decide to expand or not to expand Medicaid coverage, and budgetary issues at federal and state levels, we are unable to predict the net impact the Reform Legislation may have on our business, results of operations, cash flow, capital resources and liquidity. Furthermore, we cannot predict whether we will be able to modify certain aspects of our operations to offset any potential adverse consequences from the Reform Legislation.
In a number of markets, we have partnered with local physicians in the ownership of our facilities. Such investments have been permitted under an exception to the physician self-referral law, or Stark Law, that allows physicians to invest in an entire hospital (as opposed to individual hospital departments). The Reform Legislation changes the “whole hospital” exception to the Stark Law. The Reform Legislation permits existing physician investments in a whole hospital to continue under a “grandfather” clause if the arrangement satisfies certain requirements and restrictions, but physicians are now prohibited, from the time the Reform Legislation became effective, from increasing the aggregate percentage of their ownership in the hospital. The Reform Legislation also restricts the ability of existing physician-owned hospitals to expand the capacity of their facilities.
In addition to the Reform Legislation, the American Recovery and Reinvestment Act of 2009 included provisions for implementing health information technology under the Health Information Technology for Economic and Clinical Health Act, or HITECH. These provisions were designed to increase the use of electronic health records, or EHR, technology and establish the requirements for a Medicare and Medicaid incentive payments program beginning in 2011 for eligible hospitals and providers that adopt and meaningfully use certified EHR technology. These incentive payments are intended to offset a portion of the costs incurred to implement and qualify as a meaningful user of EHR. Rules adopted in July 2010 by the Department of Health and Human Services established an initial set of standards and certification criteria. Our hospital facilities have begun to implement EHR technology on a facility-by-facility basis beginning in 2011. We anticipate recognizing incentive reimbursement related to the Medicare or Medicaid incentives as we are able to implement the certified EHR technology, meet the defined “meaningful use criteria,” and information from completed cost report periods is available from which to calculate the incentive reimbursement. The timing of recognizing incentive reimbursement will not correlate with the timing of recognizing operating expenses and incurring capital costs in connection with the implementation of EHR technology which may result in material period-to-period changes in our future results of operations. Hospitals that do not qualify as a meaningful user of EHR technology by 2015 are subject to a reduced market basket update to the inpatient prospective payment system standardized amount in 2015 and each subsequent fiscal year. Although we believe that our hospital facilities will be in compliance with the EHR standards by 2015, there can be no assurance that all of our facilities will be in compliance and therefore not subject to the penalty provisions of HITECH. During the three and six months ended June 30, 2012, we recognized approximately $16.8 million and $43.0 million, respectively, of HITECH incentive reimbursements from Medicare and Medicaid related to certain of our hospitals and from Medicare and Medicaid for certain of our employed physicians, which are presented as a reduction of operating expenses. No incentive reimbursements were recognized during the three-month and six-month periods ended June 30, 2011.
As a result of our current levels of cash, available borrowing capacity, long-term outlook on our debt repayments, the refinancing of our term loans and senior notes and our continued projection of our ability to generate cash flows, we do not anticipate a significant impact on our ability to invest the necessary capital in our business over the next twelve months and into the foreseeable future. We believe there continues to be ample opportunity for growth in substantially all of our markets by decreasing the need for patients to travel outside their communities for healthcare services. Furthermore, we continue to benefit from synergies from our acquisitions and continue to strive to improve operating efficiencies and procedures in order to improve our profitability at all of our hospitals.
 
46

Table of Contents
Sources of Consolidated Net Operating Revenues
The following table presents the approximate percentages of operating revenues, net of contractual allowances and discounts (but before provision for bad debts) by payor source for the periods indicated. The data for the periods presented are not strictly comparable due to the effect that hospital acquisitions have had on these statistics.

 	  	Three Months Ended
June  30,	 	 	  	Six Months Ended
June  30,	
 	  	2012	    	2011	 	 	  	2012	 	 	  	2011	 	
Medicare	  	 	 	25.4 	%	    	 	 	26.8 	%	 	 	  	 	 	26.0 	%	 	(1)  	  	 	 	27.1 	%	 	
Medicaid	  	 	 	10.6 	%	    	 	 	10.1 	%	 	 	  	 	 	9.6 	%	 	 	  	 	 	9.9 	%	 	
Managed Care and other third-party payors	  	 	 	51.0 	%	    	 	 	51.0 	%	 	 	  	 	 	51.2 	%	 	 	  	 	 	50.9 	%	 	
Self-pay	  	 	 	13.0 	%	    	 	 	12.1 	%	 	 	  	 	 	13.2 	%	 	 	  	 	 	12.1 	%	 	
 	  	 	 	 	 	    	 	 	 	 	 	 	 	  	 	 	 	 	 	 	  	 	 	 	 	
Total	  	 	 	            100.0 	%	    	 	 	            100.0 	%	 	 	  	 	 	            100.0 	%	 	 	  	 	 	            100.0 	%	 	

(1) Excludes the $80.8 million reimbursement settlement and payment update as discussed below.
As shown above, we receive a substantial portion of our revenues from the Medicare and Medicaid programs. Included in Managed Care and other third-party payors is net operating revenues from insurance companies with which we have insurance provider contracts, Medicare managed care, insurance companies for which we do not have insurance provider contracts, workers’ compensation carriers and non-patient service revenue, such as rental income and cafeteria sales. In the future, we generally expect revenues received from the Medicare and Medicaid programs to increase due to the general aging of the population. In addition, the Reform Legislation, currently in effect, should increase the number of insured patients, which, in turn, should reduce revenues from self-pay patients and reduce our provision for bad debts. The Reform Legislation, however, imposes significant reductions in amounts the government pays Medicare managed care plans. Other provisions in the Reform Legislation impose minimum medical-loss ratios and require insurers to meet specific benefit requirements. In addition, specified managed care programs, insurance companies and employers are actively negotiating the amounts paid to hospitals. The trend toward increased enrollment in managed care may adversely affect our net operating revenue growth. There can be no assurance that we will retain our existing reimbursement arrangements or that these third-party payors will not attempt to further reduce the rates they pay for our services.
Net operating revenues include amounts estimated by management to be reimbursable by Medicare and Medicaid under prospective payment systems and provisions of cost-based reimbursement and other payment methods. In addition, we are reimbursed by non-governmental payors using a variety of payment methodologies. Amounts we receive for treatment of patients covered by these programs are generally less than the standard billing rates. We account for the differences between the estimated program reimbursement rates and the standard billing rates as contractual allowance adjustments, which we deduct from gross revenues to arrive at net operating revenues. Final settlements under some of these programs are subject to adjustment based on administrative review and audit by third parties. We account for adjustments to previous program reimbursement estimates as contractual allowance adjustments and report them in the periods that such adjustments become known. During the six months ended June 30, 2012, we recognized a net after-tax benefit of $42.8 million from the resolution of an industry-wide governmental settlement and a payment update related to prior periods. Other than this adjustment, contractual allowance adjustments related to final settlements and previous program reimbursement estimates impacted net operating revenues and net income by an insignificant amount in each of the three-month and six-month periods ended June 30, 2012 and 2011. In the future, we expect the percentage of revenues received from the Medicare program to increase due to the general aging of the population.
Currently, several states utilize supplemental reimbursement programs for the purpose of providing reimbursement to providers to offset a portion of the cost of providing care to Medicaid and indigent patients. These programs are designed with input from Centers for Medicare and Medicaid Services, or CMS, and are funded with a combination of state and federal resources, including, in certain instances, fees or taxes levied on the providers. Similar programs are also being considered by other states. After these supplemental programs are signed into law, we recognize revenue and related expenses in the period in which amounts are estimable and collection is reasonably assured. Reimbursement under these programs is reflected in net operating revenues and included as Medicaid revenue in the table above, and fees, taxes or other program related costs are reflected in other operating costs and expenses.
 
47

Table of Contents
The payment rates under the Medicare program for hospital inpatient and outpatient acute care services are based on a prospective payment system, depending upon the diagnosis of a patient’s condition. These rates are indexed for inflation annually, although increases have historically been less than actual inflation. On August 18, 2011, CMS issued the final rule to adjust this index by 3.0% for hospital inpatient acute care services that are reimbursed under the prospective payment system. The final rule also made other payment adjustments that, coupled with the 0.1% reduction to hospital inpatient rates implemented pursuant to the Reform Legislation, yielded a net 1.1% increase in reimbursement for hospital inpatient acute care services beginning October 1, 2011. Reductions in the rate of increase or overall reductions in Medicare reimbursement may cause a decline in the growth of our net operating revenues. In addition, specified managed care programs, insurance companies and employers are actively negotiating the amounts paid to hospitals. The trend toward increased enrollment in managed care may adversely affect our net operating revenue growth.
In addition, specified managed care programs, insurance companies and employers are actively negotiating the amounts paid to hospitals. The trend toward increased enrollment in managed care may adversely affect our net operating revenue growth.
Results of Operations
Our hospitals offer a variety of services involving a broad range of inpatient and outpatient medical and surgical services. These include general acute care, emergency room, general and specialty surgery, critical care, internal medicine, obstetrics, diagnostic services, psychiatric and rehabilitation services. The strongest demand for hospital services generally occurs during January through April and the weakest demand for these services occurs during the summer months. Accordingly, eliminating the effect of new acquisitions, our net operating revenues and earnings are historically highest during the first quarter and lowest during the third quarter.
 
48

Table of Contents
The following tables summarize, for the periods indicated, selected operating data.

 	  	Three Months Ended
June  30,	 	  	Six Months Ended
June  30,	 	
 	  	        2012        	 	  	        2011        	 	  	        2012        	 	  	        2011        	 	
 	  	(Expressed as a percentage of net operating revenues)	 	
Consolidated:	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Net operating revenues	  	 	100.0 % 	  	  	 	100.0 % 	  	  	 	100.0 % 	  	  	 	100.0 % 	  	
Operating expenses (a)	  	 	(85.5)% 	  	  	 	(85.0)% 	  	  	 	(84.8)% 	  	  	 	(85.0)% 	  	
Depreciation and amortization	  	 	(5.5)% 	  	  	 	(5.4)% 	  	  	 	(5.4)% 	  	  	 	(5.4)% 	  	
 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Income from operations	  	 	9.0 % 	  	  	 	9.6 % 	  	  	 	9.8 % 	  	  	 	9.6 % 	  	
Interest expense, net	  	 	(4.7)% 	  	  	 	(5.4)% 	  	  	 	(4.7)% 	  	  	 	(5.5)% 	  	
Loss from early extinguishment of debt	  	 	- % 	  	  	 	- % 	  	  	 	(1.0)% 	  	  	 	- % 	  	
Equity in earnings of unconsolidated affiliates	  	 	0.4 % 	  	  	 	0.4 % 	  	  	 	0.4 % 	  	  	 	0.5 % 	  	
 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Income from continuing operations before income taxes	  	 	4.7 % 	  	  	 	4.6 % 	  	  	 	4.5 % 	  	  	 	4.6 % 	  	
Provision for income taxes	  	 	(1.5)% 	  	  	 	(1.5)% 	  	  	 	(1.4)% 	  	  	 	(1.5)% 	  	
 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Income from continuing operations	  	 	3.2 % 	  	  	 	3.1 % 	  	  	 	3.1 % 	  	  	 	3.1 % 	  	
Loss from discontinued operations, net of taxes	  	 	- % 	  	  	 	(1.3)% 	  	  	 	- % 	  	  	 	(0.9)% 	  	
 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Net income	  	 	3.2 % 	  	  	 	1.8 % 	  	  	 	3.1 % 	  	  	 	2.2 % 	  	
Less: Net income attributable to noncontrolling interests	  	 	(0.6)% 	  	  	 	(0.6)% 	  	  	 	(0.7)% 	  	  	 	(0.6)% 	  	
 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Net income attributable to Community Health Systems, Inc.	  	 	2.6 % 	  	  	 	1.2 % 	  	  	 	2.4 % 	  	  	 	1.6 % 	  	

 	 	 	 	 	 	 	 	 	
 	  	Three Months Ended
June  30, 2012	 	  	Six Months Ended
June 30, 2012	 	
Percentage increase (decrease) from same period prior year:	  	 	 	 	  	 	 	 	
Net operating revenues	  	 	8.1 % 	  	  	 	9.8 % 	  	
Admissions	  	 	3.0 % 	  	  	 	3.1 % 	  	
Adjusted admissions (b)	  	 	5.7 % 	  	  	 	6.9 % 	  	
Average length of stay	  	 	(2.3)% 	  	  	 	- % 	  	
Net income attributable to Community Health Systems, Inc. (c)	  	 	135.6 % 	  	  	 	64.2 % 	  	
Same store percentage increase (decrease) from same period prior year (d)	  	 	 	 	  	 	 	 	
Net operating revenues	  	 	4.5 % 	  	  	 	4.4 % 	  	
Admissions	  	 	(2.0)% 	  	  	 	(2.2)% 	  	
Adjusted admissions (b)	  	 	0.5 % 	  	  	 	1.5 % 	  	
 
(a)	Operating expenses include salaries and benefits, supplies, other operating expenses, electronic health records incentive reimbursement and rent.	
(b)	Adjusted admissions is a general measure of combined inpatient and outpatient volume. We computed adjusted admissions by multiplying admissions by gross patient revenues and then dividing that number by gross inpatient revenues.	
(c)	Includes income (loss) from discontinued operations.	
(d)	Includes acquired hospitals to the extent we operated them in both periods.	
 
49

Table of Contents
Three Months Ended June 30, 2012 Compared to Three Months Ended June 30, 2011
Net operating revenues increased $242.1 million to approximately $3.2 billion for the three months ended June 30, 2012, from approximately $3.0 billion for the three months ended June 30, 2011. Hospitals owned throughout both periods contributed $133.0 million of that increase and hospitals acquired in 2012 and 2011 contributed $109.1 million. On a same-store basis, net operating revenues increased 4.5%. The increased net operating revenues contributed by hospitals that we owned throughout both periods were primarily attributable to general rate and reimbursement increases including revenues from states with provider assessment programs.
On a consolidated basis, inpatient admissions increased by 3.0% and adjusted admissions increased by 5.7% during the three months ended June 30, 2012. On a same-store basis, inpatient admissions decreased by 2.0% during the three months ended June 30, 2012. This decrease in same-store inpatient admissions was due primarily to a decrease in admissions from women’s services including obstetrics and gynecology, fewer flu and respiratory-related admissions and reductions due to competition and certain service closures in a few of our hospitals during the three months ended June 30, 2012, as compared to the three months ended June 30, 2011.
Operating expenses, excluding depreciation and amortization, as a percentage of net operating revenues, increased 0.5% to 85.5% for the three months ended June 30, 2012, compared to 85.0% for the three months ended June 30, 2011. Salaries and benefits, as a percentage of net operating revenues, increased 0.1% to 46.2% for the three months ended June 30, 2012, compared to 46.1% for the three months ended June 30, 2011. Supplies, as a percentage of net operating revenues, increased 0.1% to 15.1% for the three months ended June 30, 2012, as compared to 15.0% for the three months ended June 30, 2011. Other operating expenses, as a percentage of net operating revenues, increased 0.9% to 22.7% for the three months ended June 30, 2012, as compared to 21.8% for the three months ended June 30, 2011. This increase is due primarily to an increase in costs associated with provider taxes from states with provider assessment programs. Rent, as a percentage of net operating revenues, decreased 0.1% to 2.0% for the three months ended June 30, 2012, as compared to 2.1% for the three months ended June 30, 2011. Equity in earnings of unconsolidated affiliates, as a percentage of net operating revenues, remained consistent at 0.4% for each of the three months ended June 30, 2012 and 2011.
Electronic health records incentive reimbursements represent those incentives under the HITECH Act for which the recognition criterion has been met. For the three months ended June 30, 2012, we have recognized approximately $16.8 million of incentive reimbursements, or 0.5% of net operating revenues. We received payments of $22.6 million during the three months ended June 30, 2012. Operating expenses incurred related to the installation and adoption of electronic health records, including depreciation and amortization, totaled approximately 0.3% of net operating revenues for the three months ended June 30, 2012, of which depreciation and amortization represented 0.2% of net operating revenues.
Depreciation and amortization, as a percentage of net operating revenues, increased 0.1% to 5.5% for the three months ended June 30, 2012, compared to 5.4% for the three months ended June 30, 2011.
Interest expense, net, decreased by $11.6 million from $163.2 million for the three months ended June 30, 2011 to $151.6 million for the three months ended June 30, 2012. A decrease in interest rates during the three months ended June 30, 2012, compared to June 30, 2011, resulted in a decrease in interest expense of $19.7 million. Additionally, interest expense decreased by $1.6 million as a result of more interest being capitalized during the three months ended June 30, 2012, as compared to the three months ended June 30, 2011, as the current year period had more major construction projects. These decreases were partially offset by an increase in our average outstanding debt during the three months ended June 30, 2012, compared to the three months ended June 30, 2011, which resulted in an increase in interest expense of $9.7 million.
The net of the above mentioned changes resulted in income from continuing operations before income taxes increasing $14.0 million from $137.7 million for the three months ended June 30, 2011 to $151.7 million for the three months ended June 30, 2012.
Provision for income taxes increased from $44.8 million for the three months ended June 30, 2011 to $49.5 million for the three months ended June 30, 2012, due primarily to the increase in income from continuing operations before income taxes in the comparable period in 2011, as discussed above. Our effective tax rate remained consistent at 32.6% for each of the three months ended June 30, 2012 and 2011.
Income from continuing operations, as a percentage of net operating revenues, increased 0.1% to 3.2% for the three months ended June 30, 2012, compared to 3.1% for the three months ended June 30, 2011. Net income, as a percentage of net operating revenues, increased 1.4% to 3.2% for the three months ended June 30, 2012, compared to 1.8% for the three months ended June 30, 2011.
Net income attributable to noncontrolling interests as a percentage of net operating revenues, remained consistent at 0.6% for each of the three months ended June 30, 2012 and 2011.
 
50

Table of Contents
Net income attributable to Community Health Systems, Inc. was $83.6 million for the three months ended June 30, 2012, compared to $35.4 million for the three months ended June 30, 2011, representing an increase of 135.6%. The increase in net income is primarily due to the increase in net operating revenues, income from electronic health records incentive reimbursement and a decrease in interest expense, offset by increases in operating expenses as discussed above.
Six Months Ended June 30, 2012 Compared to Six Months Ended June 30, 2011
Net operating revenues increased $585.1 million to approximately $6.5 billion for the six months ended June 30, 2012, from approximately $6.0 billion for the six months ended June 30, 2011. Hospitals owned throughout both periods contributed $260.8 million of that increase and hospitals acquired in 2012 and 2011 contributed $243.5 million. On a same-store basis, net operating revenues increased 4.4%. The increased net operating revenues contributed by hospitals that we owned throughout both periods were primarily attributable to general rate and reimbursement increases including revenues from states with provider assessment programs. Included in net operating revenues on a non-same store basis is approximately $101.8 million of net operating revenues from an industry-wide settlement with the United States Department of Health and Human Services and CMS, based on a claim that acute-care hospitals in the U.S. were underpaid from the Medicare inpatient prospective payment system in federal fiscal years 1999 through 2011. The underpayments resulted from calculations related to the rural floor budget neutrality adjustments implemented in connection with the Balanced Budget Act of 1997. Also included is an unfavorable adjustment of approximately $21.0 million, related to the newly issued Supplemental Security Income ratios for federal fiscal years 2006 through 2009 utilized for calculating Medicare Disproportionate Share Hospital reimbursements.
On a consolidated basis, inpatient admissions increased by 3.1% and adjusted admissions increased by 6.9% during the six months ended June 30, 2012. On a same-store basis, inpatient admissions decreased by 2.2% during the six months ended June 30, 2012. This decrease in same-store inpatient admissions was due primarily to a decrease in admissions from women’s services including obstetrics and gynecology, fewer flu and respiratory-related admissions and reductions due to competition and certain service closures in a few of our hospitals during the six months ended June 30, 2012, as compared to the six months ended June 30, 2011.
Operating expenses, excluding depreciation and amortization, as a percentage of net operating revenues, decreased 0.2% to 84.8% for the six months ended June 30, 2012, compared to 85.0% for the six months ended June 30, 2011. Salaries and benefits, as a percentage of net operating revenues, decreased 0.2% to 46.2% for the six months ended June 30, 2012, compared to 46.4% for the six months ended June 30, 2011. This decrease in salaries and benefits, as a percentage of net operating revenues, is due primarily to the increase in non-same store net operating revenues described above as well as efficiencies gained since the prior year in our hospitals owned throughout both periods. Supplies, as a percentage of net operating revenues, decreased 0.1% to 15.1% for the six months ended June 30, 2012, as compared to 15.2% for the six months ended June 30, 2011. Other operating expenses, as a percentage of net operating revenues, increased 0.9% to 22.2% for the six months ended June 30, 2012, as compared to 21.3% for the six months ended June 30, 2011. This increase is due primarily to an increase in costs associated with provider taxes from states with provider assessment programs. Rent, as a percentage of net operating revenues, decreased 0.1% to 2.0% for the six months ended June 30, 2012, as compared to 2.1% for the six months ended June 30, 2011. Equity in earnings of unconsolidated affiliates, as a percentage of net operating revenues, decreased 0.1% to 0.4% for the six months ended June 30, 2012, compared to 0.5% for the six months ended June 30, 2011.
Electronic health records incentive reimbursements represent those incentives under the HITECH Act for which the recognition criterion has been met. For the six months ended June 30, 2012, we have recognized approximately $43.0 million of incentive reimbursements, or 0.7% of net operating revenues. We received payments of $28.8 million during the six months ended June 30, 2012. Operating expenses incurred related to the installation and adoption of electronic health records, including depreciation and amortization, totaled approximately 0.4% of net operating revenues for the six months ended June 30, 2012, of which depreciation and amortization represented 0.2% of net operating revenues.
Depreciation and amortization, as a percentage of net operating revenues, remained consistent at 5.4% for each of the six months ended June 30, 2012 and 2011.
Interest expense, net, decreased by $22.6 million from $326.4 million for the six months ended June 30, 2011 to $303.8 million for the six months ended June 30, 2012. A decrease in interest rates during the six months ended June 30, 2012, compared to June 30, 2011, resulted in a decrease in interest expense of $33.9 million. Additionally, interest expense decreased by $5.0 million as a result of more interest being capitalized during the six months ended June 30, 2012, as compared to the six months ended June 30, 2011, as the current year period had more major construction projects. These decreases were partially offset by an increase in our average outstanding debt during the six months ended June 30, 2012, compared to the six months ended June 30, 2011, and one additional day of interest expense since 2012 is a leap year, which resulted in an increase in interest expense of $14.4 million and $1.9 million, respectively.
The loss from early extinguishment of debt was recognized after the purchase of $850 million of the 8 7/8% Senior Notes due 2015 and the repayment of existing term loans and revolving credit facility under the Credit Facility.
 
51

Table of Contents
The net of the above mentioned changes resulted in income from continuing operations before income taxes increasing $23.8 million from $273.4 million for the six months ended June 30, 2011 to $297.2 million for the six months ended June 30, 2012.
Provision for income taxes increased from $88.9 million for the six months ended June 30, 2011 to $95.3 million for the six months ended June 30, 2012, due primarily to the increase in income from continuing operations before income taxes in the comparable period in 2011, as discussed above. Our effective tax rate decreased from 32.5% for the six months ended June 30, 2011 to 32.1% for the six months ended June 30, 2012 due to a one-time favorable adjustment related to an amended state tax return.
Income from continuing operations, as a percentage of net operating revenues, remained consistent at 3.1% for each of the six months ended June 30, 2012 and 2011. Net income, as a percentage of net operating revenues, increased 0.9% to 3.1% for the six months ended June 30, 2012, compared to 2.2% for the six months ended June 30, 2011. Net income, as a percentage of net operating revenues, was lower for the six months ended June 30, 2011 due to the loss on discontinued operations from loss on sale, impairment of hospitals held for sale and loss on entities sold.
Net income attributable to noncontrolling interests as a percentage of net operating revenues, increased 0.1% to 0.7% for the six months ended June 30, 2012, compared to 0.6% for the six months ended June 30, 2011.
Net income attributable to Community Health Systems, Inc. was $158.8 million for the six months ended June 30, 2012, compared to $96.7 million for the six months ended June 30, 2011, representing an increase of 64.2%. The increase in net income is primarily due to the increase in net operating revenues, income from electronic health records incentive reimbursement and a decrease in interest expense, offset by increases in operating expenses as discussed above.
Liquidity and Capital Resources
Net cash provided by operating activities decreased $101.8 million, from $584.7 million for the six months ended June 30, 2011 to $482.9 million for the six months ended June 30, 2012. The decrease in cash provided by operating activities, in comparison to the prior year period, is primarily due to a decrease in cash flow from the change in accounts receivable of $116.3 million, from the change in supplies, prepaid expenses and other current assets of $49.3 million, from the change in accounts payable, accrued liabilities and income taxes of $77.6 million and a decrease in other non-cash expenses related to the impairment of hospitals sold in 2011 of $47.9 million. These decreases in cash flows were partially offset by an increase in net income of $69.5 million, an increase in depreciation and amortization expense of $29.8 million, loss from early extinguishment of debt of $63.4 million, an increase in all other non-cash expenses of $12.4 million, and an increase in cash flow from the change in other assets and liabilities of $14.2 million. Included in net cash provided by operating activities for the six months ended June 30, 2012 is $28.8 million of cash received for HITECH incentive reimbursements.
The cash used in investing activities was $790.6 million for the six months ended June 30, 2012, compared to $604.4 million for the six months ended June 30, 2011. The increase in cash used in investing activities, in comparison to the prior year period, is primarily due to an increase in cash used for acquisition of facilities and other related equipment of $41.0 million, an increase in cash used for purchasing property and equipment of $35.1 million and an increase in cash used for other investments of $87.0 million. Included in cash outflows for other investments for the six months ended June 30, 2012 is approximately $75.8 million of capital expenditures related to the purchase and implementation of certified EHR technology. The remaining cash outflows for other investments consists primarily of purchases and development of other internal-use software and payments made under non-employee physician recruiting agreements, of $86.5 million. Other reasons for the increase in cash used in investing activities were the decrease in proceeds from the disposition of ancillary operations of $18.5 million and the decrease in proceeds received from the sale of property and equipment of $4.6 million.
The cash provided by financing activities was $292.9 million for the six months ended June 30, 2012, compared to $88.1 million used in financing activities for the six months ended June 30, 2011. The increase in cash provided by financing activities is due primarily to the increase in borrowings under the credit agreement, proceeds from the Receivables Facility and the issuance of long-term debt, offset partially by repayments of long-term debt during the six months ended June 30, 2012, in comparison to the prior year period.
 Capital Expenditures
Cash expenditures related to purchases of facilities were $245.2 million for the six months ended June 30, 2012, compared to $204.3 million for the six months ended June 30, 2011. The expenditures during the six months ended June 30, 2012 were for the purchase of two hospitals in Pennsylvania, one hospital in Illinois, a physician practice in Texas, surgery centers and other physician practices and the settlement of working capital items from prior acquisitions and divestitures. The expenditures during the six months ended June 30, 2011 were for the purchase of three hospitals in Pennsylvania, surgery centers and physician practices and the settlement of working capital items from 2010 acquisitions.
 
52

Table of Contents
Excluding the cost to construct replacement hospitals, our cash expenditures for routine capital for the six months ended June 30, 2012 totaled $315.9 million, compared to $269.3 million for the six months ended June 30, 2011. These capital expenditures related primarily to the purchase of additional equipment, minor renovations and information systems infrastructure. Costs to construct replacement hospitals for the six months ended June 30, 2012 totaled $70.6 million, compared to $82.1 million for the six months ended June 30, 2011. The costs to construct replacement hospitals for both of the six-month periods ended June 30, 2012 and 2011 represented both planning and construction costs for the four replacement hospitals discussed below.
Pursuant to hospital purchase agreements in effect as of June 30, 2012, and where final certificate of need approval has been obtained, we have commitments to build the following three replacement facilities: As required by an amendment to our lease agreement entered into in 2005, we agreed to build a replacement hospital at our Barstow, California location by November 2012. As part of an acquisition in 2007, we agreed to build a replacement hospital in Valparaiso, Indiana by April 2011; however, due to delays in receiving government approved building and zoning permits, completion is not expected until the third quarter of 2012. These delays did not result in any penalties under the terms of the applicable purchase agreement and we do not expect such delays to result in any significant increase in the costs to construct the replacement facility. As part of an acquisition in 2009, we agreed to build a replacement hospital in Siloam Springs, Arkansas, which opened in April 2012. Construction costs, including equipment costs, for these three replacement facilities are currently estimated to be approximately $308.5 million, of which approximately $280.9 million has been incurred to date. In addition, in October 2008, after the purchase of the noncontrolling owner’s interest in our Birmingham, Alabama facility, we initiated the purchase of a site, which includes a partially constructed hospital structure, for a potential replacement to our existing Birmingham facility. In September 2010, we received approval of our request for a certificate of need from the Alabama Certificate of Need Review Board; however, this certificate of need remains subject to the final resolution of an appeal process. Our estimated construction costs, including the acquisition of the site and equipment costs, are approximately $280.0 million for the Birmingham replacement facility.
 Capital Resources
Net working capital was approximately $1.1 billion at June 30, 2012, compared to approximately $935.0 million at December 31, 2011. The increase in net working capital is primarily attributable to an increase in working capital from the acquisition of three hospitals and a large physician practice and an increase in patient accounts receivable, offset by a decrease in income taxes receivable from tax refunds received.
In connection with the consummation of the Triad acquisition in July 2007, we obtained approximately $7.2 billion of senior secured financing under the Credit Facility with a syndicate of financial institutions led by Credit Suisse, as administrative agent and collateral agent. The Credit Facility consisted of an approximately $6.1 billion funded term loan facility with a maturity of seven years, a $300 million delayed draw term loan facility (subsequently reduced by us from $400 million) with a maturity of seven years and a $750 million revolving credit facility with a maturity of six years. During the fourth quarter of 2008, $100 million of the delayed draw term loan had been drawn down by us, reducing the delayed draw term loan availability to $200 million at December 31, 2008. In January 2009, we drew down the remaining $200 million of the delayed draw term loan. The revolving credit facility also includes a subfacility for letters of credit and a swingline subfacility. The Credit Facility requires quarterly amortization payments of each term loan facility equal to 0.25% of the outstanding amount of the term loans. On November 5, 2010, we entered into an amendment and restatement of our existing Credit Facility. The amendment extended by two and a half years, until January 25, 2017, the maturity date of $1.5 billion of our existing term loans under the Credit Facility and increased the pricing on these term loans to LIBOR plus 350 basis points. If more than $50 million of our 8  7 / 8 % Senior Notes remain outstanding on April 15, 2015, without having been refinanced, then the maturity date for the extended term loans will be accelerated to April 15, 2015. The amendment also increased our ability to issue additional indebtedness under the uncommitted incremental facility to $1.0 billion from $600 million, permitted us to issue term loan A loans under the incremental facility and provided up to $2.0 billion of borrowing capacity from receivable transactions, an increase of $0.5 billion, of which approximately $1.7 billion would be required to be used for repayment of our existing term loans. In addition, effective February 2, 2012, we completed an additional amendment and restatement of the Credit Facility, which extended by two and a half years, until January 25, 2017, the maturity date of an additional $1.6 billion of our existing non-extended term loans under the Credit Facility and increased the pricing on the newly extended term loans by 125 basis points. The maturity date of the balance of the term loans of approximately $2.9 billion remained unchanged at July 25, 2014.
 
53

Table of Contents
Effective March 6, 2012, we obtained a new $750 million senior secured revolving credit facility, or the Replacement Revolver Facility, and a new $750 million incremental term loan A facility, or the Incremental Term Loan. The Replacement Revolver Facility replaced in full the existing revolving credit facility under the Credit Facility. The net proceeds of the Incremental Term Loan were used to repay the same amount of the existing term loans under the Credit Facility. The execution of these agreements resulted in a loss from early extinguishment of debt of $8.5 million with an after-tax impact of $5.3 million recorded in continuing operations for the six months ended June 30, 2012. Both the Replacement Revolver Facility and the Incremental Term Loan have a maturity date of October 25, 2016, subject to customary acceleration events and to the repayment, extension or refinancing with longer maturity debt of substantially all of the outstanding term loans maturing July 25, 2014 and the 8  7 / 8 % Senior Notes due 2015. The pricing on each of the Replacement Revolver Facility and the Incremental Term Loan is initially LIBOR plus a margin of 250 basis points, subject to adjustment based on our leverage ratio. The Incremental Term Loan amortizes at 5% in year one, 10% in years two and three, 15% in year four and 60% in year five.
The term loan facility must be prepaid in an amount equal to (1) 100% of the net cash proceeds of certain asset sales and dispositions by us and our subsidiaries, subject to certain exceptions and reinvestment rights, (2) 100% of the net cash proceeds of issuances of certain debt obligations or receivables-based financing by us and our subsidiaries, subject to certain exceptions, and (3) 50%, subject to reduction to a lower percentage based on our leverage ratio (as defined in the Credit Facility generally as the ratio of total debt on the date of determination to our EBITDA, as defined, for the four quarters most recently ended prior to such date), of excess cash flow (as defined) for any year, commencing in 2008, subject to certain exceptions. Voluntary prepayments and commitment reductions are permitted in whole or in part, without any premium or penalty, subject to minimum prepayment or reduction requirements.
The obligor under the Credit Facility is CHS. All of our obligations under the Credit Facility are unconditionally guaranteed by Community Health Systems, Inc. and certain of its existing and subsequently acquired or organized domestic subsidiaries. All obligations under the Credit Facility and the related guarantees are secured by a perfected first priority lien or security interest in substantially all of the assets of Community Health Systems, Inc., CHS and each subsidiary guarantor, including equity interests held by us or any subsidiary guarantor, but excluding, among others, the equity interests of non-significant subsidiaries, syndication subsidiaries, securitization subsidiaries and joint venture subsidiaries.
The loans under the Credit Facility bear interest on the outstanding unpaid principal amount at a rate equal to an applicable percentage plus, at our option, either (a) an Alternate Base Rate (as defined) determined by reference to the greater of (1) the Prime Rate (as defined) announced by Credit Suisse or (2) the Federal Funds Effective Rate (as defined) plus 0.5% or (3) the adjusted LIBOR rate on such day for a three-month interest period commencing on the second business day after such day plus 1%, or (b) a reserve adjusted LIBOR for dollars (Eurodollar rate) (as defined). The applicable percentage for Alternate Base Rate loans is 1.25% for term loans due 2014 and 2.25% for term loans due 2017. The applicable percentage for Eurodollar rate loans is 2.25% for term loans due 2014 and 3.5% for term loans due 2017. The applicable percentage for revolving loans was initially 1.25% for Alternate Base Rate revolving loans and 2.25% for Eurodollar revolving loans, in each case subject to reduction based on our leverage ratio. Loans under the swingline subfacility bear interest at the rate applicable to Alternate Base Rate loans under the revolving credit facility.
We have agreed to pay letter of credit fees equal to the applicable percentage then in effect with respect to Eurodollar rate loans under the revolving credit facility times the maximum aggregate amount available to be drawn under all letters of credit outstanding under the subfacility for letters of credit. The issuer of any letter of credit issued under the subfacility for letters of credit will also receive a customary fronting fee and other customary processing charges. We are obligated to pay commitment fees of 0.50% per annum (subject to reduction based upon our leverage ratio), on the unused portion of the revolving credit facility. For purposes of this calculation, swingline loans are not treated as usage of the revolving credit facility. With respect to the delayed draw term loan facility, we were also obligated to pay commitment fees of 0.50% per annum for the first nine months after the close of the Credit Facility and 0.75% per annum for the next three months after such nine-month period and thereafter 1.0% per annum. In each case, the commitment fee was based on the unused amount of the delayed draw term loan facility. After the draw down of the remaining $200 million of the delayed draw term loan in January 2009, we no longer pay any commitment fees for the delayed draw term loan facility. We also paid arrangement fees on the closing of the Credit Facility and pay an annual administrative agent fee.
The Credit Facility contains customary representations and warranties, subject to limitations and exceptions, and customary covenants restricting our and our subsidiaries’ ability, subject to certain exception, to, among other things, (1) declare dividends, make distributions or redeem or repurchase capital stock, (2) prepay, redeem or repurchase other debt, (3) incur liens or grant negative pledges, (4) make loans and investments and enter into acquisitions and joint ventures, (5) incur additional indebtedness or provide certain guarantees, (6) make capital expenditures, (7) engage in mergers, acquisitions and asset sales, (8) conduct transactions with affiliates, (9) alter the nature of our businesses, (10) grant certain guarantees with respect to physician practices, (11) engage in sale and leaseback transactions or (12) change our fiscal year. We and our subsidiaries are also required to comply with specified financial covenants (consisting of a leverage ratio and an interest coverage ratio) and various affirmative covenants.
 
54

Table of Contents
Events of default under the Credit Facility include, but are not limited to, (1) our failure to pay principal, interest, fees or other amounts under the credit agreement when due (taking into account any applicable grace period), (2) any representation or warranty proving to have been materially incorrect when made, (3) covenant defaults subject, with respect to certain covenants, to a grace period, (4) bankruptcy events, (5) a cross default to certain other debt, (6) certain undischarged judgments (not paid within an applicable grace period), (7) a change of control, (8) certain ERISA-related defaults and (9) the invalidity or impairment of specified security interests, guarantees or subordination provisions in favor of the administrative agent or lenders under the Credit Facility.
As of June 30, 2012, the availability for additional borrowings under our Credit Facility was approximately $750 million pursuant to the revolving credit facility, of which $37.7 million was set aside for outstanding letters of credit and $5.0 million was outstanding at June 30, 2012. We believe that these funds, along with internally generated cash and continued access to the bank credit and capital markets, will be sufficient to finance future acquisitions, capital expenditures and working capital requirements through the next 12 months and into the foreseeable future.
On March 21, 2012, CHS completed the secondary offering of $1.0 billion aggregate principal amount of 8% Senior Notes due 2019, which were issued in a private placement (at a premium of 102.5%). The net proceeds from this issuance were used to finance the purchase of $850 million aggregate principal amount of CHS’ outstanding 8  7 / 8 % Senior Notes due 2015, to pay related fees and expenses and for general corporate purposes. On March 21, 2012, CHS completed the cash tender offer for $850 million of the $1.8 billion aggregate outstanding principal amount of 8  7 / 8 % Senior Notes due 2015. This resulted in a loss from early extinguishment of debt of $54.9 million with an after-tax impact of $34.3 million recorded in continuing operations for the six months ended June 30, 2012.
Subsequent to June 30, 2012, CHS initiated an offering of $1.2 billion aggregate principal amount of 7 1/8% Senior Notes due 2020, which were issued by means of an underwritten public offering under our automatic shelf registration filed with the Securities and Exchange Commission. We used the proceeds of the offering to purchase $639.7 million of the 8  7 / 8 % Senior Notes that were validly tendered and not validly withdrawn in the cash tender offer commenced on July 3, 2012, to pay for consents delivered in connection therewith and to pay related fees and expenses. We intend to use the remaining proceeds to redeem any remaining 8  7 / 8 % Senior Notes and, to the extent any proceeds remain, for general corporate purposes. Upon the closing of the cash tender offer for and the mandatory redemption of the remaining 8  7 / 8 % Senior Notes due 2015, we will have extended the maturity of all of our senior notes outstanding to at least 2019.
On March 21, 2012, through certain of our subsidiaries, we entered into an accounts receivables loan agreement, or the Receivables Facility, with a group of conduit lenders and liquidity banks, Credit Agricolé Corporate and Investment Bank, as a managing agent and as the administrative agent, and The Bank of Nova Scotia, as a managing agent. The existing and future patient-related accounts receivable, or the Receivables, for certain of our hospitals serve as collateral for the outstanding borrowings under the Receivables Facility. The interest rate on the borrowings is based on the commercial paper rate plus an applicable interest rate spread. Unless earlier terminated or subsequently extended pursuant to its terms, the Receivables Facility will expire on March 21, 2014, subject to customary termination events that could cause an early termination date. We maintain effective control over the Receivables because, pursuant to the terms of the Receivables Facility, the Receivables are sold from certain of our subsidiaries to us, and we then sell or contribute the Receivables to a special-purpose entity that is wholly-owned by us. The wholly-owned special-purpose entity in turn grants security interests in the Receivables in exchange for borrowings obtained from the group of third-party conduit lenders and liquidity banks of up to $300 million outstanding from time to time based on the availability of eligible Receivables and other customary factors. The group of third-party conduit lenders and liquidity banks do not have recourse to us or our subsidiaries beyond the assets of the wholly-owned special-purpose entity that collateralizes the loan. The Receivables and other assets of the wholly-owned special-purpose entity will be available first and foremost to satisfy the claims of the creditors of such entity. The outstanding borrowings pursuant to the Receivables Facility at June 30, 2012 totaled $300 million and are classified as long-term debt on the condensed consolidated balance sheet. At June 30, 2012, the carrying amount of Receivables included in the Receivables Facility totaled approximately $888.0 million and are included in patient accounts receivable on the condensed consolidated balance sheet.
 
55

Table of Contents
As of June 30, 2012, we are a party to the following interest rate swap agreements to limit the effect of changes in interest rates on approximately 60% of our variable rate debt. On each of these swaps, we receive a variable rate of interest based on the three-month LIBOR in exchange for the payment by us of a fixed rate of interest. We currently pay, on a quarterly basis, a margin above LIBOR of 225 basis points for revolving credit and term loans due 2014 and 350 basis points for term loans due 2017 under the Credit Facility.

Swap #	 	Notional
Amount
         (in 000’s)        	 	 	Fixed
           Interest          
Rate	 	 	                     Termination                    
Date	 	 	Fair Value of
 Liability (in 000’s) 	 	
1	 	$	200,000 	  	 	 	4.685%  	  	 	 	September 11, 2012	  	 	 $	1,679 	  	
2	 	 	100,000 	  	 	 	3.352%  	  	 	 	October 23, 2012	  	 	 	908 	  	
3	 	 	125,000 	  	 	 	4.375%  	  	 	 	November 23, 2012	  	 	 	1,953 	  	
4	 	 	75,000 	  	 	 	4.380%  	  	 	 	November 23, 2012	  	 	 	1,174 	  	
5	 	 	150,000 	  	 	 	5.020%  	  	 	 	November 30, 2012	  	 	 	2,862 	  	
6	 	 	200,000 	  	 	 	2.242%  	  	 	 	February 28, 2013	  	 	 	2,347 	  	
7	 	 	100,000 	  	 	 	5.023%  	  	 	 	May 30, 2013	  	 	 	4,144 	  	
8	 	 	300,000 	  	 	 	5.242%  	  	 	 	August 6, 2013	  	 	 	15,631 	  	
9	 	 	100,000 	  	 	 	5.038%  	  	 	 	August 30, 2013	  	 	 	5,276 	  	
10	 	 	50,000 	  	 	 	3.586%  	  	 	 	October 23, 2013	  	 	 	2,013 	  	
11	 	 	50,000 	  	 	 	3.524%  	  	 	 	October 23, 2013	  	 	 	1,972 	  	
12	 	 	100,000 	  	 	 	5.050%  	  	 	 	November 30, 2013	  	 	 	6,383 	  	
13	 	 	200,000 	  	 	 	2.070%  	  	 	 	December 19, 2013	  	 	 	4,540 	  	
14	 	 	100,000 	  	 	 	5.231%  	  	 	 	July 25, 2014	  	 	 	9,511 	  	
15	 	 	100,000 	  	 	 	5.231%  	  	 	 	July 25, 2014	  	 	 	9,511 	  	
16	 	 	200,000 	  	 	 	5.160%  	  	 	 	July 25, 2014	  	 	 	18,734 	  	
17	 	 	75,000 	  	 	 	5.041%  	  	 	 	July 25, 2014	  	 	 	6,843 	  	
18	 	 	125,000 	  	 	 	5.022%  	  	 	 	July 25, 2014	  	 	 	11,357 	  	
19	 	 	100,000 	  	 	 	2.621%  	  	 	 	July 25, 2014	  	 	 	4,216 	  	
20	 	 	100,000 	  	 	 	3.110%  	  	 	 	July 25, 2014	  	 	 	5,208 	  	
21	 	 	100,000 	  	 	 	3.258%  	  	 	 	July 25, 2014	  	 	 	5,508 	  	
22	 	 	200,000 	  	 	 	2.693%  	  	 	 	October 26, 2014	  	 	 	9,682 	  	
23	 	 	300,000 	  	 	 	3.447%  	  	 	 	August 8, 2016	  	 	 	30,536 	  	
24	 	 	200,000 	  	 	 	3.429%  	  	 	 	August 19, 2016	  	 	 	20,306 	  	
25	 	 	100,000 	  	 	 	3.401%  	  	 	 	August 19, 2016	  	 	 	10,048 	  	
26	 	 	200,000 	  	 	 	3.500%  	  	 	 	August 30, 2016	  	 	 	20,957 	  	
27	 	 	100,000 	  	 	 	3.005%  	  	 	 	November 30, 2016	  	 	 	8,828 	  	
The Credit Facility and/or the Notes contain various covenants that limit our ability to take certain actions including, among other things, our ability to:
 
 	•	 	incur, assume or guarantee additional indebtedness;	
 
 	•	 	issue redeemable stock and preferred stock;	
 
 	•	 	repurchase capital stock;	
 
 	•	 	make restricted payments, including paying dividends and making investments;	
 
 	•	 	redeem debt that is junior in right of payment to the notes;	
 
 	•	 	create liens without securing the notes;	
 
 	•	 	sell or otherwise dispose of assets, including capital stock of subsidiaries;	
 
 	•	 	enter into agreements that restrict dividends from subsidiaries;	
 
56

Table of Contents
 	•	 	merge, consolidate, sell or otherwise dispose of substantial portions of our assets;	
 
 	•	 	enter into transactions with affiliates; and	
 
 	•	 	guarantee certain obligations.	
In addition, our Credit Facility contains restrictive covenants and requires us to maintain specified financial ratios and satisfy other financial condition tests. We were in compliance with all financial ratios and other financial condition tests at June 30, 2012, and expect to remain in compliance in the future. Our ability to meet these restrictive covenants and financial ratios and tests can be affected by events beyond our control, and we cannot assure you that we will meet those tests. A breach of any of these covenants could result in a default under our Credit Facility and/or the Notes. Upon the occurrence of an event of default under our Credit Facility or the Notes, all amounts outstanding under our Credit Facility and the Notes may become due and payable and all commitments under the Credit Facility to extend further credit may be terminated.
We believe that internally generated cash, availability for additional borrowings under our Credit Facility of $750 million (consisting of a $750 million revolving credit facility, of which $37.7 million is set aside for outstanding letters of credit as of June 30, 2012 and $5.0 million was outstanding at June 30, 2012) and our ability to amend the Credit Facility to provide for one or more tranches of term loans in an aggregate principal amount of $1.0 billion and our continued access to the bank credit and capital markets will be sufficient to finance acquisitions, capital expenditures and working capital requirements through the next 12 months. We believe these same sources of cash, borrowings under our Credit Facility as well as access to bank credit and capital markets will be available to us beyond the next 12 months and into the foreseeable future.
On May 24, 2012, we filed a universal automatic shelf registration statement on Form S-3ASR that will permit us, from time to time, in one or more public offerings, to offer debt securities, common stock, preferred stock, warrants, depositary shares, or any combination of such securities. The shelf registration statement will also permit our subsidiary, CHS, to offer debt securities that would be guaranteed by us, from time to time in one or more public offerings. The terms of any such future offerings would be established at the time of the offering.
The ratio of earnings to fixed charges is a measure of our ability to meet our fixed obligations related to our indebtedness. The following table shows the ratio of earnings to fixed charges for the six months ended June 30, 2012:

 	  	   Six Months Ended   
June 30, 2012	
 	 	
Ratio of earnings to fixed charges (1)	  	1.79 x   	

 
(1)	Fixed charges include interest expensed and capitalized during the year plus an estimate of the interest component of rent expense. There are no shares of preferred stock outstanding. See exhibit 12 filed as part of this Report for the calculation of this ratio.	
Off-balance Sheet Arrangements
Our consolidated operating results for the six months ended June 30, 2012 and 2011, included $113.3 million and $104.4 million, respectively, of net operating revenues and $15.9 million and $10.1 million, respectively, of income from operations generated from five hospitals operated by us under operating lease arrangements. In accordance with accounting principles generally accepted in the United States of America, or U.S. GAAP, the respective assets and the future lease obligations under these arrangements are not recorded on our condensed consolidated balance sheet. Lease costs under these arrangements are included in rent expense and totaled approximately $5.8 million and $6.0 million for the six months ended June 30, 2012 and 2011, respectively. The current terms of these operating leases expire between January 2013 and June 2022, not including lease extension options. If we allow these leases to expire, we would no longer generate revenue nor incur expenses from these hospitals.
In the past, we have utilized operating leases as a financing tool for obtaining the operations of specified hospitals without acquiring, through ownership, the related assets of the hospital and without a significant outlay of cash at the front end of the lease. We utilize the same operating strategies to improve operations at those hospitals held under operating leases as we do at those hospitals that we own. We have not entered into any operating leases for hospital operations since December 2000.
 
57

Table of Contents
Noncontrolling Interests
We have sold noncontrolling interests in certain of our subsidiaries or acquired subsidiaries with existing noncontrolling interest ownership positions. As of June 30, 2012, we have hospitals in 22 of the markets we serve, with noncontrolling physician ownership interests ranging from less than 1% to 40%, including one hospital that also has a non-profit entity as a partner. In addition, we have three other hospitals with noncontrolling interests owned by non-profit entities. During the three months ended March 31, 2012, one of our subsidiaries purchased the outstanding partnership interests not already owned by us that were held by physician investors in the limited partnership that owns and operates Longview Regional Medical Center in Longview, Texas. The purchase price for these partnership interests was $28.8 million. After acquiring these partnership interests, one or more of our subsidiaries collectively own 100% of the outstanding equity of the limited partnership that owns and operates this hospital. Redeemable noncontrolling interests in equity of consolidated subsidiaries was $367.9 million and $395.7 million as of June 30, 2012 and December 31, 2011, respectively. Noncontrolling interests in equity of consolidated subsidiaries was $64.7 million and $67.3 million as of June 30, 2012 and December 31, 2011, respectively. The amount of net income attributable to noncontrolling interests was $18.8 million and $18.2 million for the three months ended June 30, 2012 and 2011, respectively, and $42.6 million and $35.2 million for the six months ended June 30, 2012 and 2011, respectively. As a result of the change in the Stark Law “whole hospital” exception included in the Reform Legislation, we are not permitted to introduce physician ownership at any of our wholly-owned facilities or increase the aggregate percentage of physician ownership in any of our existing joint ventures.
Reimbursement, Legislative and Regulatory Changes
The Reform Legislation was enacted in the context of other ongoing legislative and regulatory efforts, which would reduce or otherwise adversely affect the payments we receive from Medicare and Medicaid. Within the statutory framework of the Medicare and Medicaid programs, including programs currently unaffected by the Reform Legislation, there are substantial areas subject to administrative rulings, interpretations, and discretion which may further affect payments made under those programs, and the federal and state governments might, in the future, reduce the funds available under those programs or require more stringent utilization and quality reviews of hospital facilities. Additionally, there may be a continued rise in managed care programs and additional restructuring of the financing and delivery of healthcare in the United States. These events could cause our future financial results to decline. We cannot estimate the impact of Medicare and Medicaid reimbursement changes that have been enacted or are under consideration. We cannot predict whether additional reimbursement reductions will be made or whether any such changes would have a material adverse effect on our business, financial conditions, results of operations, cash flow, capital resources and liquidity.
Inflation
The healthcare industry is labor intensive. Wages and other expenses increase during periods of inflation and when labor shortages occur in the marketplace. In addition, our suppliers pass along rising costs to us in the form of higher prices. We have implemented cost control measures, including our case and resource management program, to curb increases in operating costs and expenses. We have generally offset increases in operating costs by increasing reimbursement for services, expanding services and reducing costs in other areas. However, we cannot predict our ability to cover or offset future cost increases, particularly any increases in our cost of providing health insurance benefits to our employees as a result of the Reform Legislation.
Critical Accounting Policies
The discussion and analysis of our financial condition and results of operations are based upon our consolidated financial statements, which have been prepared in accordance with U.S. GAAP. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amount of assets and liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities at the date of our consolidated financial statements. Actual results may differ from these estimates under different assumptions or conditions.
Critical accounting policies are defined as those that are reflective of significant judgments and uncertainties, and potentially result in materially different results under different assumptions and conditions. We believe that our critical accounting policies are limited to those described below.
Third-Party Reimbursement
Net operating revenues include amounts estimated by management to be reimbursable by Medicare and Medicaid under prospective payment systems and provisions of cost-reimbursement and other payment methods. In addition, we are reimbursed by non-governmental payors using a variety of payment methodologies. Amounts we receive for treatment of patients covered by these programs are generally less than the standard billing rates. Contractual allowances are automatically calculated and recorded through our internally developed
 
58

Table of Contents
“automated contractual allowance system.” Within the automated system, actual Medicare DRG data and payors’ historical paid claims data are utilized to calculate the contractual allowances. This data is automatically updated on a monthly basis. All hospital contractual allowance calculations are subjected to monthly review by management to ensure reasonableness and accuracy. We account for the differences between the estimated program reimbursement rates and the standard billing rates as contractual allowance adjustments, which we deduct from gross revenues to arrive at net operating revenues. The process of estimating contractual allowances requires us to estimate the amount expected to be received based on payor contract provisions. The key assumption in this process is the estimated contractual reimbursement percentage, which is based on payor classification and historical paid claims data. Due to the complexities involved in these estimates, actual payments we receive could be different from the amounts we estimate and record. If the actual contractual reimbursement percentage under government programs and managed care contracts differed by 1% at June 30, 2012 from our estimated reimbursement percentage, net income for the six months ended June 30, 2012 would have changed by approximately $40.1 million, and net accounts receivable at June 30, 2012 would have changed by $64.1 million. Final settlements under some of these programs are subject to adjustment based on administrative review and audit by third parties. We account for adjustments to previous program reimbursement estimates as contractual allowance adjustments and report them in the periods that such adjustments become known. During the six months ended June 30, 2012, we recognized a net after-tax benefit of $42.8 million from the resolution of two industry-wide governmental payment updates related to prior periods. Other than this adjustment, contractual allowance adjustments related to final settlements and previous program reimbursement estimates impacted net operating revenues and net income by an insignificant amount in each of the three-month and six-month periods ended June 30, 2012 and 2011.
Allowance for Doubtful Accounts
Substantially all of our accounts receivable are related to providing healthcare services to our hospitals’ patients. Collection of these accounts receivable is our primary source of cash and is critical to our operating performance. Our primary collection risks relate to uninsured patients and outstanding patient balances for which the primary insurance payor has paid some but not all of the outstanding balance, with the remaining outstanding balance (generally deductibles and co-payments) owed by the patient. At the point of service, for patients required to make a co-payment, we generally collect less than 15% of the related revenue. For all procedures scheduled in advance, our policy is to verify insurance coverage prior to the date of the procedure. Insurance coverage is not verified in advance of procedures for walk-in and emergency room patients.
We estimate the allowance for doubtful accounts by reserving a percentage of all self-pay accounts receivable without regard to aging category, based on collection history, adjusted for expected recoveries and, if present, anticipated changes in trends. For all other non-self-pay payor categories, we reserve 100% of all accounts aging over 365 days from the date of discharge. The percentage used to reserve for all self-pay accounts is based on our collection history. We believe that we collect substantially all of our third-party insured receivables, which include receivables from governmental agencies.
Collections are impacted by the economic ability of patients to pay and the effectiveness of our collection efforts. Significant changes in payor mix, business office operations, economic conditions or trends in federal and state governmental healthcare coverage could affect our collection of accounts receivable. The process of estimating the allowance for doubtful accounts requires us to estimate the collectability of self-pay accounts receivable, which is primarily based on our collection history, adjusted for expected recoveries and, if available, anticipated changes in collection trends. Significant change in payor mix, business office operations, economic conditions, trends in federal and state governmental healthcare coverage or other third-party payors could affect our estimates of accounts receivable collectability. If the actual collection percentage differed by 1% at June 30, 2012 from our estimated collection percentage as a result of a change in expected recoveries, net income for the six months ended June 30, 2012 would have changed by $21.8 million, and net accounts receivable at June 30, 2012 would have changed by $34.8 million. We also continually review our overall reserve adequacy by monitoring historical cash collections as a percentage of trailing net revenue less provision for bad debts, as well as by analyzing current period net revenue and admissions by payor classification, aged accounts receivable by payor, days revenue outstanding and the impact of recent acquisitions and dispositions.
Our policy is to write-off gross accounts receivable if the balance is under $10.00 or when such amounts are placed with outside collection agencies. We believe this policy accurately reflects our ongoing collection efforts and is consistent with industry practices. We had approximately $2.3 billion and $2.2 billion at June 30, 2012 and December 31, 2011, respectively, being pursued by various outside collection agencies. We expect to collect less than 3%, net of estimated collection fees, of the amounts being pursued by outside collection agencies. As these amounts have been written-off, they are not included in our gross accounts receivable or our allowance for doubtful accounts. Collections on amounts previously written-off are recognized as a reduction to bad debt expense when received. However, we take into consideration estimated collections of these future amounts written-off in evaluating the reasonableness of our allowance for doubtful accounts.
All of the following information is derived from our hospitals, excluding clinics, unless otherwise noted.
Patient accounts receivable from our hospitals represent approximately 95% of our total consolidated accounts receivable.
 
59

Table of Contents
Days revenue outstanding was 58 days and 56 days at June 30, 2012 and December 31, 2011, respectively. Our target range for days revenue outstanding is 53 to 63 days.
Total gross accounts receivable (prior to allowance for contractual adjustments and doubtful accounts) was approximately $9.5 billion and $8.3 billion as of June 30, 2012 and December 31, 2011, respectively.
The approximate percentage of total gross accounts receivable (prior to allowances for contractual adjustments and doubtful accounts) summarized by payor category is as follows:

 	  	June 30,
2012	  	 	  	December 31,
2011	
 	 	 	 	 	 	
Insured receivables	  	64.3	 	%   	  	 	  	63.7	 	%   	
Self-pay receivables	  	35.7	 	%   	  	 	  	36.3	 	%   	
 	  	 	 	 	  	 	  	 	 	 	
Total	  	            100.0	 	%   	  	 	  	            100.0	 	%   	
 	  	 	 	 	  	 	  	 	 	 	
For the hospital segment, the combined total of the allowance for doubtful accounts for self-pay accounts receivable and related allowances for other self-pay discounts and contractuals, as a percentage of gross self-pay receivables, was approximately 84% at both June 30, 2012 and December 31, 2011. If the receivables that have been written-off, but where collections are still being pursued by outside collection agencies, were included in both the allowances and gross self-pay receivables specified above, the percentage of combined allowances to total self-pay receivables would have been approximately 91% at both June 30, 2012 and December 31, 2011.
Goodwill and Other Intangibles
Goodwill represents the excess of the fair value of the consideration conveyed in the acquisition over the fair value of net assets acquired. Goodwill is evaluated for impairment at the same time every year and when an event occurs or circumstances change that, more likely than not, reduce the fair value of the reporting unit below its carrying value. There is a two-step method for determining goodwill impairment. Step one is to compare the fair value of the reporting unit with the unit’s carrying amount, including goodwill. If this test indicates the fair value is less than the carrying value, then step two is required to compare the implied fair value of the reporting unit’s goodwill with the carrying value of the reporting unit’s goodwill. We have selected September 30 as our annual testing date. Based on the results of our most recent annual impairment test, we have concluded that we do not have any reporting units that are at risk of failing step one of the goodwill impairment test.
Impairment or Disposal of Long-Lived Assets
Whenever events or changes in circumstances indicate that the carrying values of certain long-lived assets may be impaired, we project the undiscounted cash flows expected to be generated by these assets. If the projections indicate that the reported amounts are not expected to be recovered, such amounts are reduced to their estimated fair value based on a quoted market price, if available, or an estimate based on valuation techniques available in the circumstances.
Professional Liability Insurance Claims
As part of our business of owning and operating hospitals, we are subject to legal actions alleging liability on our part. We accrue for losses resulting from such liability claims, as well as loss adjustment expenses that are out-of-pocket and directly related to such liability claims. These direct out-of-pocket expenses include fees of outside counsel and experts. We do not accrue for costs that are part of our corporate overhead, such as the costs of our in-house legal and risk management departments. The losses resulting from professional liability claims primarily consist of estimates for known claims, as well as estimates for incurred but not reported claims. The estimates are based on specific claim facts, our historical claim reporting and payment patterns, the nature and level of our hospital operations, and actuarially determined projections. The actuarially determined projections are based on our actual claim data, including historic reporting and payment patterns which have been gathered over approximately a 20-year period. As discussed below, since we purchase excess insurance on a claims-made basis that transfers risk to third-party insurers, the liability we accrue does include an amount for the losses covered by our excess insurance. We also record a receivable for the expected reimbursement of losses covered by our excess insurance. Since we believe that the amount and timing of our future claims payments are reliably determinable, we discount the amount we accrue for losses resulting from professional liability claims using the risk-free interest rate corresponding to the timing of our expected payments.
 
60

Table of Contents
The net present value of the projected payments was discounted using a weighted-average risk-free rate of 1.2% and 1.3% in 2011 and 2010, respectively. This liability is adjusted for new claims information in the period such information becomes known to us. Professional malpractice expense includes the losses resulting from professional liability claims and loss adjustment expense, as well as paid excess insurance premiums, and is presented within other operating expenses in the accompanying condensed consolidated statements of income.
Our processes for obtaining and analyzing claims and incident data are standardized across all of our hospitals and have been consistent for many years. We monitor the outcomes of the medical care services that we provide and for each reported claim, we obtain various information concerning the facts and circumstances related to that claim. In addition, we routinely monitor current key statistics and volume indicators in our assessment of utilizing historical trends. The average lag period between claim occurrence and payment of a final settlement is between four and five years, although the facts and circumstances of individual claims could result in the timing of such payments being different from this average. Since claims are paid promptly after settlement with the claimant is reached, settled claims represent less than 1.0% of the total liability at the end of any period.
For purposes of estimating our individual claim accruals, we utilize specific claim information, including the nature of the claim, the expected claim amount, the year in which the claim occurred and the laws of the jurisdiction in which the claim occurred. Once the case accruals for known claims are determined, information is stratified by loss layers and retentions, accident years, reported years, geography, and claims relating to the acquired Triad hospitals versus claims relating to our other hospitals. Several actuarial methods are used against this data to produce estimates of ultimate paid losses and reserves for incurred but not reported claims. Each of these methods uses our company-specific historical claims data and other information. This company-specific data includes information regarding our business, including historical paid losses and loss adjustment expenses, historical and current case loss reserves, actual and projected hospital statistical data, a variety of hospital census information, employed physician information, professional liability retentions for each policy year, geographic information and other data.
Based on these analyses, we determine our estimate of the professional liability claims. The determination of management’s estimate, including the preparation of the reserve analysis that supports such estimate, involves subjective judgment of management. Changes in reserving data or the trends and factors that influence reserving data may signal fundamental shifts in our future claim development patterns or may simply reflect single-period anomalies. Even if a change reflects a fundamental shift, the full extent of the change may not become evident until years later. Moreover, since our methods and models use different types of data and we select our liability from the results of all of these methods, we typically cannot quantify the precise impact of such factors on our estimates of the liability. Due to our standardized and consistent processes for handling claims and the long history and depth of our company-specific data, our methodologies have produced reliably determinable estimates of ultimate paid losses.
We are primarily self-insured for these claims; however, we obtain excess insurance that transfers the risk of loss to a third-party insurer for claims in excess of our self-insured retentions. Our excess insurance is underwritten on a claims-made basis. For claims reported prior to June 1, 2002, substantially all of our professional and general liability risks were subject to a $0.5 million per occurrence self-insured retention and for claims reported from June 1, 2002 through June 1, 2003, these self-insured retentions were $2.0 million per occurrence. Substantially all claims reported after June 1, 2003 and before June 1, 2005 are self-insured up to $4 million per claim. Substantially all claims reported on or after June 1, 2005 are self-insured up to $5 million per claim. Management, on occasion, has selectively increased the insured risk at certain hospitals based upon insurance pricing and other factors and may continue that practice in the future. Excess insurance for all hospitals has been purchased through commercial insurance companies and generally covers us for liabilities in excess of the self-insured retentions. The excess coverage consists of multiple layers of insurance, the sum of which totals up to $95 million per occurrence and in the aggregate for claims reported on or after June 1, 2003, up to $145 million per occurrence and in the aggregate for claims incurred and reported after January 1, 2008 and up to $195 million per occurrence and in the aggregate for claims reported after June 1, 2010. For certain policy years, if the first aggregate layer of excess coverage becomes fully utilized, then the self-insured retention could increase to $10 million per claim for any subsequent claims in that policy year until our total aggregate coverage is met.
Effective January 1, 2008, the former Triad hospitals are insured on a claims-made basis as described above and through commercial insurance companies as described above for substantially all claims occurring on or after January 1, 2002 and reported on or after January 1, 2008. Substantially all losses for the former Triad hospitals in periods prior to May 1, 1999 were insured through a wholly-owned insurance subsidiary of HCA Inc., or HCA, Triad’s owner prior to that time, and excess loss policies maintained by HCA. HCA has agreed to indemnify the former Triad hospitals in respect of claims covered by such insurance policies arising prior to May 1, 1999. From May 1, 1999 through December 31, 2006, the former Triad hospitals obtained insurance coverage on a claims incurred basis from HCA’s wholly-owned insurance subsidiary with excess coverage obtained from other carriers that is subject to certain deductibles. Effective for claims incurred after December 31, 2006, Triad began insuring its claims from $1 million to $5 million through its wholly-owned captive insurance company, replacing the coverage provided by HCA. Substantially all claims occurring during 2007 were self-insured up to $10 million per claim.
 
61

Table of Contents
There have been no significant changes in our estimate of the reserve for professional liability claims during the three and six months ended June 30, 2012.
Income Taxes
We must make estimates in recording provision for income taxes, including determination of deferred tax assets and deferred tax liabilities and any valuation allowances that might be required against the deferred tax assets. We believe that future income will enable us to realize certain deferred tax assets, subject to the valuation allowance we have established.
The total amount of unrecognized benefit that would impact the effective tax rate, if recognized, was approximately $2.0 million as of June 30, 2012. During the six months ended June 30, 2012, we increased liabilities for uncertain tax positions by $1.0 million and increased interest and penalties by approximately $0.3 million. A total of approximately $0.5 million of interest and penalties is included in the amount of liability for uncertain tax positions at June 30, 2012. It is our policy to recognize interest and penalties related to unrecognized benefits in our condensed consolidated statements of income as income tax expense.
It is possible the amount of unrecognized tax benefit could change in the next twelve months as a result of a lapse of the statute of limitations and settlements with taxing authorities; however, we do not anticipate the change will have a material impact on our consolidated results of operations or consolidated financial position.
We, or one or more of our subsidiaries, file income tax returns in the United States federal jurisdiction and various state jurisdictions. We have extended the federal statute of limitations for Triad for the tax periods ended December 31, 1999, December 31, 2000, April 30, 2001, June 30, 2001, December 31, 2001, December 31, 2002 and December 31, 2003. The IRS has concluded its examination of the federal tax return of Triad for the tax periods ended December 31, 2004, December 31, 2005, December 31, 2006 and July 25, 2007, and the statutes of limitations for those years will close on December 31, 2012. With few exceptions, we are no longer subject to state income tax examinations for years prior to 2008 and federal income tax examinations with respect to Community Health Systems, Inc. federal returns for years prior to 2007. Our federal income tax returns for the 2007, 2008, 2009 and 2010 tax years are currently under examination by the IRS. We believe the results of this examination will not be material to our consolidated results of operations or consolidated financial position. In connection with our 2007 and 2008 IRS examinations, the IRS has taken exception to the timing of our malpractice expense deductions. Management believes that our deduction timing is appropriate, and will work to resolve this item over the next 24 months. If management is unable to sustain the current timing of our deduction, then it would be subject to interest and penalty costs. Management does not consider this matter to have met the recognition criteria to be considered an uncertain tax position for which a reserve is necessary.
Recent Accounting Pronouncements
In July 2011, the FASB issued ASU 2011-07, which requires healthcare organizations that perform services for patients for which the ultimate collection of all or a portion of the amounts billed or billable cannot be determined at the time services are rendered to present all bad debt expense associated with patient service revenue as an offset to the patient service revenue line item in the statement of operations. The ASU also requires qualitative disclosures about our policy for recognizing revenue and bad debt expense for patient service transactions and quantitative information about the effects of changes in the assessment of collectibility of patient service revenue. This ASU is effective for fiscal years beginning after December 15, 2011, and was adopted by us on January 1, 2012. Upon adoption, our provision for bad debts was presented as a reduction of operating revenue after contractual adjustments and discounts.
In September 2011, the FASB issued ASU 2011-08, which modifies how entities test goodwill for impairment. Previous guidance required an entity to perform a two-step goodwill impairment test at least annually by comparing the fair value of a reporting unit with its carrying amount, including goodwill, and recording an impairment loss if the fair value is less than the carrying amount. This ASU allows an entity to first assess qualitative factors to determine whether the existence of events or circumstances leads to a determination that it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If an entity determines after that assessment that it is not more likely than not that the fair value of a reporting unit is less than its carrying amount, then performing the two-step impairment test is not required. This ASU is required to be applied to interim and annual goodwill impairment tests performed for fiscal years beginning after December 15, 2011, and was adopted by us on January 1, 2012. The adoption of this ASU is not expected to impact our consolidated financial position, results of operations or cash flows.
FORWARD-LOOKING STATEMENTS
Some of the matters discussed in this report include forward-looking statements. Statements that are predictive in nature, that depend upon or refer to future events or conditions or that include words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “estimates,” “thinks,” and similar expressions are forward-looking statements. These statements involve known and unknown risks, uncertainties, and other factors that may cause our actual results and performance to be materially different from any future results or performance expressed or implied by these forward-looking statements. These factors include the following:
 
 	•	 	general economic and business conditions, both nationally and in the regions in which we operate,	
 
62

Table of Contents
 	•	 	implementation and effect of adopted and potential federal and state healthcare legislation,	
 
 	•	 	risks associated with our substantial indebtedness, leverage and debt service obligations,	
 
 	•	 	demographic changes,	
 
 	•	 	changes in, or the failure to comply with, governmental regulations,	
 
 	•	 	potential adverse impact of known and unknown government investigations, audits, and Federal and State False Claims Act litigation and other legal proceedings,	
 
 	•	 	our ability, where appropriate, to enter into and maintain managed care provider arrangements and the terms of these arrangements,	
 
 	•	 	changes in, or the failure to comply with, managed care provider contracts could result in disputes and changes in reimbursement that could be applied retroactively,	
 
 	•	 	changes in inpatient or outpatient Medicare and Medicaid payment levels,	
 
 	•	 	increases in the amount and risk of collectability of patient accounts receivable,	
 
 	•	 	increases in wages as a result of inflation or competition for highly technical positions and rising supply costs due to market pressure from pharmaceutical companies and new product releases,	
 
 	•	 	liabilities and other claims asserted against us, including self-insured malpractice claims,	
 
 	•	 	competition,	
 
 	•	 	our ability to attract and retain, at reasonable employment costs, qualified personnel, key management, physicians, nurses and other healthcare workers,	
 
 	•	 	trends toward treatment of patients in less acute or specialty healthcare settings, including ambulatory surgery centers or specialty hospitals,	
 
 	•	 	changes in medical or other technology,	
 
 	•	 	changes in U.S. GAAP,	
 
 	•	 	the availability and terms of capital to fund additional acquisitions or replacement facilities,	
 
 	•	 	our ability to successfully acquire additional hospitals or complete divestitures,	
 
 	•	 	our ability to successfully integrate any acquired hospitals or to recognize expected synergies from such acquisitions,	
 
 	•	 	our ability to obtain adequate levels of general and professional liability insurance and	
 
 	•	 	timeliness of reimbursement payments received under government programs.	
Although we believe that these statements are based upon reasonable assumptions, we can give no assurance that our goals will be achieved. Given these uncertainties, prospective investors are cautioned not to place undue reliance on these forward-looking statements. These forward-looking statements are made as of the date of this filing. We assume no obligation to update or revise them or provide reasons why actual results may differ.
 
63

Table of Contents
Item 3.  Quantitative and Qualitative Disclosures about Market Risk
We are exposed to interest rate changes, primarily as a result of our Credit Facility which bears interest based on floating rates. In order to manage the volatility relating to the market risk, we entered into interest rate swap agreements described under the heading “Liquidity and Capital Resources” in Item 2. We utilize risk management procedures and controls in executing derivative financial instrument transactions. We do not execute transactions or hold derivative financial instruments for trading purposes. Derivative financial instruments related to interest rate sensitivity of debt obligations are used with the goal of mitigating a portion of the exposure when it is cost effective to do so. As interest rate swap agreements expire throughout the year, we will become more subject to variable interest rates during 2012.
A 1% change in interest rates on variable rate debt in excess of that amount covered by interest rate swaps would have resulted in interest expense fluctuating approximately $6.2 million and $1.6 million for the three months ended June 30, 2012 and 2011, respectively, and $9.9 million and $3.2 million for the six months ended June 30, 2012 and 2011, respectively.
Item 4.  Controls and Procedures
Our Chief Executive Officer and Chief Financial Officer, with the participation of other members of management, have evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities and Exchange Act of 1934, as amended, or the Exchange Act), as of the end of the period covered by this report. Based on such evaluations, our Chief Executive Officer and Chief Financial Officer concluded that, as of such date, our disclosure controls and procedures were effective (at the reasonable assurance level) to ensure that the information required to be included in this report has been recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms and to ensure that the information required to be included in this report was accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure.
There have been no changes in our internal control over financial reporting during the quarter ended June 30, 2012, that have materially affected or are reasonably likely to materially affect our internal control over financial reporting.
 
64

Table of Contents
PART II OTHER INFORMATION
Item 1.  Legal Proceedings
From time to time, we receive various inquiries or subpoenas from state regulators, fiscal intermediaries, the Centers for Medicare and Medicaid Services and the Department of Justice regarding various Medicare and Medicaid issues. In addition to the subpoenas discussed below, we are currently responding to subpoenas and administrative demands concerning: operations of a cardiovascular surgery department at our Oregon hospital, lab operations at a New Mexico hospital and certain cardiology procedures medical records and policies at a New Mexico hospital. In addition, we are subject to other claims and lawsuits arising in the ordinary course of our business. We are not aware of any pending or threatened litigation that is not covered by insurance policies or reserved for in our financial statements or which we believe would have a material adverse impact on us; however, some pending or threatened proceedings against us may involve potentially substantial amounts as well as the possibility of civil, criminal, or administrative fines, penalties, or other sanctions, which could be material. Settlements of suits involving Medicare and Medicaid issues routinely require both monetary payments as well as corporate integrity agreements. Additionally, qui tam or “whistleblower” actions initiated under the civil False Claims Act may be pending but placed under seal by the court to comply with the False Claims Act’s requirements for filing such suits.
Community Health Systems, Inc. Legal Proceedings
On February 10, 2006, we received a letter from the Civil Division of the Department of Justice requesting documents in an investigation it was conducting involving the Company. The inquiry related to the way in which different state Medicaid programs apply to the federal government for matching or supplemental funds that are ultimately used to pay for a small portion of the services provided to Medicaid and indigent patients. These programs are referred to by different names, including “intergovernmental payments,” “upper payment limit programs,” and “Medicaid disproportionate share hospital payments.” The February 2006 letter focused on our hospitals in three states: Arkansas, New Mexico and South Carolina. On August 31, 2006, we received a follow up letter from the Department of Justice requesting additional documents relating to the programs in New Mexico and the payments to our three hospitals in that state. Through the beginning of 2009, we provided the Department of Justice with requested documents, met with its personnel on numerous occasions and otherwise cooperated in its investigation. During the course of the investigation, the Civil Division notified us that it believed that we and these three New Mexico hospitals caused the State of New Mexico to submit improper claims for federal funds, in violation of the Federal False Claims Act. At one point, the Civil Division calculated that the three hospitals received ineligible federal participation payments from August 2000 to June 2006 of approximately $27.5 million and said that if it proceeded to trial, it would seek treble damages plus an appropriate penalty for each of the violations of the Federal False Claims Act. This investigation has culminated in the federal government’s intervention in a qui tam lawsuit styled U.S. ex rel. Baker vs. Community Health Systems, Inc., pending in the United States District Court for the District of New Mexico. The federal government filed its complaint in intervention on June 30, 2009. The relator filed a second amended complaint on July 1, 2009. Both of these complaints expand the time period during which alleged improper payments were made. We filed motions to dismiss all of the federal government’s and the relator’s claims on August 28, 2009. On March 19, 2010, the court granted in part and denied in part our motion to dismiss as to the relator’s complaint. On July 7, 2010, the court denied our motion to dismiss the federal government’s complaint in intervention. On July 21, 2010, we filed our answer and pretrial discovery began. On June 2, 2011, the relator filed a Third Amended Complaint adding subsidiaries Community Health Systems Professional Services Corporation and CHS/Community Health Systems, Inc. as defendants. On June 6, 2011, the government filed its First Amended Complaint in intervention adding Community Health Systems Professional Services Corporation as a defendant. Discovery is closed. Motions for Summary Judgment were filed on March 27, 2012 and there is currently no hearing date on the motions nor has a trial date been set. On March 30, 2012, the court denied our motion to exclude Plaintiffs’ expert witness testimony, which we believe fails to follow the controlling Medicaid statute and regulations and results in an exaggeration of the damages estimate by fourfold. We will have the opportunity to challenge the methodology employed at trial. We are vigorously defending this action.
On June 12, 2008, two of our hospitals received letters from the United States Attorney’s Office for the Western District of New York requesting documents in an investigation it was conducting into billing practices with respect to kyphoplasty procedures performed during the period January 1, 2002 through June 9, 2008. On September 16, 2008, one of our hospitals in South Carolina also received an inquiry. Kyphoplasty is a surgical spine procedure that returns a compromised vertebrae (either from trauma or osteoporotic disease process) to its previous height, reducing or eliminating severe pain. We have been informed that similar investigations have been initiated at unaffiliated facilities in Alabama, South Carolina, Indiana and other states. We believe that this investigation is related to a qui tam settlement between the same United States Attorney’s office and the manufacturer and distributor of the Kyphon product, which is used in performing the kyphoplasty procedure. We are cooperating with the investigation and we are continuing to evaluate and discuss this matter with the federal government.
 
65

Table of Contents
On April 19, 2009, we were served in Roswell, New Mexico with an answer and counterclaim in the case of Roswell Hospital Corporation d/b/a Eastern New Mexico Medical Center vs. Patrick Sisneros and Tammie McClain (sued as Jane Doe Sisneros). The case was originally filed as a collection matter. The counterclaim was filed as a putative class action and alleged theories of breach of contract, unjust enrichment, misrepresentation, prima facie tort, Fair Trade Practices Act and violation of the New Mexico RICO statute. On May 7, 2009, the hospital filed a notice of removal to federal court. On July 27, 2009, the case was remanded to state court for lack of a federal question. A motion to dismiss and a motion to dismiss misjoined counterclaim plaintiffs were filed on October 20, 2009. These motions were denied. Extensive discovery has been conducted. A motion for class certification for all uninsured patients was heard on March 3 through March 5, 2010 and on April 13, 2010, the state district court judge certified the case as a class action. Numerous hearings have been conducted to assess the sufficiency of the methodology used to determine class damages. On December 5, 2011, the court entered an order approving the suggested damages methodology. The court has now ordered that class notice be sent by April 30, 2012. A discovery cut-off date has been set for August 24, 2012 and a trial date has been set for November 27, 2012. We are vigorously defending this action.
On December 7, 2009, we received a document subpoena from the United States Department of Health and Human Services, Office of the Inspector General, or OIG, requesting documents related to our hospital in Laredo, Texas. The categories of documents requested included case management, resource management, admission criteria, patient medical records, coding, billing, compliance, the Joint Commission accreditation, physician documentation, payments to referral sources, transactions involving physicians, disproportionate share hospital status and audits by the hospital’s Quality Improvement organization. On January 22, 2010, we received a “request for information or assistance” from the OIG’s Office of Investigation requesting patient medical records from Laredo Medical Center in Laredo, Texas for certain Medicaid patients with an extended length of stay. Additional requests for records have also been received, including a request containing follow-up questions received on January 5, 2011. We continue to cooperate fully with this investigation.
On May 16, 2011, we received a subpoena dated May 10, 2011 from the Houston Office of the United States Department of Health and Human Services, OIG, requesting 71 patient medical records from our hospital in Shelbyville, Tennessee, and directing the return of the records to the Assistant United States Attorney handling the Laredo investigation. We are unaware of any connection between these two facilities other than they are both affiliated with us. We continue to cooperate fully with this investigation.
On September 20, 2010, we received a letter from the United States Department of Justice, Civil Division, advising us that an investigation is being conducted to determine whether certain hospitals have improperly submitted claims for payment for implantable cardioverter defibrillators, or ICD. The period of time covered by the investigation is 2003 to the present. The letter states that the Department of Justice’s data indicates that many of our hospitals have claims that need to be reviewed to determine if Medicare payment was appropriate. We understand that the Department of Justice has submitted similar requests to many other hospitals and hospital systems across the country as well as to the ICD manufacturers themselves. We continue to fully cooperate with the government in this investigation and have provided requested records and documents.
On November 15, 2010, we were served with substantially identical Civil Investigative Demands (CIDs) from the Office of Attorney General, State of Texas for all 18 of our affiliated Texas hospitals. The subject of the requests appears to concern emergency department procedures and billing. We have complied with these requests and are providing all documentation and reports requested. We are continuing to cooperate with the government in this investigation.
On April 8, 2011, we received a document subpoena, dated March 31, 2011, from the United States Department of Health and Human Services, OIG, in connection with an investigation of possible improper claims submitted to Medicare and Medicaid. The subpoena, issued from the OIG’s Chicago, Illinois office, requested documents from all of our hospitals and appears to concern emergency department processes and procedures, including our hospitals’ use of the Pro-MED Clinical Information System, which is a third-party software system that assists with the management of patient care and provides operational support and data collection for emergency department management and has the ability to track discharge, transfer and admission recommendations of emergency department physicians. The subpoena also requested other information about our relationships with emergency department physicians, including financial arrangements. The subpoena’s requests were very similar to those contained in the Civil Investigative Demands received by our Texas hospitals from the Office of the Attorney General of the State of Texas on November 15, 2010 (described above). This investigation is being led by the Department of Justice. We are continuing to cooperate with the government including detailing a process for a medical necessity review by clinical reviewers and physicians of a sampling of medical records at a small number of hospitals.
On April 22, 2011, a joint motion was filed by the relator and the United States Department of Justice in the case styled United States ex rel. and Reuille vs. Community Health Systems Professional Services Corporation and Lutheran Musculoskeletal Center, LLC d/b/a Lutheran Hospital, in the United States District Court for the Northern District of Indiana, Fort Wayne Division. The lawsuit was originally filed under seal on January 7, 2009. The suit is brought under the False Claims Act and alleges that Lutheran Hospital of Indiana billed the Medicare program for (a) false 23 hour observation after outpatient surgeries and procedures, and (b) intentional assignment of inpatient status to one-day stays for cases that do not meet Medicare criteria for inpatient intensity of service or severity of illness. The relator had worked in the case management department of Lutheran Hospital of Indiana but was reassigned to another
 
66

Table of Contents
department in the fall of 2006. This facility was acquired by us as part of the July 25, 2007 merger transaction with Triad Hospitals, Inc. The complaint also includes allegations of age discrimination in Ms. Reuille’s 2006 reassignment and retaliation in connection with her resignation on October 1, 2008. We had cooperated fully with the government in its investigation of this matter, but had been unaware of the exact nature of the allegations in the complaint. On December 27, 2010, the government filed a notice that it declined to intervene in this suit. The April 22, 2011 motion contained additional information about how the government intended to proceed with an investigation regarding “allegations of improper billing for inpatient care at other hospitals associated with Community Health Systems, Inc. . . . asserted in other qui tam complaints in other jurisdictions.” The motion stated that the Department of Justice has “consolidated its investigations” of the Company and other related entities and that “the Civil Division of the Department of Justice, multiple United States Attorneys’ offices, and the Office of Inspector General for the Department of Health and Human Services, or HHS, are now closely coordinating their investigation of these overlapping allegations. The Attorney General of Texas has initiated an investigation; the United States intends to work cooperatively with Texas and any other States investigating these allegations.” The motion also stated that the Office of Audit Services for the Office of Investigations for HHS has been engaged to conduct a national audit of certain of our Medicare claims. The government confirmed that it considers the allegations made in the complaint styled Tenet Healthcare Corporation vs. Community Health Systems, Inc., et al. filed in the United States District Court for the Northern District of Texas, Dallas Division on April 11, 2011 to be related to the allegations in the qui tam and to what the government is now describing as a consolidated investigation. (Because qui tam suits are filed “under seal,” no one but the relator and the government knows that the suit has been filed or what allegations are being made by the relator on behalf of the government. Initially, the government has 60 days to make a determination about whether to intervene in a case and to act as the plaintiff or to decline to intervene and allow the relator to act as the plaintiff in the suit, but extensions of time are frequently granted to allow the government additional time to investigate the allegations. Even if, in the course of an investigation, the court partially unseals a complaint to allow the government and a defendant to work to a resolution of the complaint’s allegations, the defendant is prohibited from revealing to anyone even that the partial unsealing has occurred. As the investigation proceeds, we may learn of additional qui tam suits filed against us or our affiliated hospitals or related entities, or that contact letters, document requests, or medical record requests we have received in the past from various governmental agencies are generated from qui tam cases filed under seal.) The motion filed on April 22, 2011 concluded by requesting a stay of the litigation in the Reuille case for 180 days, and on April 25, 2011, the court granted the motion. Our management company subsidiary, Community Health Systems Professional Services Corporation, the defendant in the Reuille case, consented to the request for the stay. On October 19, 2011, the government filed an application to transfer the Reuille case to the Middle District of Tennessee or for an extension of the stay for an additional 180 days. We agreed that a stay for an additional, but shorter period of time, 90 days, was appropriate, but did not consent to the transfer of the case. Our response setting forth our legal arguments was filed on October 24, 2011. On November 1, 2011, the court denied the motion to transfer the matter and extended the stay until April 30, 2012. On April 26, 2012, we joined the government and the relator in a motion to extend the stay in this case for an additional 180 days. As noted in that filing, we are working with the government on a probe audit of medical records (described above with respect to the April 2011 subpoena). The stay has been extended until October 29, 2012. We are cooperating fully with the government in its investigations.
On May 13, 2011, we received a subpoena from the SEC requesting documents related to or requested in connection with the various inquiries, lawsuits and investigations regarding, generally, emergency room admissions or observation practices at our hospitals. The subpoena also requested documents relied upon by us in responding to the Tenet litigation, as well as other communications about the Tenet litigation. As with all government investigations, we are cooperating fully with the SEC.
Three purported class action shareholder federal securities cases have been filed in the United States District Court for the Middle District of Tennessee; namely, Norfolk County Retirement System v. Community Health Systems, Inc., Wayne T. Smith and W. Larry Cash, filed May 5, 2011; De Zheng v. Community Health Systems, Inc., Wayne T. Smith and W. Larry Cash, filed May 12, 2011; and Minneapolis Firefighters Relief Association v. Community Health Systems, Inc., Wayne T. Smith, W. Larry Cash and Thomas Mark Buford, filed June 2, 2011. All three seek class certification on behalf of purchasers of our common stock between July 27, 2006 and April 11, 2011 and allege that misleading statements resulted in artificially inflated prices for our common stock. On September 20, 2011, all three were assigned to the same judge as related cases. On December 28, 2011, the court consolidated all three shareholder cases for pretrial purposes, selected NYC Funds as lead plaintiffs, and selected NYC Funds’ counsel as lead plaintiffs’ counsel. The parties negotiated operative dates for these consolidated shareholder federal securities actions. An operative consolidated complaint was filed on July 13, 2012 and a responsive pleading is due September 11, 2012.
Three purported shareholder derivative actions have also been filed in the United States District Court for the Middle District of Tennessee; Plumbers and Pipefitters Local Union No. 630 Pension Annuity Trust Fund v. Wayne T. Smith, W. Larry Cash, T. Mark Buford, John A. Clerico, James S. Ely III, John A. Fry, William Norris Jennings, Julia B. North and H. Mitchell Watson, Jr., filed May 24, 2011; Roofers Local No. 149 Pension Fund v. Wayne T. Smith, W. Larry Cash, John A. Clerico, James S. Ely, III, John A. Fry, William Norris Jennings, Julia B. North and H. Mitchell Watson, Jr., filed June 21, 2011; and Lambert Sweat v. Wayne T. Smith, W. Larry Cash, T. Mark Buford, John A. Clerico, James S. Ely, III, John A. Fry, William Norris Jennings, Julia B. North, H. Mitchell Watson, Jr. and Community Health Systems, Inc., filed October 5, 2011. These three cases allege breach of fiduciary duty arising out of allegedly improper inpatient admission practices, mismanagement, waste and unjust enrichment. On September 28, 2011, the court ordered that the Plumbers and Pipefitters Local Union No. 630 Pension Annuity Trust Fund action and the Roofers Local No. 149 Pension
 
67

Table of Contents
Fund action be consolidated for pretrial purposes, and appointed the derivative plaintiffs’ lead counsel. On November 29, 2011, the court ordered that the Lambert Sweat action be consolidated with the Plumbers and Roofers consolidated derivative actions. The Plaintiffs filed an operative amended derivative complaint in these three consolidated actions on March 15, 2012. A motion to dismiss was filed on May 14, 2012 and Plaintiffs’ response was filed on July 13, 2012. A reply is due on August 27, 2012. We believe all of these matters are without merit and will vigorously defend them.
On May 2, 2012, suit was filed in the matter styled Daniel Eagle v. Community Health Systems, Inc., Chancery Court, State of Delaware. Suit was filed under Section 220 of the Delaware General Corporation Law to inspect certain of the Company’s books and records pertaining to matters concerning alleged improper admissions practices. An answer was filed on June 25, 2012 and the matter is set for a hearing on September 27, 2012. We are vigorously defending this action.
On June 2, 2011, an order was entered unsealing a relator’s qui tam complaint in the matter of U.S. ex rel. Wood M. Deming, MD, individually and on behalf of Regional Cardiology Consultants, PC v. Jackson-Madison County General Hospital, an Affiliate of West Tennessee Healthcare, Regional Hospital of Jackson, a Division of Community Health Systems Professional Services Corporation, James Moss, individually, Timothy Puthoff, individually, Joel Perchik, MD, individually, and Elie H. Korban, MD, individually. The action is pending in the Western District of Tennessee, Jackson Division. Regional Hospital of Jackson is an affiliated hospital and Mr. Puthoff is a former chief executive officer there. The Order recited that the United States had elected to intervene to a limited degree only concerning the claims against Dr. Korban for false and fraudulent billing for allegedly unnecessary stent procedures and for causing the submission of false claims by the hospitals. The United States expressly declined to intervene in all other claims against all other named defendants. On July 28, 2011, we were served by the relator. On September 7, 2011, we filed our answer. On January 26, 2012, the relator was granted unopposed leave to file an amended complaint, which he filed on May 25, 2012. We filed an answer on June 14, 2012. We believe the claims against our hospital are without merit and we will vigorously defend this case.
On June 13, 2011, our hospital in Easton, Pennsylvania received a document subpoena from the Philadelphia office of the United States Department of Justice. The documents requested included medical records for certain urological procedures performed by a non-employed physician who is no longer on the medical staff and other records concerning the hospital’s relationship with the physician. Certain procedures performed by the physician had been previously reviewed and appropriate repayments had been made. We are cooperating fully with the government in this investigation.
On February 2, 2012, an order was entered unsealing a relator’s qui tam complaint in the matter of U.S. ex rel. Pamela Gronemeyer v. Crossroads Community Hospital. The action is pending in the United States District Court, Southern District of Illinois. Crossroads Community Hospital is an affiliated hospital. The order recited that the United States had declined to intervene in this matter. We had previously disclosed this matter in the context of our response to a subpoena concerning blood administration practices at an affiliated Illinois hospital. We were served in this case on April 18, 2012 and filed a motion to dismiss on May 31, 2012. On July 2, 2012, Plaintiff filed a response seeking permission to file a second amended complaint. We believe the claim against our hospital is without merit and we will vigorously defend this case.
On February 4, 2010, suit was filed in the matter styled Managed Care Solutions, Inc. v. Community Health Systems, Inc., United States District Court for the Southern District of Florida. Plaintiff contracted with two affiliated hospitals to provide services collecting receivables from third-party payors. Plaintiff seeks to extend the contract to additional facilities at which it never provided any services and is claiming $435 million in damages. A motion for summary judgment was filed on February 17, 2012. On June 4, 2012, the District Court affirmed the recommendation of the Magistrate Judge limiting the Plaintiff’s claims to only two hospitals. The Court also bifurcated the case with liability set to be tried on September 24, 2012. We will continue to vigorously defend this action.
On February 23, 2012, our hospital in Hattiesburg, Mississippi received a document subpoena from the United States Department of Health and Human Services, OIG relating to its relationship with Allegiance Health Management, Inc., or Allegiance, a company that provides intensive outpatient psychiatric, or IOP, services to its patients. The subpoena seeks information concerning the hospital’s financial relationship with Allegiance, medical records of patients receiving IOP services, and other documents relating to Allegiance such as agreements, policies and procedures, audits, complaints, budgets, financial analyses and identities of those delivering services. This is our only hospital that received services from this vendor. We are cooperating fully with this investigation.
On January 30, 2012, an order was entered unsealing a relator’s qui tam complaint in the matter of U.S. ex rel. Wilson v. Crestwood Healthcare LP d/b/a Crestwood Medical Center, et al., United States District Court for the Northern District of Alabama and originally filed on September 16, 2011. Co-defendant Dr. Pamela Hudson is the chief executive officer there. The matter concerns lease arrangements with the other named physician co-defendants. The government declined to intervene in this case. The hospital was served on February 21, 2012, and a motion to dismiss was filed on April 30, 2012. The motion to dismiss was granted with prejudice on May 18, 2012.
 
68

Table of Contents
On February 29, 2012, Gregg Becker, a former chief financial officer at Rockwood Clinic in Spokane, Washington, sued “Community Health Systems, Inc. d/b/a Community Health Systems Professional Services Corporation d/b/a Community Health Systems d/b/a Community Health Systems PSC, Inc. d/b/a Rockwood Clinic P.S and Rockwood Clinic, PS” in Superior Court, Spokane, Washington. On March 9, 2012, the case was removed to federal court in Spokane. Becker claims he was wrongfully terminated for allegedly refusing to certify a budget for Rockwood Clinic in 2012. On February 29, 2012, he also filed an administrative complaint with the Department of Labor, Occupational Safety and Health Administration alleging that he is a whistleblower under Sarbanes-Oxley and a response was filed on May 21, 2012. On April 5, 2012, motions to dismiss on the merits and jurisdictional grounds were filed in the civil case and are set for a hearing on July 27, 2012. We are vigorously defending this action.
Management of Significant Legal Proceedings
In accordance with our governance documents, including our Governance Guidelines and the charter of the Audit and Compliance Committee, our management of significant legal proceedings is overseen by the independent members of the Board of Directors and, in particular, the Audit and Compliance Committee. The Audit and Compliance Committee is charged with oversight of compliance, regulatory and litigation matters, and enterprise risk management. All significant legal proceedings and allegations of financial statement fraud, error, or misstatement are promptly referred to the Audit and Compliance Committee for its oversight and evaluation. Consistent with New York Stock Exchange and Sarbanes-Oxley independence requirements, the Audit and Compliance Committee is comprised entirely of individuals who are independent of Company management, and all three members of the Audit and Compliance Committee are “audit committee financial experts” as defined in the Exchange Act.
In addition, the Audit and Compliance Committee and the other independent members of the Board of Directors oversee the functions of the voluntary compliance program, including its auditing and monitoring functions and confidential disclosure program. In recent years, the voluntary compliance program has addressed the potential for a variety of billing errors that might be the subject of audits and payment denials by the CMS Recovery Audit Contractors’ permanent project, including MS-DRG coding, outpatient hospital and physician coding and billing, and medical necessity for services (including a focus on hospital stays of very short duration). Efforts by management, through the voluntary compliance program, to identify and limit risk from these government audits included significant policy and guidance revisions, training and education, and auditing. With respect to Medicare inpatient admissions, improvements in case management, including updating of inpatient medical necessity criteria, heightened focus on correct use of observation status, and new policies requiring unambiguous signed physician orders prior to billing, were all adopted in 2009 and 2010. These activities were communicated to and discussed with the Audit and Compliance Committee.
With respect to the various assertions of third parties about the Audit and Compliance Committee’s oversight:
 
 	—	 	The September 2010 allegation made by CtW Investment Group (that a high percentage of our hospitals had a high percentage of Medicare short-stay inpatient admissions, which could signal billing improprieties) was promptly referred to the Audit and Compliance Committee and an investigation was authorized and initiated with outside counsel and consultants in December 2010 (on February 15, 2012, we received a follow-up letter from CtW Investment Group that discusses the inherent limitations in using only publicly available data and points out that other factors can affect admission and length of stay patterns; the letter also concludes that CtW Investment Group is now satisfied with the commitment of the Company, its management and its Board of Directors to acting in accordance with their respective duties and obligations);	
 
 	—	 	Prior to the receipt of the civil investigative demands in Texas in November 2010, no concerns had been raised that the Pro-MED emergency department management system inappropriately caused physicians or hospitals to order tests or admit patients, and we continue to dispute that it does so; and	
 
 	—	 	The purported “observation rate” metric, which served as a basis for allegations contained in Tenet’s lawsuit, is not generally accepted in the industry and fails to account for patients who are treated and discharged promptly (i.e., neither admitted as inpatients nor placed in observation). We continue to dispute the validity of the metric in the manner used by Tenet or that the metric is a meaningful indicator of incorrect billing practices, and on March 21, 2012, Tenet’s lawsuit was dismissed in its entirety.	
Since April 2011, our Audit and Compliance Committee and/or Board of Directors has met, on average, monthly to review the status of the lawsuits and investigations relating to allegations of improper billing for inpatient care at our hospitals and to oversee management in connection with our investigation and defense of these matters. At many of those meetings, the independent members of the Board of Directors have met in separate session, first with outside counsel handling the investigations and lawsuits, and then alone, to discuss their duties and oversight of these matters. The independent members of the Board of Directors have determined that (a) the Audit and Compliance Committee is the correct and most capable group of directors to oversee these matters and, given the independence and authority of the Audit and Compliance Committee, there is no need to form a further special committee to oversee these matters, and (b) outside counsel is handling the investigation and defense of these matters in the best interests of us and our stockholders and there is no need to engage separate counsel in connection with the investigation of these matters.
 
69

Table of Contents
The independent members of our Board of Directors remain fully engaged in the oversight of these matters. We intend to provide additional updates about these matters as we are able to do so (taking into account any potential impact on these matters) through appropriate, widely-disseminated means.
Triad Hospitals, Inc. Legal Proceedings
In a case styled U.S. ex rel. Bartlett v. Quorum Health Resources, LLC, et al., pending in the Western District of Pennsylvania, Johnstown Division, the relator alleges in his second amended complaint, filed in January 2006 (the first amended complaint having been dismissed), that QHR conspired with an unaffiliated hospital to pay illegal remuneration in violation of the federal anti-kickback statute and the Stark Law, thus causing false claims to be filed. A renewed motion to dismiss was filed in March 2006 asserting that the second amended complaint did not cure the defects contained in the first amended complaint. In September 2006, the hospital and one of the other defendants affiliated with the hospital filed for protection under Chapter 11 of the federal bankruptcy code, which imposed an automatic stay on proceedings in the case. Relators entered into a settlement agreement with the hospital, subject to confirmation of the hospital’s reorganization plan. The District Court conducted a status conference on January 30, 2009 and later convened another conference on March 30, 2009 and heard arguments on whether to proceed with a motion to dismiss, but did not make a ruling. The government and relator have reached a settlement with the hospital. On March 22, 2011, the court denied all other defendants’ motions to dismiss and discovery in the case proceeded. On May 30, 2012, QHR was voluntarily dismissed from this case.
Item 1A.  Risk Factors
In addition to the risk factors disclosed under Item 1A to Part 1 of our Annual Report on Form 10-K for the fiscal year ended December 31, 2011, the following risk factor should be read carefully in connection with evaluating our business and the forward-looking information contained within our Annual Report on Form 10-K and our Quarterly Reports on Form 10-Q. Other than the update to our risk factors presented below, there have been no material changes in the risk factors previously disclosed in our Annual Report on Form 10-K.
If there are delays in regulatory updates by governmental entities to federal and state healthcare programs, we may experience increased volatility in our operating results as such delays may result in a timing difference between when such program revenues are earned and when they become known or estimable for purposes of accounting recognition.
We derive a significant amount of our net operating revenues from governmental health care programs, primarily from the Medicare and Medicaid programs. The reimbursements due to us from those programs are subject to legislative and regulatory changes that can have a significant impact on our operating results. When delays occur in the passage of regulations or legislation, there is the potential for material increases or decreases in operating revenues to be recognized in periods subsequent to when such related services were performed, resulting in the potential for a material effect on our consolidated financial position and consolidated results of operations.
Item 2.  Unregistered Sales of Equity Securities and Use of Proceeds
We have not paid any cash dividends since our inception, and do not anticipate the payment of cash dividends in the foreseeable future. Our Credit Facility limits our ability to pay dividends and/or repurchase stock to an amount not to exceed $50 million in the aggregate plus the aggregate amount of proceeds from the exercise of stock options. The indenture governing our Notes also limits our ability to pay dividends and/or repurchase stock. As of June 30, 2012, under the most restrictive test under these agreements, we have approximately $81.3 million available with which to pay permitted dividends and/or repurchase shares of stock or our Senior Notes.
Item 3.  Defaults Upon Senior Securities
None
Item 4.  Mine Safety Disclosures
None
Item 5.  Other Information
None
 
70

Table of Contents
Item 6.  Exhibits

  No.  	 	    	Description	
 	12	  	    	Computation of Ratio of Earnings to Fixed Charges	
 	31.1	  	    	Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002	
 	31.2	  	    	Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002	
 	32.1	  	    	Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002	
 	32.2	  	    	Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002	
 	101.INS	  	    	XBRL Instance Document*	
 	101.SCH	  	    	XBRL Taxonomy Extension Schema*	
 	101.CAL	  	    	XBRL Taxonomy Extension Calculation Linkbase*	
 	101.DEF	  	    	XBRL Taxonomy Extension Definition Linkbase*	
 	101.LAB	  	    	XBRL Taxonomy Extension Label Linkbase*	
 	101.PRE	  	    	XBRL Taxonomy Extension Presentation Linkbase*	

* Pursuant to applicable securities laws and regulations, we are deemed to have complied with the reporting obligation relating to the submission of interactive data files in such exhibits and are not subject to liability under any anti-fraud provisions of the federal securities laws as long as we have made a good faith attempt to comply with the submission requirements and promptly amend the interactive data files after becoming aware that the interactive data files fail to comply with the submission requirements. Users of this data are advised pursuant to Rule 406T of Regulation S-T that this interactive data file is deemed not filed or part of a registration statement or prospectus for purposes of sections 11 or 12 of the Securities Act of 1933, is deemed not filed for purposes of section 18 of the Securities Exchange Act of 1934, and otherwise is not subject to liability under these sections.
 
71

Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned thereunto duly authorized.

 	 	COMMUNITY HEALTH SYSTEMS, INC.	  	 	
 	 	                      (Registrant)	  	 	
 	 	 	 	
 	 	By:	  	/s/  Wayne T. Smith	  	 	
 	 	 	  	Wayne T. Smith	  	 	
 	 	 	  	Chairman of the Board,	  	 	
 	 	 	  	President and Chief Executive Officer	  	 	
 	 	 	  	(principal executive officer)	  	 	
 	 	 	 	
 	 	By:	  	/s/  W. Larry Cash	  	 	
 	 	 	  	W. Larry Cash	  	 	
 	 	 	  	Executive Vice President, Chief Financial	  	 	
 	 	 	  	Officer and Director	  	 	
 	 	 	  	(principal financial officer)	  	 	
 	 	 	 	
 	 	By:	  	/s/  Kevin J. Hammons	  	 	
 	 	 	  	Kevin J. Hammons	  	 	
 	 	 	  	Vice President and Chief Accounting Officer	  	 	
 	 	 	  	(principal accounting officer)	  	 	
Date: July 27, 2012
 
72

Table of Contents
Index to Exhibits

  No.  	 	    	Description	
 	12	  	    	Computation of Ratio of Earnings to Fixed Charges	
 	31.1	  	    	Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002	
 	31.2	  	    	Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002	
 	32.1	  	    	Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002	
 	32.2	  	    	Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002	
 	101.INS	  	    	XBRL Instance Document*	
 	101.SCH	  	    	XBRL Taxonomy Extension Schema*	
 	101.CAL	  	    	XBRL Taxonomy Extension Calculation Linkbase*	
 	101.DEF	  	    	XBRL Taxonomy Extension Definition Linkbase*	
 	101.LAB	  	    	XBRL Taxonomy Label Linkbase*	
 	101.PRE	  	    	XBRL Taxonomy Presentation Linkbase*	

* Pursuant to applicable securities laws and regulations, we are deemed to have complied with the reporting obligation relating to the submission of interactive data files in such exhibits and are not subject to liability under any anti-fraud provisions of the federal securities laws as long as we have made a good faith attempt to comply with the submission requirements and promptly amend the interactive data files after becoming aware that the interactive data files fail to comply with the submission requirements. Users of this data are advised pursuant to Rule 406T of Regulation S-T that this interactive data file is deemed not filed or part of a registration statement or prospectus for purposes of sections 11 or 12 of the Securities Act of 1933, is deemed not filed for purposes of section 18 of the Securities Exchange Act of 1934, and otherwise is not subject to liability under these sections.
 
73

Exhibit 12
STATEMENT RE: COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES
(DOLLARS IN THOUSANDS)

 	  	Six Months Ended	 	
 	  	June 30, 2012	 	
Earnings	  	 	 	 	
Income from continuing operations before provision for income taxes	  	$	297,223	  	
Income from equity investees	  	 	(25,194	) 	
Distributed income from equity investees	  	 	16,198	  	
Interest and amortization of deferred finance costs	  	 	303,782	  	
Amortization of capitalized interest	  	 	3,396	  	
Implicit rental interest expense	  	 	33,422	  	
 	  	 	 	 	
Total Earnings	  	$	628,827	  	

Fixed Charges	  	 	 	 	
Interest and amortization of deferred finance costs	  	$	303,782	  	
Capitalized interest	  	 	14,924	  	
Implicit rental interest expense	  	 	33,422	  	
 	  	 	 	 	
Total Fixed Charges	  	$	352,128	  	

Ratio of earnings to fixed charges	  	 	1.79x	  	

Exhibit 31.1
I, Wayne T. Smith, certify that:
1. I have reviewed this quarterly report on Form 10-Q of Community Health Systems, Inc.;
2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;
3. Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;
4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and we have:
a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared;
b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors:
a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: July 27, 2012	  	/s/ Wayne T. Smith	
 	  	Wayne T. Smith
Chairman of the Board, President and Chief Executive Officer	

Exhibit 31.2
I, W. Larry Cash, certify that:
1. I have reviewed this quarterly report on Form 10-Q of Community Health Systems, Inc.;
2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;
3. Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;
4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and we have:
a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared;
b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors:
a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: July 27, 2012	  	/s/ W. Larry Cash	
 	  	W. Larry Cash
Executive Vice President, Chief Financial Officer and Director	

Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Community Health Systems, Inc. (the “Company”) on Form 10-Q for the period ending June 30, 2012, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Wayne T. Smith, Chairman of the Board, President and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

/s/ Wayne T. Smith	
Wayne T. Smith	
Chairman of the Board, President and Chief Executive Officer	
July 27, 2012
A signed original of this written statement required by Section 906 has been provided to Community Health Systems, Inc. and will be retained by Community Health Systems, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Community Health Systems, Inc. (the “Company”) on Form 10-Q for the period ending June 30, 2012, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, W. Larry Cash, Executive Vice President, Chief Financial Officer and Director of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

/s/ W. Larry Cash	
W. Larry Cash	
Executive Vice President, Chief Financial Officer and Director	
July 27, 2012
A signed original of this written statement required by Section 906 has been provided to Community Health Systems, Inc. and will be retained by Community Health Systems, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.